<!DOCTYPE html>
<html lang="en" dir="ltr" class="client-nojs">
<head>
<meta charset="UTF-8" />
<title>Dopamine - Wikipedia, the free encyclopedia</title>
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />
<meta name="generator" content="MediaWiki 1.23wmf19" />
<link rel="alternate" href="android-app://org.wikipedia/http/en.m.wikipedia.org/wiki/Dopamine" />
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Dopamine&amp;action=edit" />
<link rel="edit" title="Edit this page" href="/w/index.php?title=Dopamine&amp;action=edit" />
<link rel="apple-touch-icon" href="//bits.wikimedia.org/apple-touch/wikipedia.png" />
<link rel="shortcut icon" href="//bits.wikimedia.org/favicon/wikipedia.ico" />
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd" />
<link rel="copyright" href="//creativecommons.org/licenses/by-sa/3.0/" />
<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
<link rel="canonical" href="http://en.wikipedia.org/wiki/Dopamine" />
<link rel="stylesheet" href="//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&amp;lang=en&amp;modules=ext.gadget.DRN-wizard%2CReferenceTooltips%2Ccharinsert%2Cteahouse%7Cext.rtlcite%2Cwikihiero%7Cext.uls.nojs%7Cext.visualEditor.viewPageTarget.noscript%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmediawiki.ui.button%7Cskins.common.interface%7Cskins.vector.styles&amp;only=styles&amp;skin=vector&amp;*" />
<meta name="ResourceLoaderDynamicStyles" content="" />
<link rel="stylesheet" href="//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&amp;lang=en&amp;modules=site&amp;only=styles&amp;skin=vector&amp;*" />
<style>a:lang(ar),a:lang(kk-arab),a:lang(mzn),a:lang(ps),a:lang(ur){text-decoration:none}
/* cache key: enwiki:resourceloader:filter:minify-css:7:3904d24a08aa08f6a68dc338f9be277e */</style>

<script src="//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&amp;lang=en&amp;modules=startup&amp;only=scripts&amp;skin=vector&amp;*"></script>
<script>if(window.mw){
mw.config.set({"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"Dopamine","wgTitle":"Dopamine","wgCurRevisionId":599801436,"wgRevisionId":599801436,"wgArticleId":48548,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["Use dmy dates from February 2014","All articles with unsourced statements","Articles with unsourced statements from June 2011","Articles with unsourced statements from November 2013","Catecholamines","Hormones of the hypothalamus","Inotropic agents","Motivation","Neurotransmitters","World Health Organization essential medicines","TAAR1 agonists"],"wgBreakFrames":false,"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgMonthNamesShort":["","Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec"],"wgRelevantPageName":"Dopamine","wgIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgWikiEditorEnabledModules":{"toolbar":true,"dialogs":true,"hidesig":true,"templateEditor":false,"templates":false,"preview":false,"previewDialog":false,"publish":false,"toc":false},"wgBetaFeaturesFeatures":[],"wgVisualEditor":{"isPageWatched":false,"magnifyClipIconURL":"//bits.wikimedia.org/static-1.23wmf19/skins/common/images/magnify-clip.png","pageLanguageCode":"en","pageLanguageDir":"ltr","svgMaxSize":2048},"wikilove-recipient":"","wikilove-anon":0,"wgGuidedTourHelpGuiderUrl":"Help:Guided tours/guider","wgFlowTermsOfUseEdit":"By saving changes, you agree to our \u003Ca class=\"external text\" href=\"//wikimediafoundation.org/wiki/Terms_of_use\"\u003ETerms of Use\u003C/a\u003E and agree to irrevocably release your text under the \u003Ca rel=\"nofollow\" class=\"external text\" href=\"//creativecommons.org/licenses/by-sa/3.0\"\u003ECC BY-SA 3.0 License\u003C/a\u003E and \u003Ca class=\"external text\" href=\"//en.wikipedia.org/wiki/Wikipedia:Text_of_the_GNU_Free_Documentation_License\"\u003EGFDL\u003C/a\u003E","wgULSAcceptLanguageList":[],"wgULSCurrentAutonym":"English","wgFlaggedRevsParams":{"tags":{"status":{"levels":1,"quality":2,"pristine":3}}},"wgStableRevisionId":null,"wgCategoryTreePageCategoryOptions":"{\"mode\":0,\"hideprefix\":20,\"showcount\":true,\"namespaces\":false}","wgNoticeProject":"wikipedia","wgWikibaseItemId":"Q170304"});
}</script><script>if(window.mw){
mw.loader.implement("user.options",function(){mw.user.options.set({"ccmeonemails":0,"cols":80,"date":"default","diffonly":0,"disablemail":0,"editfont":"default","editondblclick":0,"editsectiononrightclick":0,"enotifminoredits":0,"enotifrevealaddr":0,"enotifusertalkpages":1,"enotifwatchlistpages":0,"extendwatchlist":0,"fancysig":0,"forceeditsummary":0,"gender":"unknown","hideminor":0,"hidepatrolled":0,"imagesize":2,"math":0,"minordefault":0,"newpageshidepatrolled":0,"nickname":"","norollbackdiff":0,"numberheadings":0,"previewonfirst":0,"previewontop":1,"rcdays":7,"rclimit":50,"rememberpassword":0,"rows":25,"showhiddencats":false,"shownumberswatching":1,"showtoolbar":1,"skin":"vector","stubthreshold":0,"thumbsize":4,"underline":2,"uselivepreview":0,"usenewrc":0,"watchcreations":1,"watchdefault":0,"watchdeletion":0,"watchlistdays":3,"watchlisthideanons":0,"watchlisthidebots":0,"watchlisthideliu":0,"watchlisthideminor":0,"watchlisthideown":0,"watchlisthidepatrolled":0,"watchmoves":0,
"wllimit":250,"useeditwarning":1,"prefershttps":1,"flaggedrevssimpleui":1,"flaggedrevsstable":0,"flaggedrevseditdiffs":true,"flaggedrevsviewdiffs":false,"usebetatoolbar":1,"usebetatoolbar-cgd":1,"visualeditor-enable":0,"visualeditor-enable-experimental":0,"visualeditor-betatempdisable":0,"wikilove-enabled":1,"echo-subscriptions-web-page-review":true,"echo-subscriptions-email-page-review":false,"ep_showtoplink":false,"ep_bulkdelorgs":false,"ep_bulkdelcourses":true,"ep_showdyk":true,"echo-subscriptions-web-education-program":true,"echo-subscriptions-email-education-program":false,"echo-notify-show-link":true,"echo-show-alert":true,"echo-email-frequency":0,"echo-email-format":"html","echo-subscriptions-email-system":true,"echo-subscriptions-web-system":true,"echo-subscriptions-email-other":false,"echo-subscriptions-web-other":true,"echo-subscriptions-email-edit-user-talk":false,"echo-subscriptions-web-edit-user-talk":true,"echo-subscriptions-email-reverted":false,
"echo-subscriptions-web-reverted":true,"echo-subscriptions-email-article-linked":false,"echo-subscriptions-web-article-linked":false,"echo-subscriptions-email-mention":false,"echo-subscriptions-web-mention":true,"echo-subscriptions-web-edit-thank":true,"echo-subscriptions-email-edit-thank":false,"echo-subscriptions-web-flow-discussion":true,"echo-subscriptions-email-flow-discussion":false,"gettingstarted-task-toolbar-show-intro":true,"uls-preferences":"","language":"en","variant-gan":"gan","variant-iu":"iu","variant-kk":"kk","variant-ku":"ku","variant-shi":"shi","variant-sr":"sr","variant-tg":"tg","variant-uz":"uz","variant-zh":"zh","searchNs0":true,"searchNs1":false,"searchNs2":false,"searchNs3":false,"searchNs4":false,"searchNs5":false,"searchNs6":false,"searchNs7":false,"searchNs8":false,"searchNs9":false,"searchNs10":false,"searchNs11":false,"searchNs12":false,"searchNs13":false,"searchNs14":false,"searchNs15":false,"searchNs100":false,"searchNs101":false,"searchNs108":false,
"searchNs109":false,"searchNs118":false,"searchNs119":false,"searchNs446":false,"searchNs447":false,"searchNs710":false,"searchNs711":false,"searchNs828":false,"searchNs829":false,"gadget-teahouse":1,"gadget-ReferenceTooltips":1,"gadget-DRN-wizard":1,"gadget-charinsert":1,"gadget-mySandbox":1,"variant":"en"});},{},{});mw.loader.implement("user.tokens",function(){mw.user.tokens.set({"editToken":"+\\","patrolToken":false,"watchToken":false});},{},{});
/* cache key: enwiki:resourceloader:filter:minify-js:7:868e43d07ede2616d2d1dc3507cd8145 */
}</script>
<script>if(window.mw){
mw.loader.load(["mediawiki.page.startup","mediawiki.legacy.wikibits","mediawiki.legacy.ajax","ext.centralauth.centralautologin","skins.vector.compactPersonalBar.defaultTracking","ext.visualEditor.viewPageTarget.init","ext.uls.init","ext.uls.interface","wikibase.client.init","ext.centralNotice.bannerController","skins.vector.js"]);
}</script>
<link rel="dns-prefetch" href="//meta.wikimedia.org" /><!--[if lt IE 7]><style type="text/css">body{behavior:url("/w/static-1.23wmf19/skins/vector/csshover.min.htc")}</style><![endif]--></head>
<body class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Dopamine skin-vector action-view vector-animateLayout">
		<div id="mw-page-base" class="noprint"></div>
		<div id="mw-head-base" class="noprint"></div>
		<div id="content" class="mw-body" role="main">
			<a id="top"></a>
			<div id="mw-js-message" style="display:none;"></div>
						<div id="siteNotice"><!-- CentralNotice --></div>
						<h1 id="firstHeading" class="firstHeading" lang="en"><span dir="auto">Dopamine</span></h1>
						<div id="bodyContent">
								<div id="siteSub">From Wikipedia, the free encyclopedia</div>
								<div id="contentSub"></div>
												<div id="jump-to-nav" class="mw-jump">
					Jump to:					<a href="#mw-navigation">navigation</a>, 					<a href="#p-search">search</a>
				</div>
				<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><div class="dablink">For other uses, see <a href="/wiki/Dopamine_(disambiguation)" title="Dopamine (disambiguation)">Dopamine (disambiguation)</a>.</div>
<table class="infobox" style="width: 22em">
<caption>Dopamine</caption>
<tr>
<th colspan="2" style="text-align: center"><a href="/wiki/File:Dopamine2.svg" class="image"><img alt="Dopamine2.svg" src="//upload.wikimedia.org/wikipedia/commons/thumb/6/6c/Dopamine2.svg/200px-Dopamine2.svg.png" width="200" height="93" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/6/6c/Dopamine2.svg/300px-Dopamine2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/6c/Dopamine2.svg/400px-Dopamine2.svg.png 2x" /></a></th>
</tr>
<tr>
<th colspan="2" style="text-align: center"><a href="/wiki/File:Dopamine-3d-CPK.png" class="image"><img alt="Dopamine-3d-CPK.png" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Dopamine-3d-CPK.png/180px-Dopamine-3d-CPK.png" width="180" height="123" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Dopamine-3d-CPK.png/270px-Dopamine-3d-CPK.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Dopamine-3d-CPK.png/360px-Dopamine-3d-CPK.png 2x" /></a></th>
</tr>
<tr>
<th colspan="2" style="background-color: #ddd; text-align: center"></th>
</tr>
<tr>
<th colspan="2" style="background-color: #ddd; text-align: center">Clinical data</th>
</tr>
<tr>
<th><a href="/wiki/Regulation_of_therapeutic_goods" title="Regulation of therapeutic goods">Licence data</a></th>
<td><a href="/wiki/U.S._Food_and_Drug_Administration" title="U.S. Food and Drug Administration" class="mw-redirect">US&#160;FDA</a>:<span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&amp;SearchTerm=Dopamine&amp;SearchType=BasicSearch">link</a></span></td>
</tr>
<tr>
<th><a href="/wiki/Regulation_of_therapeutic_goods" title="Regulation of therapeutic goods">Legal status</a></th>
<td><span class="Unicode">℞</span> P<small>rescription only</small></td>
</tr>
<tr>
<th><a href="/wiki/Route_of_administration" title="Route of administration">Routes</a></th>
<td><a href="/wiki/Intravenous" title="Intravenous" class="mw-redirect">Intravenous</a> Injection</td>
</tr>
<tr>
<th colspan="2" style="background-color: #ddd; text-align: center">Pharmacokinetic data</th>
</tr>
<tr>
<th><a href="/wiki/Drug_metabolism" title="Drug metabolism">Metabolism</a></th>
<td><a href="/wiki/Aldehyde_dehydrogenase" title="Aldehyde dehydrogenase">ALDH</a>, <a href="/wiki/Monoamine_oxidase_A" title="Monoamine oxidase A">MAO-A</a>, <a href="/wiki/Monoamine_oxidase_B" title="Monoamine oxidase B">MAO-B</a>, <a href="/wiki/Catechol-O-methyl_transferase" title="Catechol-O-methyl transferase">COMT</a></td>
</tr>
<tr>
<th><a href="/wiki/Excretion" title="Excretion">Excretion</a></th>
<td>Renal</td>
</tr>
<tr>
<th colspan="2" style="background-color: #ddd; text-align: center">Identifiers</th>
</tr>
<tr>
<th><a href="/wiki/CAS_registry_number" title="CAS registry number">CAS number</a></th>
<td><span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="http://www.nlm.nih.gov/cgi/mesh/2009/MB_cgi?term=51-61-6&amp;rn=1">51-61-6</a></span><sup>&#160;<img alt="Yes" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" width="7" height="7" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" /><span style="display:none">Y</span></sup> <a class="external text" href="http://tools.wmflabs.org/magnustools/cas.php?language=en&amp;cas=62-31-7&amp;title=">62-31-7</a> (hydrochloride)</td>
</tr>
<tr>
<th><a href="/wiki/Anatomical_Therapeutic_Chemical_Classification_System" title="Anatomical Therapeutic Chemical Classification System">ATC code</a></th>
<td><a href="/wiki/ATC_code_C01" title="ATC code C01">C01</a><span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="http://www.whocc.no/atc_ddd_index/?code=C01CA04">CA04</a></span></td>
</tr>
<tr>
<th><a href="/wiki/PubChem" title="PubChem">PubChem</a></th>
<td><span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=681">CID 681</a></span></td>
</tr>
<tr>
<th><a href="/wiki/International_Union_of_Basic_and_Clinical_Pharmacology" title="International Union of Basic and Clinical Pharmacology">IUPHAR ligand</a></th>
<td><span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="http://www.iuphar-db.org/DATABASE/LigandDisplayForward?ligandId=940">940</a></span></td>
</tr>
<tr>
<th><a href="/wiki/DrugBank" title="DrugBank">DrugBank</a></th>
<td><span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="http://www.drugbank.ca/drugs/DB00988">DB00988</a></span></td>
</tr>
<tr>
<th><a href="/wiki/ChemSpider" title="ChemSpider">ChemSpider</a></th>
<td><span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="http://www.chemspider.com/Chemical-Structure.661">661</a></span><sup>&#160;<img alt="Yes" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" width="7" height="7" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" /><span style="display:none">Y</span></sup></td>
</tr>
<tr>
<th><a href="/wiki/Unique_Ingredient_Identifier" title="Unique Ingredient Identifier">UNII</a></th>
<td><span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="http://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=VTD58H1Z2X">VTD58H1Z2X</a></span><sup>&#160;<img alt="Yes" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" width="7" height="7" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" /><span style="display:none">Y</span></sup></td>
</tr>
<tr>
<th><a href="/wiki/KEGG" title="KEGG">KEGG</a></th>
<td><span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="http://www.kegg.jp/entry/D07870">D07870</a></span><sup>&#160;<img alt="Yes" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" width="7" height="7" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" /><span style="display:none">Y</span></sup></td>
</tr>
<tr>
<th><a href="/wiki/ChEBI" title="ChEBI">ChEBI</a></th>
<td><span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:18243">CHEBI:18243</a></span><sup>&#160;<img alt="Yes" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" width="7" height="7" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" /><span style="display:none">Y</span></sup></td>
</tr>
<tr>
<th><a href="/wiki/ChEMBL" title="ChEMBL">ChEMBL</a></th>
<td><span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL59">CHEMBL59</a></span><sup>&#160;<img alt="Yes" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" width="7" height="7" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" /><span style="display:none">Y</span></sup></td>
</tr>
<tr>
<th><a href="/wiki/Synonym" title="Synonym">Synonyms</a></th>
<td>2-(3,4-dihydroxyphenyl)ethylamine;<br />
3,4-dihydroxyphenethylamine;<br />
3-hydroxytyramine; DA; Intropin; Revivan; Oxytyramine</td>
</tr>
<tr>
<th colspan="2" style="background-color: #ddd; text-align: center">Chemical data</th>
</tr>
<tr>
<th><a href="/wiki/Chemical_formula" title="Chemical formula">Formula</a></th>
<td><a href="/wiki/Carbon" title="Carbon"><span style="color: rgb(000,000,000); font-weight: bold;">C</span></a><sub>8</sub><a href="/wiki/Hydrogen" title="Hydrogen"><span style="color: rgb(77,77,77); font-weight: bold;">H</span></a><sub>11</sub><a href="/wiki/Nitrogen" title="Nitrogen"><span style="color: rgb(0,0,128); font-weight: bold;">N</span></a><a href="/wiki/Oxygen" title="Oxygen"><span style="color: rgb(116,35,35); font-weight: bold;">O</span></a><sub>2</sub><sup>&#160;</sup></td>
</tr>
<tr>
<th><a href="/wiki/Molecular_mass" title="Molecular mass">Mol. mass</a></th>
<td>153.18 g/mol</td>
</tr>
<tr>
<td colspan="2">
<div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;"><a href="/wiki/International_Chemical_Identifier" title="International Chemical Identifier">InChI</a></div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;">
<li style="line-height: inherit; margin: 0">
<p style="word-wrap: break-word;">InChI=1S/C8H11NO2/c9-4-3-6-1-2-7(10)8(11)5-6/h1-2,5,10-11H,3-4,9H2<sup>&#160;<img alt="Yes" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" width="7" height="7" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" /><span style="display:none">Y</span></sup><br />
Key:VYFYYTLLBUKUHU-UHFFFAOYSA-N<sup>&#160;<img alt="Yes" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" width="7" height="7" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" /><span style="display:none">Y</span></sup></p>
</li>
</ul>
</div>
</td>
</tr>
<tr>
<th colspan="2" style="background-color: #ddd; text-align: center">Physical data</th>
</tr>
<tr>
<th><a href="/wiki/Density" title="Density">Density</a></th>
<td>1.26&#160;g/cm³</td>
</tr>
<tr>
<th><a href="/wiki/Melting_point" title="Melting point">Melt. point</a></th>
<td>128&#160;°C (262&#160;°F)</td>
</tr>
<tr>
<th colspan="2" style="background-color: #ddd; text-align: center">&#160;<img alt="Yes" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png" width="14" height="14" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/21px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/28px-Yes_check.svg.png 2x" /><span style="display:none">Y</span>&#160;<a href="/wiki/Wikipedia:WikiProject_Chemicals/Chembox_validation" title="Wikipedia:WikiProject Chemicals/Chembox validation">(what is this?)</a>&#160;&#160;<span class="reflink plainlinks nourlexpansion"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Special:ComparePages&amp;rev1=595793408&amp;page2=Dopamine">(verify)</a></span></th>
</tr>
</table>
<p><b>Dopamine</b> (or <b>3,4-<a href="/wiki/Hydroxyl" title="Hydroxyl">dihydroxy</a><a href="/wiki/Phenyl" title="Phenyl" class="mw-redirect">phen</a><a href="/wiki/Ethyl_group" title="Ethyl group">ethyl</a><a href="/wiki/Amine" title="Amine">amine</a></b>) is a <a href="/wiki/Neurohormone" title="Neurohormone">neuroendocrine transmitter</a> (i.e., a <a href="/wiki/Hormone" title="Hormone">hormone</a> and <a href="/wiki/Neurotransmitter" title="Neurotransmitter">neurotransmitter</a>) in the <a href="/wiki/Catecholamine" title="Catecholamine">catecholamine</a> and <a href="/wiki/Phenethylamine" title="Phenethylamine">phenethylamine</a> families that plays a number of important roles in the brains and bodies of humans. Its name derives from its chemical structure: it is an <a href="/wiki/Amine" title="Amine">amine</a> that is formed by removing a <a href="/wiki/C-terminus" title="C-terminus">carboxyl group</a> from a molecule of <a href="/wiki/L-DOPA" title="L-DOPA">L-DOPA</a>.</p>
<p>In the <a href="/wiki/Brain" title="Brain">brain</a>, dopamine functions as a <a href="/wiki/Neurotransmitter" title="Neurotransmitter">neurotransmitter</a>—a chemical released by nerve cells to send signals to other nerve cells. The brain includes several distinct dopamine systems, one of which plays a major role in reward-motivated behavior. Most types of reward increase the level of dopamine in the brain, and a variety of addictive drugs increase dopamine neuronal activity. Other brain dopamine systems are involved in motor control and in controlling the release of several other important hormones.</p>
<p>Several important diseases of the nervous system are associated with dysfunctions of the dopamine system. <a href="/wiki/Parkinson%27s_disease" title="Parkinson's disease">Parkinson's disease</a>, a degenerative condition causing tremor and motor impairment, is caused by loss of dopamine-secreting neurons in the midbrain area called the <a href="/wiki/Substantia_nigra" title="Substantia nigra">substantia nigra</a>. There is evidence that <a href="/wiki/Schizophrenia" title="Schizophrenia">schizophrenia</a> involves altered levels of dopamine activity, and the antipsychotic drugs that are frequently used to treat it have a primary effect of attenuating dopamine activity. <a href="/wiki/Attention_deficit_hyperactivity_disorder" title="Attention deficit hyperactivity disorder">Attention deficit hyperactivity disorder</a> (ADHD) and <a href="/wiki/Restless_legs_syndrome" title="Restless legs syndrome">restless legs syndrome</a> (RLS) are also believed to be associated with decreased dopamine activity.</p>
<p>Outside the nervous system, dopamine functions in several parts of the body as a local chemical messenger. In the blood vessels, it inhibits norepinephrine release and acts as a vasodilator; in the kidneys, it increases sodium excretion and urine output; in the pancreas, it reduces insulin production; in the digestive system, it reduces <a href="/wiki/Gastrointestinal_motility" title="Gastrointestinal motility" class="mw-redirect">gastrointestinal motility</a> and protects intestinal mucosa; and in the immune system, it reduces the activity of lymphocytes. With the exception of the blood vessels, dopamine in each of these peripheral systems has a "<a href="/wiki/Paracrine_signalling" title="Paracrine signalling">paracrine</a>" function: it is synthesized locally and exerts its effects on cells that are located near the cells that release it.</p>
<p>A variety of important drugs work by altering the way the body makes or uses dopamine. Dopamine itself is available for intravenous injection: although it cannot reach the brain from the bloodstream, its peripheral effects make it useful in the treatment of heart failure or shock, especially in newborn babies. <a href="/wiki/L-DOPA" title="L-DOPA">L-DOPA</a>, the metabolic precursor of dopamine, does reach the brain and is the most widely used treatment for Parkinson's disease. Dopaminergic stimulants can be addictive in high doses, but some are used at lower doses to treat ADHD. Conversely, many antipsychotic drugs act by suppressing the effects of dopamine. Drugs that act against dopamine by a different mechanism are also some of the most effective anti-nausea agents.</p>
<p></p>
<div id="toc" class="toc">
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Dopaminergic_systems_of_the_body"><span class="tocnumber">1</span> <span class="toctext">Dopaminergic systems of the body</span></a>
<ul>
<li class="toclevel-2 tocsection-2"><a href="#In_the_brain"><span class="tocnumber">1.1</span> <span class="toctext"> In the brain</span></a></li>
<li class="toclevel-2 tocsection-3"><a href="#Outside_the_nervous_system"><span class="tocnumber">1.2</span> <span class="toctext">Outside the nervous system</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-4"><a href="#Cellular_effects"><span class="tocnumber">2</span> <span class="toctext">Cellular effects</span></a></li>
<li class="toclevel-1 tocsection-5"><a href="#The_substantia_nigra_dopamine_system_and_motor_control"><span class="tocnumber">3</span> <span class="toctext">The substantia nigra dopamine system and motor control</span></a>
<ul>
<li class="toclevel-2 tocsection-6"><a href="#Anatomy_and_physiology"><span class="tocnumber">3.1</span> <span class="toctext">Anatomy and physiology</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-7"><a href="#The_ventral_tegmental_area.2C_reward.2C_and_cognition"><span class="tocnumber">4</span> <span class="toctext">The ventral tegmental area, reward, and cognition</span></a>
<ul>
<li class="toclevel-2 tocsection-8"><a href="#Reward"><span class="tocnumber">4.1</span> <span class="toctext">Reward</span></a>
<ul>
<li class="toclevel-3 tocsection-9"><a href="#.22Seeking.22_versus_.22liking.22"><span class="tocnumber">4.1.1</span> <span class="toctext">"Seeking" versus "liking"</span></a></li>
</ul>
</li>
<li class="toclevel-2 tocsection-10"><a href="#Role_in_cognition"><span class="tocnumber">4.2</span> <span class="toctext">Role in cognition</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-11"><a href="#Diseases_and_disorders"><span class="tocnumber">5</span> <span class="toctext">Diseases and disorders</span></a>
<ul>
<li class="toclevel-2 tocsection-12"><a href="#Parkinson.27s_disease"><span class="tocnumber">5.1</span> <span class="toctext">Parkinson's disease</span></a></li>
<li class="toclevel-2 tocsection-13"><a href="#Attention_deficit_hyperactivity_disorder"><span class="tocnumber">5.2</span> <span class="toctext">Attention deficit hyperactivity disorder</span></a></li>
<li class="toclevel-2 tocsection-14"><a href="#Drug_addiction"><span class="tocnumber">5.3</span> <span class="toctext">Drug addiction</span></a></li>
<li class="toclevel-2 tocsection-15"><a href="#Pain"><span class="tocnumber">5.4</span> <span class="toctext">Pain</span></a></li>
<li class="toclevel-2 tocsection-16"><a href="#Nausea"><span class="tocnumber">5.5</span> <span class="toctext">Nausea</span></a></li>
<li class="toclevel-2 tocsection-17"><a href="#Psychosis"><span class="tocnumber">5.6</span> <span class="toctext">Psychosis</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-18"><a href="#Comparative_biology_and_evolution"><span class="tocnumber">6</span> <span class="toctext">Comparative biology and evolution</span></a>
<ul>
<li class="toclevel-2 tocsection-19"><a href="#Microorganisms"><span class="tocnumber">6.1</span> <span class="toctext">Microorganisms</span></a></li>
<li class="toclevel-2 tocsection-20"><a href="#Animals"><span class="tocnumber">6.2</span> <span class="toctext">Animals</span></a></li>
<li class="toclevel-2 tocsection-21"><a href="#Plants"><span class="tocnumber">6.3</span> <span class="toctext">Plants</span></a></li>
<li class="toclevel-2 tocsection-22"><a href="#As_a_precursor_for_melanin"><span class="tocnumber">6.4</span> <span class="toctext">As a precursor for melanin</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-23"><a href="#Pharmacology"><span class="tocnumber">7</span> <span class="toctext">Pharmacology</span></a>
<ul>
<li class="toclevel-2 tocsection-24"><a href="#Dopamine_as_an_injectable_drug"><span class="tocnumber">7.1</span> <span class="toctext">Dopamine as an injectable drug</span></a></li>
<li class="toclevel-2 tocsection-25"><a href="#L-DOPA"><span class="tocnumber">7.2</span> <span class="toctext">L-DOPA</span></a></li>
<li class="toclevel-2 tocsection-26"><a href="#Psychomotor_stimulants"><span class="tocnumber">7.3</span> <span class="toctext">Psychomotor stimulants</span></a></li>
<li class="toclevel-2 tocsection-27"><a href="#Antipsychotic_drugs"><span class="tocnumber">7.4</span> <span class="toctext">Antipsychotic drugs</span></a></li>
<li class="toclevel-2 tocsection-28"><a href="#Toxicity"><span class="tocnumber">7.5</span> <span class="toctext">Toxicity</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-29"><a href="#Biochemical_mechanisms"><span class="tocnumber">8</span> <span class="toctext">Biochemical mechanisms</span></a>
<ul>
<li class="toclevel-2 tocsection-30"><a href="#Biosynthesis"><span class="tocnumber">8.1</span> <span class="toctext">Biosynthesis</span></a></li>
<li class="toclevel-2 tocsection-31"><a href="#Storage.2C_release.2C_and_reuptake"><span class="tocnumber">8.2</span> <span class="toctext">Storage, release, and reuptake</span></a></li>
<li class="toclevel-2 tocsection-32"><a href="#Degradation"><span class="tocnumber">8.3</span> <span class="toctext">Degradation</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-33"><a href="#Chemistry"><span class="tocnumber">9</span> <span class="toctext">Chemistry</span></a>
<ul>
<li class="toclevel-2 tocsection-34"><a href="#Oxidation"><span class="tocnumber">9.1</span> <span class="toctext">Oxidation</span></a></li>
<li class="toclevel-2 tocsection-35"><a href="#Polydopamine"><span class="tocnumber">9.2</span> <span class="toctext"> Polydopamine</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-36"><a href="#History"><span class="tocnumber">10</span> <span class="toctext">History</span></a></li>
<li class="toclevel-1 tocsection-37"><a href="#See_also"><span class="tocnumber">11</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1 tocsection-38"><a href="#References"><span class="tocnumber">12</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1 tocsection-39"><a href="#External_links"><span class="tocnumber">13</span> <span class="toctext">External links</span></a></li>
</ul>
</div>
<p></p>
<h2><span class="mw-headline" id="Dopaminergic_systems_of_the_body">Dopaminergic systems of the body</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Dopamine&amp;action=edit&amp;section=1" title="Edit section: Dopaminergic systems of the body">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<h3><span class="mw-headline" id="In_the_brain"><span id="Functions_in_the_brain"></span> In the brain</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Dopamine&amp;action=edit&amp;section=2" title="Edit section: In the brain">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Dopamine_pathways.svg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/d/de/Dopamine_pathways.svg/220px-Dopamine_pathways.svg.png" width="220" height="154" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/d/de/Dopamine_pathways.svg/330px-Dopamine_pathways.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/d/de/Dopamine_pathways.svg/440px-Dopamine_pathways.svg.png 2x" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Dopamine_pathways.svg" class="internal" title="Enlarge"><img src="//bits.wikimedia.org/static-1.23wmf19/skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Major dopamine pathways. As part of the reward pathway, dopamine is manufactured in nerve cell bodies located within the ventral tegmental area (VTA) and is released in the nucleus accumbens and the prefrontal cortex. The motor functions of dopamine are linked to a separate pathway, with cell bodies in the substantia nigra that manufacture and release dopamine into the striatum.</div>
</div>
</div>
<div class="rellink relarticle mainarticle">Main article: <a href="/wiki/Dopaminergic_pathways" title="Dopaminergic pathways">Dopaminergic pathways</a></div>
<p>Inside the brain, dopamine plays important roles in <a href="/wiki/Motor_control" title="Motor control">motor control</a>, <a href="/wiki/Motivation" title="Motivation">motivation</a>, <a href="/wiki/Arousal" title="Arousal">arousal</a>, cognition, and <a href="/wiki/Reward_system" title="Reward system">reward</a>, as well as a number of basic lower-level functions including <a href="/wiki/Prolactin#Effects" title="Prolactin">lactation</a>, <a href="/wiki/Sexual_gratification" title="Sexual gratification" class="mw-redirect">sexual gratification</a>, and <a href="/wiki/Nausea" title="Nausea">nausea</a>.</p>
<p><a href="/wiki/Dopaminergic" title="Dopaminergic">Dopaminergic</a> neurons (i.e., neurons whose primary neurotransmitter is dopamine) are comparatively few in number&#160;— a total of around 400,000 in the human brain<sup id="cite_ref-SchultzAnnRev_1-0" class="reference"><a href="#cite_note-SchultzAnnRev-1"><span>[</span>1<span>]</span></a></sup>&#160;— and their cell bodies are confined to a few relatively small brain areas, but they send projections to many other brain areas and exert powerful effects on their targets. These <a href="/wiki/Dopaminergic_cell_groups" title="Dopaminergic cell groups">dopaminergic cell groups</a> were first mapped in 1964 by Annica Dahlström and Kjell Fuxe, who assigned them labels starting with the letter "A" (for "aminergic").<sup id="cite_ref-2" class="reference"><a href="#cite_note-2"><span>[</span>2<span>]</span></a></sup> In their scheme, areas A1 through A7 contain the neurotransmitter <a href="/wiki/Norepinephrine" title="Norepinephrine">norepinephrine</a>, whereas A8 through A14 contain dopamine. Here is a list of the dopaminergic areas they identified:</p>
<ul>
<li>The <a href="/wiki/Substantia_nigra" title="Substantia nigra">substantia nigra</a>, a small midbrain area that forms a component of the <a href="/wiki/Basal_ganglia" title="Basal ganglia">basal ganglia</a>. The dopamine neurons are found mainly in a part of this structure called the <i>pars compacta</i> (cell group A8) and nearby (group A9).<sup id="cite_ref-Bjorklund_3-0" class="reference"><a href="#cite_note-Bjorklund-3"><span>[</span>3<span>]</span></a></sup> In rodents, their most important projections go to the <a href="/wiki/Striatum" title="Striatum">striatum</a>, <a href="/wiki/Globus_pallidus" title="Globus pallidus">globus pallidus</a>, and <a href="/wiki/Subthalamic_nucleus" title="Subthalamic nucleus">subthalamic nucleus</a>, all of which also belong to the basal ganglia, and play important roles in motor control. The name <i>substantia nigra</i> is Latin for "dark substance", and refers to the fact that the dopaminergic neurons there are darkly pigmented. These neurons are especially vulnerable to damage. When a large fraction of them die, the result is a <a href="/wiki/Parkinsonism" title="Parkinsonism">Parkinsonian syndrome</a>.<sup id="cite_ref-4" class="reference"><a href="#cite_note-4"><span>[</span>4<span>]</span></a></sup></li>
</ul>
<ul>
<li>The <a href="/wiki/Ventral_tegmental_area" title="Ventral tegmental area">ventral tegmental area</a> (VTA), another midbrain area. This cell group (A10) is the largest group of dopaminergic cells in the human brain, though still quite small in absolute terms. Projections from these dopaminergic neurons go to the <a href="/wiki/Nucleus_accumbens" title="Nucleus accumbens">nucleus accumbens</a> and the <a href="/wiki/Prefrontal_cortex" title="Prefrontal cortex">prefrontal cortex</a> as well as several other areas.<sup id="cite_ref-Bjorklund_3-1" class="reference"><a href="#cite_note-Bjorklund-3"><span>[</span>3<span>]</span></a></sup> These neurons play a central role in reward and other aspects of motivation. The nucleus accumbens is often considered to be the "limbic" part of the <a href="/wiki/Striatum" title="Striatum">striatum</a>. As such, it is the part of the striatum involved in the highest level aspects of motor control, which include motivation and decision-making. Thus, the role of the VTA in motivation and decision-making is structurally analogous to the role of the substantia nigra in low-level motor control.<sup id="cite_ref-DeLong_5-0" class="reference"><a href="#cite_note-DeLong-5"><span>[</span>5<span>]</span></a></sup> In primates (i.e. monkeys and humans), the dopamine neurons from the regions of the substantia nigra and VTA project throughout most of the cortical mantle, with particularly dense innervation of the motor and premotor cortices. Thus, there are major species differences in cortical dopamine projections.<sup id="cite_ref-6" class="reference"><a href="#cite_note-6"><span>[</span>6<span>]</span></a></sup></li>
</ul>
<ul>
<li>The posterior <a href="/wiki/Hypothalamus" title="Hypothalamus">hypothalamus</a>. These dopaminergic cells (group A11) project to the spinal cord, and their function is not well established. There is some evidence that pathology in this area plays a role in <a href="/wiki/Restless_legs_syndrome" title="Restless legs syndrome">restless legs syndrome</a>, a condition in which people have difficulty sleeping due to an overwhelming compulsion to constantly move parts of the body, especially the legs.<sup id="cite_ref-7" class="reference"><a href="#cite_note-7"><span>[</span>7<span>]</span></a></sup></li>
</ul>
<ul>
<li>The <a href="/wiki/Arcuate_nucleus" title="Arcuate nucleus">arcuate nucleus</a> (cell group A12) and <a href="/wiki/Periventricular_nucleus" title="Periventricular nucleus">periventricular nucleus</a> (cell group A14) of the hypothalamus. An important projection from these dopaminergic neurons goes to the <a href="/wiki/Pituitary_gland" title="Pituitary gland">pituitary gland</a>, where it influences the secretion of the hormone <a href="/wiki/Prolactin" title="Prolactin">prolactin</a>. Dopamine is the primary <a href="/wiki/Neuroendocrine" title="Neuroendocrine" class="mw-redirect">neuroendocrine</a> inhibitor of the secretion of <a href="/wiki/Prolactin" title="Prolactin">prolactin</a> from the <a href="/wiki/Anterior_pituitary" title="Anterior pituitary">anterior pituitary</a> gland. Dopamine produced by neurons in the arcuate nucleus is secreted into the <a href="/wiki/Hypophyseal_portal_system" title="Hypophyseal portal system">hypothalamo-hypophysial blood vessels</a> of the <a href="/wiki/Median_eminence" title="Median eminence">median eminence</a>, which supply the <a href="/wiki/Pituitary_gland" title="Pituitary gland">pituitary gland</a>. The lactotrope cells that produce <a href="/wiki/Prolactin" title="Prolactin">prolactin</a>, in the absence of dopamine, secrete prolactin continuously; dopamine inhibits this secretion. Thus, in the context of regulating prolactin secretion, dopamine is occasionally called prolactin-inhibiting factor (PIF), prolactin-inhibiting hormone (PIH), or prolactostatin.<sup id="cite_ref-prolactininhibition_8-0" class="reference"><a href="#cite_note-prolactininhibition-8"><span>[</span>8<span>]</span></a></sup></li>
</ul>
<ul>
<li>The <a href="/wiki/Zona_incerta" title="Zona incerta">zona incerta</a>. These cells (group A13) project to several areas of the hypothalamus, and participate in the control of <a href="/wiki/Gonadotropin-releasing_hormone" title="Gonadotropin-releasing hormone">gonadotropin-releasing hormone</a>, which is necessary to activate the development of reproductive systems that occurs following puberty, both in males and females.<sup id="cite_ref-prolactininhibition_8-1" class="reference"><a href="#cite_note-prolactininhibition-8"><span>[</span>8<span>]</span></a></sup></li>
</ul>
<p>An additional group of dopamine-secreting neurons are located in the <a href="/wiki/Retina" title="Retina">retina</a> of the eye. These neurons are <a href="/wiki/Retina_amacrine_cell" title="Retina amacrine cell">amacrine cells</a>, meaning that they have no axons. They release dopamine into the extracellular medium, and are specifically active during daylight hours, becoming silent at night. This retinal dopamine acts to enhance the activity of <a href="/wiki/Cone_cell" title="Cone cell">cone cells</a> in the retina while suppressing <a href="/wiki/Rod_cell" title="Rod cell">rod cells</a>&#160;— the result is to increase sensitivity to color and contrast during bright light conditions, at the cost of reduced sensitivity when the light is dim.<sup id="cite_ref-9" class="reference"><a href="#cite_note-9"><span>[</span>9<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Outside_the_nervous_system">Outside the nervous system</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Dopamine&amp;action=edit&amp;section=3" title="Edit section: Outside the nervous system">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Dopamine does not cross the <a href="/wiki/Blood%E2%80%93brain_barrier" title="Blood–brain barrier">blood–brain barrier</a>, so its synthesis and functions in peripheral areas are to a large degree independent of its synthesis and functions in the brain. A substantial amount of dopamine circulates in the bloodstream, but its functions there are not entirely clear. Dopamine is found in blood plasma at levels comparable to those of <a href="/wiki/Epinephrine" title="Epinephrine">epinephrine</a>, but in humans, over 95% of the dopamine in the plasma is in the form of dopamine sulphate, a conjugate produced by the enzyme <a href="/wiki/SULT1A3" title="SULT1A3">Sulfotransferase 1A3/1A4</a> acting on free dopamine. The bulk of this dopamine sulphate is produced in the <a href="/wiki/Mesentery" title="Mesentery">mesentric organs</a> that surround parts of the digestive system. The production of dopamine sulphate is thought to be a mechanism for detoxifying dopamine that is ingested as food or produced by the digestive process&#160;— plasma levels typically rise more than fifty-fold after a meal. Dopamine sulphate has no known biological functions and is excreted in urine.<sup id="cite_ref-Eisenhofer_10-0" class="reference"><a href="#cite_note-Eisenhofer-10"><span>[</span>10<span>]</span></a></sup></p>
<p>The relatively small quantity of unconjugated dopamine in the bloodstream may be produced by the <a href="/wiki/Sympathetic_nervous_system" title="Sympathetic nervous system">sympathetic nervous system</a>, the digestive system, or possibly other organs. It may act on dopamine receptors in peripheral tissues, or be metabolized, or be converted to <a href="/wiki/Norepinephrine" title="Norepinephrine">norepinephrine</a> by the enzyme <a href="/wiki/Dopamine_beta_hydroxylase" title="Dopamine beta hydroxylase" class="mw-redirect">dopamine beta hydroxylase</a>, which is released into the bloodstream by the <a href="/wiki/Adrenal_medulla" title="Adrenal medulla">adrenal medulla</a>.<sup id="cite_ref-Eisenhofer_10-1" class="reference"><a href="#cite_note-Eisenhofer-10"><span>[</span>10<span>]</span></a></sup> Some dopamine receptors are located in the walls of arteries, where they act as a <a href="/wiki/Vasodilation" title="Vasodilation">vasodilator</a> and an inhibitor of <a href="/wiki/Norepinephrine" title="Norepinephrine">norepinephrine</a> release.<sup id="cite_ref-Missale_11-0" class="reference"><a href="#cite_note-Missale-11"><span>[</span>11<span>]</span></a></sup> These responses might be activated by dopamine released from the <a href="/wiki/Carotid_body" title="Carotid body">carotid body</a> under conditions of low oxygen, but whether arterial dopamine receptors perform other biologically useful functions is not known.</p>
<p>Beyond its role in modulating blood flow, there are several peripheral systems in which dopamine circulates within a limited area and performs an <a href="/wiki/Exocrine_gland" title="Exocrine gland">exocrine</a> or <a href="/wiki/Paracrine_signalling" title="Paracrine signalling">paracrine</a> function.<sup id="cite_ref-Eisenhofer_10-2" class="reference"><a href="#cite_note-Eisenhofer-10"><span>[</span>10<span>]</span></a></sup> The peripheral systems in which dopamine plays an important role include:</p>
<ul>
<li><b>The immune system.</b> Dopamine acts upon receptors present on immune cells, especially <a href="/wiki/Lymphocyte" title="Lymphocyte">lymphocytes</a>.<sup id="cite_ref-Buttarelli_12-0" class="reference"><a href="#cite_note-Buttarelli-12"><span>[</span>12<span>]</span></a></sup> Dopamine can also affect immune cells in the <a href="/wiki/Spleen" title="Spleen">spleen</a>, <a href="/wiki/Bone_marrow" title="Bone marrow">bone marrow</a>, and <a href="/wiki/Circulatory_system" title="Circulatory system">circulatory system</a>.<sup id="cite_ref-pmid10636479_13-0" class="reference"><a href="#cite_note-pmid10636479-13"><span>[</span>13<span>]</span></a></sup> In addition, dopamine can be synthesized and released by immune cells themselves.<sup id="cite_ref-Buttarelli_12-1" class="reference"><a href="#cite_note-Buttarelli-12"><span>[</span>12<span>]</span></a></sup> The main effect of dopamine on lymphocytes is to reduce their activation level. The functional significance of this system is unclear, but it afford a possible route for interactions between the nervous system and immune system, and may be relevant to some autoimmune disorders.<sup id="cite_ref-pmid19896530_14-0" class="reference"><a href="#cite_note-pmid19896530-14"><span>[</span>14<span>]</span></a></sup></li>
</ul>
<ul>
<li><b>The kidneys.</b> Multiple types of dopamine receptors are present in cells of the <a href="/wiki/Kidney" title="Kidney">kidneys</a>. Dopamine is also synthesized there, by <a href="/wiki/Nephron" title="Nephron">tubule</a> cells, and discharged into the <a href="/wiki/Tubular_fluid" title="Tubular fluid">tubular fluid</a>. Its actions include increasing the blood supply to the kidneys, increasing filtration by the glomeruli, and increasing excretion of sodium in the urine. Defects in renal dopamine function can be produced by high blood pressure or by genetic problems, and can lead to reduced sodium excretion as well as hypertension.<sup id="cite_ref-pmid11566894_15-0" class="reference"><a href="#cite_note-pmid11566894-15"><span>[</span>15<span>]</span></a></sup></li>
</ul>
<ul>
<li><b>The pancreas.</b> The role of dopamine here is somewhat complex. The <a href="/wiki/Pancreas" title="Pancreas">pancreas</a> consists of two parts, known as <a href="/wiki/Exocrine_component_of_pancreas" title="Exocrine component of pancreas" class="mw-redirect">exocrine</a> and <a href="/wiki/Islets_of_Langerhans" title="Islets of Langerhans">endocrine</a>. The exocrine part synthesizes enzymes and other substances, and secretes them into the <a href="/wiki/Small_intestine" title="Small intestine">small intestine</a>, where food is digested. One of the substances synthesized and secreted by the exocrine pancreas is dopamine. The function of this secreted dopamine after it enters the small intestine is not clearly established&#160;— the possibilities include protecting the intestinal mucosa from damage and reducing <a href="/wiki/Gastrointestinal_motility" title="Gastrointestinal motility" class="mw-redirect">gastrointestinal motility</a> (the rate at which food moves through the intestines).<sup id="cite_ref-Rubi_16-0" class="reference"><a href="#cite_note-Rubi-16"><span>[</span>16<span>]</span></a></sup></li>
</ul>
<dl>
<dd>The endocrine part of the pancreas, also known as the <a href="/wiki/Islets_of_Langerhans" title="Islets of Langerhans">islets of Langerhans</a>, synthesizes a number of hormones, including <a href="/wiki/Insulin" title="Insulin">insulin</a>, and secretes them into the bloodstream. There is evidence that the <a href="/wiki/Beta_cell" title="Beta cell">beta cells</a> that synthesize insulin contain dopamine receptors, and that dopamine acts to reduce the amount of insulin they release. The source of their dopamine input is not clearly established&#160;— it may come from dopamine that circulates in the bloodstream and derives from the sympathetic nervous system, or it may be synthesized locally by other types of pancreatic cells.<sup id="cite_ref-Rubi_16-1" class="reference"><a href="#cite_note-Rubi-16"><span>[</span>16<span>]</span></a></sup></dd>
</dl>
<h2><span class="mw-headline" id="Cellular_effects">Cellular effects</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Dopamine&amp;action=edit&amp;section=4" title="Edit section: Cellular effects">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="rellink relarticle mainarticle">Main article: <a href="/wiki/Dopamine_receptor" title="Dopamine receptor">Dopamine receptor</a></div>
<table class="wikitable" style="float:right; text-align:center;" border="10">
<caption>Dopamine receptors in the mammal brain</caption>
<tr>
<th>Family</th>
<th>Receptor</th>
<th>Gene</th>
<th>Type</th>
<th>Mechanism</th>
</tr>
<tr>
<td rowspan="2"><a href="/wiki/D1-like_receptor" title="D1-like receptor">D1-like</a></td>
<td><a href="/wiki/Dopamine_receptor_D1" title="Dopamine receptor D1">D<sub>1</sub></a></td>
<td><i><a rel="nofollow" class="external text" href="http://www.genenames.org/data/hgnc_data.php?match=DRD1">DRD1</a></i></td>
<td rowspan="2"><a href="/wiki/Gs_alpha_subunit" title="Gs alpha subunit">G<sub>s</sub></a>-coupled.</td>
<td rowspan="2">Increase intracellular levels of <a href="/wiki/Cyclic_adenosine_monophosphate" title="Cyclic adenosine monophosphate">cAMP</a><br />
by activating <a href="/wiki/Adenylate_cyclase" title="Adenylate cyclase">adenylate cyclase</a>.</td>
</tr>
<tr>
<td><a href="/wiki/Dopamine_receptor_D5" title="Dopamine receptor D5">D<sub>5</sub></a></td>
<td><i><a rel="nofollow" class="external text" href="http://www.genenames.org/data/hgnc_data.php?match=DRD5">DRD5</a></i></td>
</tr>
<tr>
<td rowspan="3"><a href="/wiki/D2-like_receptor" title="D2-like receptor">D2-like</a></td>
<td><a href="/wiki/Dopamine_receptor_D2" title="Dopamine receptor D2">D<sub>2</sub></a></td>
<td><i><a rel="nofollow" class="external text" href="http://www.genenames.org/data/hgnc_data.php?match=DRD2">DRD2</a></i></td>
<td rowspan="3"><a href="/wiki/Gi_alpha_subunit" title="Gi alpha subunit">G<sub>i</sub>/G<sub>o</sub></a>-coupled.</td>
<td rowspan="3">Decrease intracellular levels of <a href="/wiki/Cyclic_adenosine_monophosphate" title="Cyclic adenosine monophosphate">cAMP</a><br />
by inhibiting <a href="/wiki/Adenylate_cyclase" title="Adenylate cyclase">adenylate cyclase</a>.</td>
</tr>
<tr>
<td><a href="/wiki/Dopamine_receptor_D3" title="Dopamine receptor D3">D<sub>3</sub></a></td>
<td><i><a rel="nofollow" class="external text" href="http://www.genenames.org/data/hgnc_data.php?match=DRD3">DRD3</a></i></td>
</tr>
<tr>
<td><a href="/wiki/Dopamine_receptor_D4" title="Dopamine receptor D4">D<sub>4</sub></a></td>
<td><i><a rel="nofollow" class="external text" href="http://www.genenames.org/data/hgnc_data.php?match=DRD4">DRD4</a></i></td>
</tr>
</table>
<p>Like many other biologically active substances, dopamine exerts its effects by binding to and activating <a href="/wiki/Receptor_(biochemistry)" title="Receptor (biochemistry)">receptors</a> located on the surface of cells. In mammals, five subtypes of dopamine receptors have been identified, labeled D1 through D5. All of them function as <a href="/wiki/G_protein-coupled_receptor" title="G protein-coupled receptor">G protein-coupled receptors</a>, meaning that they exert their effects via a complex <a href="/wiki/Second_messenger_system" title="Second messenger system">second messenger system</a>. Glossing over the details, dopamine receptors in mammals can be divided into two families, known as <a href="/wiki/D1-like_receptor" title="D1-like receptor">D1-like</a> and <a href="/wiki/D2-like_receptor" title="D2-like receptor">D2-like</a>. The ultimate effect of D1-like receptors (D1 and D5) can be excitation (via opening of sodium channels) or inhibition (via opening of potassium channels); the ultimate effect of D2-like receptors (D2, D3, and D4) is usually inhibition of the target neuron. Consequently, it is incorrect to describe dopamine itself as either excitatory or inhibitory. Its effect on a target neuron depends on which types of receptors are present on the membrane of that neuron and on the internal responses of that neuron to cyclic AMP. D1 receptors are the most numerous dopamine receptors in the central nervous system; D2 receptors are next; D3, D4, and D5 receptors are present at significantly lower levels.</p>
<p>The level of extracellular dopamine is modulated by two mechanisms: tonic and phasic dopamine transmission. Tonic dopamine transmission occurs when small amounts of dopamine are released independently of neuronal activity, and is regulated by the activity of other neurons and neurotransmitter reuptake.<sup id="cite_ref-17" class="reference"><a href="#cite_note-17"><span>[</span>17<span>]</span></a></sup> Phasic dopamine release results from the activity of the dopamine-containing cells themselves. This activity is characterized by irregular <a href="/wiki/Pacemaker_action_potential" title="Pacemaker action potential">pacemaking</a> activity of single spikes, and rapid bursts of typically 2–6 spikes in quick succession.<sup id="cite_ref-18" class="reference"><a href="#cite_note-18"><span>[</span>18<span>]</span></a></sup><sup id="cite_ref-19" class="reference"><a href="#cite_note-19"><span>[</span>19<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="The_substantia_nigra_dopamine_system_and_motor_control">The substantia nigra dopamine system and motor control</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Dopamine&amp;action=edit&amp;section=5" title="Edit section: The substantia nigra dopamine system and motor control">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:302px;"><a href="/wiki/File:Basal_ganglia_circuits.svg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/9/9e/Basal_ganglia_circuits.svg/300px-Basal_ganglia_circuits.svg.png" width="300" height="432" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/9/9e/Basal_ganglia_circuits.svg/450px-Basal_ganglia_circuits.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/9/9e/Basal_ganglia_circuits.svg/600px-Basal_ganglia_circuits.svg.png 2x" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Basal_ganglia_circuits.svg" class="internal" title="Enlarge"><img src="//bits.wikimedia.org/static-1.23wmf19/skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Main circuits of the <a href="/wiki/Basal_ganglia" title="Basal ganglia">basal ganglia</a>. The dopaminergic pathway from the <a href="/wiki/Substantia_nigra_pars_compacta" title="Substantia nigra pars compacta">substantia nigra pars compacta</a> to the <a href="/wiki/Striatum" title="Striatum">striatum</a> is shown in light blue.</div>
</div>
</div>
<p>The <a href="/wiki/Substantia_nigra" title="Substantia nigra">substantia nigra</a> is a component of the <a href="/wiki/Basal_ganglia" title="Basal ganglia">basal ganglia</a>, a group of interconnected structures in the forebrain and midbrain that play a central role in motor control. The precise nature of that role has been difficult to work out, but one popular line of thought describes it as "response selection". The response selection theory proposes that when a person or animal is in a situation where several behaviors are possible, activity in the basal ganglia determines which of them is executed, by releasing that response from inhibition. Thus the basal ganglia are responsible for initiating behaviors but not for determining the details of how they are carried out.</p>
<p>Dopamine is thought to modulate the response selection process in at least two important ways. First, dopamine sets the "effort threshold" for initiating behaviors. The higher the level of dopamine activity, the lower the impetus required to evoke a given behavior. As a consequence, high levels of dopamine lead to high levels of motor activity and "impulsive" behavior; low levels of dopamine lead to torpor and slowed reactions. <a href="/wiki/Parkinson%27s_disease" title="Parkinson's disease">Parkinson's disease</a>, in which dopamine levels in the <i>substantia nigra</i> circuit are greatly reduced, is characterized by stiffness and greatly reduced movement—however, when people with the disease are confronted with strong stimuli such as a serious threat, their reactions can be as vigorous as those of a healthy person. In the opposite direction, drugs that increase the effects of dopamine, such as cocaine or amphetamine, produce heightened levels of activity, including at the highest levels <a href="/wiki/Psychomotor_agitation" title="Psychomotor agitation">psychomotor agitation</a> and stereotyped movements.</p>
<p>The second important effect of dopamine is as a "teaching" signal. When a motor response is followed by an increase in dopamine activity, the basal ganglia circuit is altered in a way that makes the same response easier to evoke when similar situations arise in the future. This is a form of <a href="/wiki/Operant_conditioning" title="Operant conditioning">operant conditioning</a>, in which dopamine plays the role of a reward signal.</p>
<h3><span class="mw-headline" id="Anatomy_and_physiology">Anatomy and physiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Dopamine&amp;action=edit&amp;section=6" title="Edit section: Anatomy and physiology">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The anatomy of the basal ganglia is extraordinarily complex, and the role of dopamine there is correspondingly complex. On a macroscopic scale there is only one major dopamine projection, from the <a href="/wiki/Substantia_nigra_pars_compacta" title="Substantia nigra pars compacta">substantia nigra pars compacta</a> to the <a href="/wiki/Striatum" title="Striatum">striatum</a>, but the dopamine inputs contact multiple types of neurons and have several distinct effects on their targets, activating some via D1 receptors while inhibiting others via D2 receptors. A substantial number of dopamine inputs are delivered to the necks of <a href="/wiki/Dendritic_spine" title="Dendritic spine">dendritic spines</a>, where they are well-placed to exert a gating effect on specific synaptic connections, often arising from the cerebral cortex. There are two distinct pathways of signal flow arising from the striatum, known as the <a href="/wiki/Direct_pathway_of_movement" title="Direct pathway of movement">direct pathway</a> and <a href="/wiki/Indirect_pathway_of_movement" title="Indirect pathway of movement">indirect pathway</a>. Dopamine is thought to promote action by upregulating the direct pathway while suppressing the indirect pathway.</p>
<p>Many theoreticians believe that the mechanism underlying motor learning in the basal ganglia involves a form of <a href="/wiki/Long-term_potentiation" title="Long-term potentiation">long-term potentiation</a> that occurs in the <a href="/wiki/Striatum" title="Striatum">striatum</a> and is strongly modulated by dopamine—in other words, a mechanism by which dopamine activity induces strengthening or weakening of synaptic connections inside the striatum.<sup id="cite_ref-20" class="reference"><a href="#cite_note-20"><span>[</span>20<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="The_ventral_tegmental_area.2C_reward.2C_and_cognition">The ventral tegmental area, reward, and cognition</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Dopamine&amp;action=edit&amp;section=7" title="Edit section: The ventral tegmental area, reward, and cognition">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The <a href="/wiki/Ventral_tegmental_area" title="Ventral tegmental area">ventral tegmental area</a> (VTA) contains the largest group of dopamine neurons in the human brain. They project to numerous brain areas, but the two largest projections are the <a href="/wiki/Mesolimbic_pathway" title="Mesolimbic pathway">mesolimbic pathway</a>, which targets the <a href="/wiki/Nucleus_accumbens" title="Nucleus accumbens">nucleus accumbens</a> and other <a href="/wiki/Limbic_system" title="Limbic system">limbic</a> structures, and the <a href="/wiki/Mesocortical_pathway" title="Mesocortical pathway">mesocortical pathway</a>, which targets the <a href="/wiki/Prefrontal_cortex" title="Prefrontal cortex">prefrontal</a> and <a href="/wiki/Insular_cortex" title="Insular cortex">insular</a> parts of the cerebral cortex.</p>
<h3><span class="mw-headline" id="Reward">Reward</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Dopamine&amp;action=edit&amp;section=8" title="Edit section: Reward">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The VTA dopamine system is strongly associated with the <a href="/wiki/Reward_system" title="Reward system">reward system</a> of the brain. Dopamine is released in areas such as the <a href="/wiki/Nucleus_accumbens" title="Nucleus accumbens">nucleus accumbens</a> and <a href="/wiki/Prefrontal_cortex" title="Prefrontal cortex">prefrontal cortex</a> as a result of rewarding experiences such as food, sex, and <a href="/wiki/Neutral_stimulus" title="Neutral stimulus">neutral stimuli</a> that become <a href="/wiki/Classical_conditioning" title="Classical conditioning">associated</a> with them.<sup id="cite_ref-fn5_21-0" class="reference"><a href="#cite_note-fn5-21"><span>[</span>21<span>]</span></a></sup> The source of this dopamine is primarily the VTA, although the substantia nigra may also contribute. Electrical <a href="/wiki/Brain_stimulation_reward" title="Brain stimulation reward">stimulation of the VTA or its output pathways</a> can itself serve as a potent reward: animals will quickly learn to press a lever if it results in stimulation of dopamine release, and often will continue pressing the lever for a long time, at steadily increasing rates.<sup id="cite_ref-Wise_22-0" class="reference"><a href="#cite_note-Wise-22"><span>[</span>22<span>]</span></a></sup> A variety of drugs that increase dopamine levels are intrinsically rewarding and increase the effects of other types of reward.<sup id="cite_ref-Wise_22-1" class="reference"><a href="#cite_note-Wise-22"><span>[</span>22<span>]</span></a></sup></p>
<p>In spite of the overwhelming evidence showing a strong association between dopamine and reward, there has been a great deal of dispute about whether the function of dopamine should be described as reward <i>per se</i>, or as some more complex construct that relates strongly to reward. The difficulty arises mainly from two observations: (1) in addition to being rewarding, dopamine is also arousing&#160;— it produces a general increase in movement of all sorts; (2) dopamine release can be caused by events that do not seem to have anything to do with reward, most notably pain. One of the most popular alternatives to the reward theory is the "<a href="/wiki/Incentive_salience" title="Incentive salience">incentive salience</a>" theory, which argues that the function of dopamine is to increase the effects of motivators of all sorts, both positive and negative.<sup id="cite_ref-Schultz_23-0" class="reference"><a href="#cite_note-Schultz-23"><span>[</span>23<span>]</span></a></sup></p>
<p>A substantial body of evidence suggests that dopamine encodes not reward itself, but rather <i>reward prediction error</i>, that is, the degree to which reward is surprising. According to this hypothesis, which derives initially from recordings made by <a href="/w/index.php?title=Wolfram_Schultz&amp;action=edit&amp;redlink=1" class="new" title="Wolfram Schultz (page does not exist)">Wolfram Schultz</a>, rewards that are expected do not produce any activation of dopamine cells, but rewards that are greater than expected produce a short-lasting increase in dopamine, whereas the omission of an expected reward actually causes dopamine release to drop below its ordinary background level. The "prediction error" hypothesis has drawn particular interest from computational neuroscientists, because an influential computational-learning method known as <a href="/wiki/Temporal_difference_learning" title="Temporal difference learning">temporal difference learning</a> makes heavy use of a signal that encodes prediction error. This confluence of theory and data has led to a fertile interaction between theoretical and empirical neuroscientists.<sup id="cite_ref-Schultz_23-1" class="reference"><a href="#cite_note-Schultz-23"><span>[</span>23<span>]</span></a></sup></p>
<p>Recent research finds that while some dopaminergic neurons react in the way expected of reward neurons, others do not and seem to respond in regard to salience, including aversive stimuli.<sup id="cite_ref-Matsumoto_24-0" class="reference"><a href="#cite_note-Matsumoto-24"><span>[</span>24<span>]</span></a></sup> This research finds the reward neurons predominate in the ventromedial region of the <a href="/wiki/Pars_compacta" title="Pars compacta" class="mw-redirect">substantia nigra pars compacta</a>, as well as in the <a href="/wiki/Ventral_tegmental_area" title="Ventral tegmental area">ventral tegmental area</a>. Neurons in these areas project mainly to the <a href="/wiki/Ventral_striatum" title="Ventral striatum">ventral striatum</a> and thus might transmit value-related information in regard to reward values.<sup id="cite_ref-Matsumoto_24-1" class="reference"><a href="#cite_note-Matsumoto-24"><span>[</span>24<span>]</span></a></sup> The salience neurons are predominate in the dorsolateral area of the substantia nigra pars compacta which projects to the dorsal <a href="/wiki/Striatum" title="Striatum">striatum</a> and may relate to orienting behaviour.<sup id="cite_ref-Matsumoto_24-2" class="reference"><a href="#cite_note-Matsumoto-24"><span>[</span>24<span>]</span></a></sup> It has been suggested that the difference between these two types of dopaminergic neurons arises from their input: reward-linked ones have input from the <a href="/wiki/Basal_forebrain" title="Basal forebrain">basal forebrain</a>, while the salience-related ones from the <a href="/wiki/Habenula#Lateral_habenula" title="Habenula">lateral habenula</a>.<sup id="cite_ref-Matsumoto_24-3" class="reference"><a href="#cite_note-Matsumoto-24"><span>[</span>24<span>]</span></a></sup> In primates, neurons from the regions of both the substantia nigra and VTA project to the prefrontal cortex;<sup id="cite_ref-Williams_25-0" class="reference"><a href="#cite_note-Williams-25"><span>[</span>25<span>]</span></a></sup> the origins of the dopamine innervation of other cortical areas in primate have not been studied. It has been appreciated for many years that exposure to even mild, uncontrollable stress increases dopamine release in the rodent prefrontal cortex, e.g. reviewed in,<sup id="cite_ref-Deutch_26-0" class="reference"><a href="#cite_note-Deutch-26"><span>[</span>26<span>]</span></a></sup> suggesting that dopamine salience cells have a large influence on this cortical region.</p>
<h4><span class="mw-headline" id=".22Seeking.22_versus_.22liking.22">"Seeking" versus "liking"</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Dopamine&amp;action=edit&amp;section=9" title="Edit section: &quot;Seeking&quot; versus &quot;liking&quot;">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p><a href="/wiki/Kent_C._Berridge" title="Kent C. Berridge">Kent Berridge</a> and other researchers have argued for a distinction between reward, which is defined in terms of motivation, and pleasure, which is defined in terms of emotional expression. A simpler way of describing this is as a distinction between "seeking" and "liking". "Seeking" occurs when an animal, given access to some stimulus such as food, executes some type of active behavior in order to acquire it. "Liking" occurs when an animal shows expressions of happiness or satisfaction while consuming something. There is considerable evidence that the dopamine system is part of the brain system that mediates seeking but not part of the system that mediates liking. Drugs that increase the effects of dopamine (most notably stimulants such as methamphetamine or cocaine) produce corresponding increases in seeking behaviors, but do not greatly alter expressions of pleasure. Conversely, opiate drugs such as heroin or morphine produce increases in expressions of pleasure but do not greatly alter seeking behaviors. Animals in which the VTA dopamine system has been rendered inactive do not seek food, and will starve to death if left to themselves, but if food is placed in their mouths they will consume it and show facial expressions indicative of pleasure.<sup id="cite_ref-fn5_21-1" class="reference"><a href="#cite_note-fn5-21"><span>[</span>21<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Role_in_cognition">Role in cognition</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Dopamine&amp;action=edit&amp;section=10" title="Edit section: Role in cognition">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Dopamine's effects on higher cognitive function have been studied in monkeys and rodents. This work began with the landmark study of Brozoski et al., 1979 showing that depletion of catecholamines from the dorsolateral prefrontal cortex in monkeys impaired spatial working memory to the same degree as removing the cortex itself.<sup id="cite_ref-Brozoski_27-0" class="reference"><a href="#cite_note-Brozoski-27"><span>[</span>27<span>]</span></a></sup> It is now known that both dopamine and norepinephrine have essential actions on prefrontal cortical function, and help coordinate cognitive state with arousal state.<sup id="cite_ref-Arnsten_28-0" class="reference"><a href="#cite_note-Arnsten-28"><span>[</span>28<span>]</span></a></sup> Dopamine has an "inverted U" influence on prefrontal function through its actions on D1 receptors, where either too little or too much impairs working memory function.<sup id="cite_ref-Vijayraghavan_29-0" class="reference"><a href="#cite_note-Vijayraghavan-29"><span>[</span>29<span>]</span></a></sup> In the primate prefrontal cortex, dopamine D1 receptor stimulation selectively influences the firing of "Delay" cells (also called "Memory" cells), while dopamine D2 receptors selectively alter the firing of "Response cells".<sup id="cite_ref-Wang_30-0" class="reference"><a href="#cite_note-Wang-30"><span>[</span>30<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Diseases_and_disorders">Diseases and disorders</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Dopamine&amp;action=edit&amp;section=11" title="Edit section: Diseases and disorders">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The dopamine system plays a central role in a number of important medical conditions, including Parkinson's disease, attention deficit hyperactivity disorder, schizophrenia, and drug addiction.</p>
<h3><span class="mw-headline" id="Parkinson.27s_disease">Parkinson's disease</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Dopamine&amp;action=edit&amp;section=12" title="Edit section: Parkinson's disease">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a href="/wiki/Parkinson%27s_disease" title="Parkinson's disease">Parkinson's disease</a> is a disorder characterized by stiffness of the body, slowing of movement, and trembling of limbs when they are not in use. In advanced stages it progresses to dementia and eventually death. The main symptoms are caused by massive loss of dopamine-secreting cells in the <a href="/wiki/Substantia_nigra" title="Substantia nigra">substantia nigra</a>. These dopamine cells are especially vulnerable to damage, and a variety of insults, including <a href="/wiki/Encephalitis" title="Encephalitis">encephalitis</a> (as depicted in the book and movie "<a href="/wiki/Awakenings" title="Awakenings">Awakenings</a>"), repeated sports-related <a href="/wiki/Concussion" title="Concussion">concussions</a>, and some forms of chemical poisoning (ex. <a href="/wiki/MPTP" title="MPTP">MPTP</a>), can lead to substantial cell loss, producing a <a href="/wiki/Parkinsonism" title="Parkinsonism">Parkinsonian syndrome</a> that is similar in its main features to Parkinson's disease. Most cases of Parkinson's disease, however, are "idiopathic", meaning that the cause of cell death cannot be identified.</p>
<p>The most widely used treatment for Parkinsonism is administration of <a href="/wiki/L-DOPA" title="L-DOPA">L-DOPA</a>, the metabolic precursor for dopamine. This treatment cannot restore the dopamine cells that have been lost, but it causes the remaining cells to produce more dopamine, thereby compensating for the loss to at least some degree. In advanced stages the treatment begins to fail because the cell loss is so severe that the remaining ones cannot produce enough dopamine regardless of L-DOPA levels. As this stage is approached, the metabolic regulatory mechanisms in the dopamine cells, operating far above their normal level, become erratic, producing <a href="/wiki/Dopamine_dysregulation_syndrome" title="Dopamine dysregulation syndrome">dopamine dysregulation syndrome</a>, in which patients fluctuate unpredictably between states of hyperactivity and paralysis.<sup id="cite_ref-pmid17988927_31-0" class="reference"><a href="#cite_note-pmid17988927-31"><span>[</span>31<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Attention_deficit_hyperactivity_disorder">Attention deficit hyperactivity disorder</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Dopamine&amp;action=edit&amp;section=13" title="Edit section: Attention deficit hyperactivity disorder">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Altered dopamine neurotransmission is implicated in <a href="/wiki/Attention_deficit_hyperactivity_disorder" title="Attention deficit hyperactivity disorder">attention deficit hyperactivity disorder</a> (ADHD), a condition associated with impaired ability to regulate attention, behavior, and/or impulses. There are some genetic links between dopamine receptors, the dopamine transporter and ADHD,<sup id="cite_ref-32" class="reference"><a href="#cite_note-32"><span>[</span>32<span>]</span></a></sup> in addition to links to other neurotransmitter receptors and transporters. The most important relationship between dopamine and ADHD involves the drugs that are used to treat ADHD. Some of the most effective therapeutic agents for ADHD are psychostimulants such as <a href="/wiki/Methylphenidate" title="Methylphenidate">methylphenidate</a> (Ritalin) and <a href="/wiki/Amphetamine" title="Amphetamine">amphetamine</a>, drugs that increase both dopamine and norepinephrine levels in brain.<sup id="cite_ref-33" class="reference"><a href="#cite_note-33"><span>[</span>33<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Drug_addiction">Drug addiction</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Dopamine&amp;action=edit&amp;section=14" title="Edit section: Drug addiction">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Current models of addiction from chronic drug use involve alterations in <a href="/wiki/Gene_expression" title="Gene expression">gene expression</a> in the nucleus accumbens, in turn affecting dopaminergic neurotransmission.<sup id="cite_ref-Nestler.2C_Hyman.2C_and_Malenka_2_34-0" class="reference"><a href="#cite_note-Nestler.2C_Hyman.2C_and_Malenka_2-34"><span>[</span>34<span>]</span></a></sup><sup id="cite_ref-Nestler_35-0" class="reference"><a href="#cite_note-Nestler-35"><span>[</span>35<span>]</span></a></sup> The most important <a href="/wiki/Transcription_factor" title="Transcription factor">transcription factors</a> that produce these alterations are <a href="/wiki/%CE%94FosB" title="ΔFosB" class="mw-redirect">ΔFosB</a>, <a href="/wiki/CAMP_response_element_binding_protein" title="CAMP response element binding protein" class="mw-redirect">cyclic adenosine monophosphate (cAMP) response element binding protein</a> (CREB), and <a href="/wiki/Nuclear_factor_kappa_B" title="Nuclear factor kappa B" class="mw-redirect">nuclear factor kappa B</a> (NFκB).<sup id="cite_ref-Nestler_35-1" class="reference"><a href="#cite_note-Nestler-35"><span>[</span>35<span>]</span></a></sup> ΔFosB is the most significant among these, since its overexpression in the <a href="/wiki/Nucleus_accumbens" title="Nucleus accumbens">nucleus accumbens</a> is <a href="/wiki/Necessary_and_sufficient" title="Necessary and sufficient" class="mw-redirect">necessary and sufficient</a> for many of the neural adaptations seen in drug addiction;<sup id="cite_ref-Nestler_35-2" class="reference"><a href="#cite_note-Nestler-35"><span>[</span>35<span>]</span></a></sup> it has been implicated in addictions to many types of drugs, including <a href="/wiki/Cannabinoid" title="Cannabinoid">cannabinoids</a>, <a href="/wiki/Cocaine" title="Cocaine">cocaine</a>, <a href="/wiki/Nicotine" title="Nicotine">nicotine</a>, <a href="/wiki/Phenylcyclidine" title="Phenylcyclidine" class="mw-redirect">phenylcyclidine</a>, and <a href="/wiki/Substituted_amphetamines" title="Substituted amphetamines" class="mw-redirect">substituted amphetamines</a>.<sup id="cite_ref-Nestler.2C_Hyman.2C_and_Malenka_2_34-1" class="reference"><a href="#cite_note-Nestler.2C_Hyman.2C_and_Malenka_2-34"><span>[</span>34<span>]</span></a></sup><sup id="cite_ref-Nestler_35-3" class="reference"><a href="#cite_note-Nestler-35"><span>[</span>35<span>]</span></a></sup> <a href="/wiki/%CE%94JunD" title="ΔJunD" class="mw-redirect">ΔJunD</a> is the transcription factor which directly opposes ΔFosB.<sup id="cite_ref-Nestler_35-4" class="reference"><a href="#cite_note-Nestler-35"><span>[</span>35<span>]</span></a></sup> Increases in nucleus accumbens ΔJunD expression can reduce or, with a large increase, even block most of the neural alterations seen in chronic drug abuse (i.e., the alterations mediated by ΔFosB).<sup id="cite_ref-Nestler_35-5" class="reference"><a href="#cite_note-Nestler-35"><span>[</span>35<span>]</span></a></sup> ΔFosB also plays an important role in regulating behavioral responses to natural rewards, such as palatable food, sex, and exercise.<sup id="cite_ref-Nestler.2C_Hyman.2C_and_Malenka_2_34-2" class="reference"><a href="#cite_note-Nestler.2C_Hyman.2C_and_Malenka_2-34"><span>[</span>34<span>]</span></a></sup><sup id="cite_ref-Nestler_35-6" class="reference"><a href="#cite_note-Nestler-35"><span>[</span>35<span>]</span></a></sup> Since natural rewards, like drugs of abuse, induce ΔFosB, chronic acquisition of these rewards can result in a similar pathological addictive state.<sup id="cite_ref-Nestler.2C_Hyman.2C_and_Malenka_2_34-3" class="reference"><a href="#cite_note-Nestler.2C_Hyman.2C_and_Malenka_2-34"><span>[</span>34<span>]</span></a></sup><sup id="cite_ref-Nestler_35-7" class="reference"><a href="#cite_note-Nestler-35"><span>[</span>35<span>]</span></a></sup> ΔFosB <a href="/wiki/Antagonist" title="Antagonist">antagonists</a> (drugs that oppose its action) may be an effective treatment for addiction and addictive disorders.<sup id="cite_ref-Malenka_2009_04_36-0" class="reference"><a href="#cite_note-Malenka_2009_04-36"><span>[</span>36<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Pain">Pain</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Dopamine&amp;action=edit&amp;section=15" title="Edit section: Pain">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Dopamine has been demonstrated to play a role in <a href="/wiki/Pain" title="Pain">pain</a> processing in multiple levels of the <a href="/wiki/Central_nervous_system" title="Central nervous system">central nervous system</a> including the <a href="/wiki/Spinal_cord" title="Spinal cord">spinal cord</a>, <a href="/wiki/Periaqueductal_gray" title="Periaqueductal gray">periaqueductal gray</a> (PAG), <a href="/wiki/Thalamus" title="Thalamus">thalamus</a>, <a href="/wiki/Basal_ganglia" title="Basal ganglia">basal ganglia</a>, and <a href="/wiki/Cingulate_cortex" title="Cingulate cortex">cingulate cortex</a>. Accordingly, decreased levels of dopamine have been associated with painful symptoms that frequently occur in <a href="/wiki/Parkinson%27s_disease" title="Parkinson's disease">Parkinson's disease</a>. Abnormalities in dopaminergic neurotransmission have also been demonstrated in painful clinical conditions, including <a href="/wiki/Burning_mouth_syndrome" title="Burning mouth syndrome">burning mouth syndrome</a>,<sup id="cite_ref-pmid11207397_37-0" class="reference"><a href="#cite_note-pmid11207397-37"><span>[</span>37<span>]</span></a></sup> <a href="/wiki/Fibromyalgia" title="Fibromyalgia">fibromyalgia</a>, and <a href="/wiki/Restless_legs_syndrome" title="Restless legs syndrome">restless legs syndrome</a>. In general, the analgesic capacity of dopamine occurs as a result of dopamine D2 receptor activation; however, exceptions to this exist in the PAG, in which dopamine D1 receptor activation attenuates pain presumably <i>via</i> activation of neurons involved in descending inhibition.<sup id="cite_ref-pmid18457535_38-0" class="reference"><a href="#cite_note-pmid18457535-38"><span>[</span>38<span>]</span></a></sup> In addition, D1 receptor activation in the insular cortex appears to attenuate subsequent pain-related behavior.</p>
<h3><span class="mw-headline" id="Nausea">Nausea</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Dopamine&amp;action=edit&amp;section=16" title="Edit section: Nausea">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Nausea and vomiting are largely determined by activity in a brainstem area known as the <a href="/wiki/Chemoreceptor_trigger_zone" title="Chemoreceptor trigger zone">chemoreceptor trigger zone</a>. This area contains a large population of type D2 dopamine receptors. Consequently, drugs that activate D2 receptors have a high potential to cause nausea. This group includes some medications that are administered for <a href="/wiki/Parkinson%27s_disease" title="Parkinson's disease">Parkinson's disease</a>, as well as other dopamine agonists such as <a href="/wiki/Apomorphine" title="Apomorphine">apomorphine</a>. In many cases, D2-receptor antagonists such as <a href="/wiki/Metoclopramide" title="Metoclopramide">metoclopramide</a> are useful as anti-nausea drugs.</p>
<h3><span class="mw-headline" id="Psychosis">Psychosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Dopamine&amp;action=edit&amp;section=17" title="Edit section: Psychosis">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="rellink relarticle mainarticle">Main article: <a href="/wiki/Dopamine_hypothesis_of_schizophrenia" title="Dopamine hypothesis of schizophrenia">Dopamine hypothesis of schizophrenia</a></div>
<p>Abnormally high dopaminergic transmission has been linked to <a href="/wiki/Psychosis" title="Psychosis">psychosis</a> and <a href="/wiki/Schizophrenia" title="Schizophrenia">schizophrenia</a>.<sup id="cite_ref-39" class="reference"><a href="#cite_note-39"><span>[</span>39<span>]</span></a></sup> However, clinical studies relating schizophrenia to brain dopamine metabolism have ranged from controversial to negative, with HVA levels in the CSF the same for schizophrenics and controls.<sup id="cite_ref-pmid9050120_40-0" class="reference"><a href="#cite_note-pmid9050120-40"><span>[</span>40<span>]</span></a></sup> Increased dopaminergic functional activity, specifically in the <a href="/wiki/Mesolimbic_pathway" title="Mesolimbic pathway">mesolimbic pathway</a>, is found in schizophrenic individuals. However, decreased activity in another dopaminergic pathway, the <a href="/wiki/Mesocortical_pathway" title="Mesocortical pathway">mesocortical pathway</a>, may also be involved. The two pathways are thought to be responsible for differing sets of symptoms seen in schizophrenia.<sup class="Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (June 2011)">citation needed</span></a></i>]</sup></p>
<p><a href="/wiki/Antipsychotic" title="Antipsychotic">Antipsychotic</a> <a href="/wiki/Medication" title="Medication" class="mw-redirect">medications</a> act largely as dopamine antagonists, inhibiting dopamine at the <a href="/wiki/Dopamine_receptor" title="Dopamine receptor">receptor</a> level, and thereby blocking the effects of the neurochemical in a dose-dependent manner. The older, so-called <a href="/wiki/Typical_antipsychotics" title="Typical antipsychotics" class="mw-redirect">typical antipsychotics</a> most commonly act on D2 receptors,<sup id="cite_ref-41" class="reference"><a href="#cite_note-41"><span>[</span>41<span>]</span></a></sup> while the <a href="/wiki/Atypical_antipsychotic" title="Atypical antipsychotic">atypical drugs</a> also act on D1, D3 and D4 receptors, though they have a lower affinity for dopamine receptors in general.<sup id="cite_ref-pmid7475902_42-0" class="reference"><a href="#cite_note-pmid7475902-42"><span>[</span>42<span>]</span></a></sup> The finding that drugs such as amphetamines, methamphetamine and cocaine, which can increase dopamine levels by more than tenfold,<sup id="cite_ref-43" class="reference"><a href="#cite_note-43"><span>[</span>43<span>]</span></a></sup> can temporarily cause psychosis, provides further evidence for this link.<sup id="cite_ref-pmid2884687_44-0" class="reference"><a href="#cite_note-pmid2884687-44"><span>[</span>44<span>]</span></a></sup> However, many non-dopaminergic drugs can induce acute and chronic <a href="/wiki/Psychosis" title="Psychosis">psychosis</a>.<sup id="cite_ref-Cardinal_2011_diagnosis_psychosis_45-0" class="reference"><a href="#cite_note-Cardinal_2011_diagnosis_psychosis-45"><span>[</span>45<span>]</span></a></sup> The NMDA antagonists Ketamine and PCP both are used in research to reproduce the positive and negative symptoms commonly associated with schizophrenia.<sup id="cite_ref-pmid10063482_46-0" class="reference"><a href="#cite_note-pmid10063482-46"><span>[</span>46<span>]</span></a></sup><sup id="cite_ref-pmid9754841_47-0" class="reference"><a href="#cite_note-pmid9754841-47"><span>[</span>47<span>]</span></a></sup></p>
<p>Dopaminergic dysregulation has also been linked to depressive disorders.<sup id="cite_ref-48" class="reference"><a href="#cite_note-48"><span>[</span>48<span>]</span></a></sup> Early research in humans used various methods of analyzing dopamine levels and function in depressed patients. Studies have reported that there is decreased concentration of <a href="/wiki/Tyrosine" title="Tyrosine">tyrosine</a>, a precursor to dopamine, in the blood plasma, ventricular spinal fluid, and lumbar spinal fluid of depressed patients compared to control subjects.<sup id="cite_ref-pmid5116991_49-0" class="reference"><a href="#cite_note-pmid5116991-49"><span>[</span>49<span>]</span></a></sup><sup id="cite_ref-50" class="reference"><a href="#cite_note-50"><span>[</span>50<span>]</span></a></sup> One study measured the amount of <a href="/wiki/Homovanillic_acid" title="Homovanillic acid">homovanillic acid</a>, the major metabolite of dopamine in the CSF, as a marker for the dopamine pathway turnover rate, and found decreased concentrations of homovanillic acid in the CSF of depressed patients.<sup id="cite_ref-pmid5796265_51-0" class="reference"><a href="#cite_note-pmid5796265-51"><span>[</span>51<span>]</span></a></sup> Postmordem real time <a href="/w/index.php?title=Reverse_transcriptase-polymerase_chain_reaction&amp;action=edit&amp;redlink=1" class="new" title="Reverse transcriptase-polymerase chain reaction (page does not exist)">reverse transcriptase-polymerase chain reaction</a> (RT-PCR) has also been used to find that gene expression of a specific subtype of dopamine receptor was elevated in the <a href="/wiki/Amygdala" title="Amygdala">amygdala</a> of people suffering from depression as compared to control subjects.<sup id="cite_ref-pmid18371940_52-0" class="reference"><a href="#cite_note-pmid18371940-52"><span>[</span>52<span>]</span></a></sup></p>
<p>The action of commonly used antidepressant drugs also has yielded information about possible alterations of the dopaminergic pathway in treating depression. It has been reported that many antidepressant drugs increase extracellular dopamine concentrations in the rat prefrontal cortex,<sup id="cite_ref-pmid8866721_53-0" class="reference"><a href="#cite_note-pmid8866721-53"><span>[</span>53<span>]</span></a></sup> but vary greatly in their effects on the <a href="/wiki/Striatum" title="Striatum">striatum</a> and <a href="/wiki/Nucleus_accumbens" title="Nucleus accumbens">nucleus accumbens</a>.<sup id="cite_ref-pmid9888623_54-0" class="reference"><a href="#cite_note-pmid9888623-54"><span>[</span>54<span>]</span></a></sup><sup id="cite_ref-pmid2901126_55-0" class="reference"><a href="#cite_note-pmid2901126-55"><span>[</span>55<span>]</span></a></sup> This can be compared to <a href="/wiki/Electroconvulsive_therapy" title="Electroconvulsive therapy">electro convulsive shock treatment</a> (ECT), which has been shown to have a multiple fold increase in striatal dopamine levels in rats.<sup id="cite_ref-pmid2482026_56-0" class="reference"><a href="#cite_note-pmid2482026-56"><span>[</span>56<span>]</span></a></sup></p>
<p>More recent research studies with rodents have found that depression-related behaviors are associated with dopaminergic system dysregulation.<sup id="cite_ref-Tye_2012_537-541_57-0" class="reference"><a href="#cite_note-Tye_2012_537-541-57"><span>[</span>57<span>]</span></a></sup> In rodents exposed to chronic mild stress, decreased escape behavior and decreased forced swimming is reversed with activation of the dopaminergic <a href="/wiki/Mesolimbic_pathway" title="Mesolimbic pathway">mesolimbic pathway</a>.<sup id="cite_ref-Tye_2012_537-541_57-1" class="reference"><a href="#cite_note-Tye_2012_537-541-57"><span>[</span>57<span>]</span></a></sup> Also, rodents that are susceptible to depression-related behavior after <a href="/wiki/Social_defeat" title="Social defeat">social defeat</a> can have their behavior reversed with dopamine pathway activation.<sup id="cite_ref-pmid23235832_58-0" class="reference"><a href="#cite_note-pmid23235832-58"><span>[</span>58<span>]</span></a></sup> Depletion of dopamine in the <a href="/wiki/Caudate_nucleus" title="Caudate nucleus">caudate nucleus</a> and nucleus accumbens has also been reported in cases of <a href="/wiki/Learned_helplessness" title="Learned helplessness">learned helplessness</a> in animals. These symptoms can be reversed with dopamine agonists and antidepressant administration prior to the learned helplessness protocol.<sup id="cite_ref-pmid2378927_59-0" class="reference"><a href="#cite_note-pmid2378927-59"><span>[</span>59<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Comparative_biology_and_evolution">Comparative biology and evolution</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Dopamine&amp;action=edit&amp;section=18" title="Edit section: Comparative biology and evolution">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<h3><span class="mw-headline" id="Microorganisms">Microorganisms</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Dopamine&amp;action=edit&amp;section=19" title="Edit section: Microorganisms">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>There are no reports of dopamine in <a href="/wiki/Archaea" title="Archaea">archaea</a>, but it has been detected in some types of <a href="/wiki/Bacteria" title="Bacteria">bacteria</a> and in a type of protozoan called <i><a href="/wiki/Tetrahymena" title="Tetrahymena">Tetrahymena</a></i>.<sup id="cite_ref-60" class="reference"><a href="#cite_note-60"><span>[</span>60<span>]</span></a></sup> Perhaps more importantly, there are types of bacteria that contain homologs of all the enzymes that animals use to synthesize dopamine. It has even been proposed that animals derived their dopamine-synthesizing machinery from bacteria, via <a href="/wiki/Horizontal_gene_transfer" title="Horizontal gene transfer">horizontal gene transfer</a> that may have occurred relatively late in evolutionary time, perhaps as a result of the symbiotic incorporation of bacteria into <a href="/wiki/Eukaryote" title="Eukaryote">eukaryotic</a> cells that gave rise to <a href="/wiki/Mitochondrion" title="Mitochondrion">mitochondria</a>.<sup id="cite_ref-61" class="reference"><a href="#cite_note-61"><span>[</span>61<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Animals">Animals</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Dopamine&amp;action=edit&amp;section=20" title="Edit section: Animals">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Dopamine is used as an intercellular messenger in virtually all multicellular animals. In sponges only a single report exists of the presence of dopamine, with no indication of its function;<sup id="cite_ref-62" class="reference"><a href="#cite_note-62"><span>[</span>62<span>]</span></a></sup> however, dopamine has been reported in the nervous systems of numerous radially symmetric species, including <a href="/wiki/Cnidaria" title="Cnidaria">cnidaria</a> (jellyfish, hydra, corals, etc.).<sup id="cite_ref-63" class="reference"><a href="#cite_note-63"><span>[</span>63<span>]</span></a></sup> This dates the emergence of dopamine as a neurotransmitter back to the earliest appearance of the nervous system, over 500 million years ago in the <a href="/wiki/Cambrian" title="Cambrian">Cambrian era</a>. Among existing species, dopamine functions as a neurotransmitter in vertebrates, <a href="/wiki/Echinoderm" title="Echinoderm">echinoderms</a>, <a href="/wiki/Arthropod" title="Arthropod">arthropods</a>, <a href="/wiki/Mollusca" title="Mollusca">molluscs</a>, and several types of worms.<sup id="cite_ref-64" class="reference"><a href="#cite_note-64"><span>[</span>64<span>]</span></a></sup><sup id="cite_ref-65" class="reference"><a href="#cite_note-65"><span>[</span>65<span>]</span></a></sup></p>
<p>In every type of animal that has been examined, dopamine acts to modify motor behavior.<sup id="cite_ref-Barron_66-0" class="reference"><a href="#cite_note-Barron-66"><span>[</span>66<span>]</span></a></sup> In the much-studied nematode worm <i><a href="/wiki/Caenorhabditis_elegans" title="Caenorhabditis elegans">Caenorhabditis elegans</a></i>, it reduces locomotion and increases food-exploratory movements; in <a href="/wiki/Planaria" title="Planaria">planarian</a> worms it produces "screw-like" movements; in <a href="/wiki/Leech" title="Leech">leeches</a> it inhibits swimming and promotes crawling; etc. Across a wide range of vertebrates, dopamine has an "activating" effect on behavior-switching and response selection, comparable to its effect in mammals.<sup id="cite_ref-Barron_66-1" class="reference"><a href="#cite_note-Barron-66"><span>[</span>66<span>]</span></a></sup></p>
<p>Dopamine also consistently plays a role in reward learning, in all animal groups that have been examined except arthropods. In nematodes, planarians, molluscs, and vertebrates, animals can be trained to repeat an action if it is consistently followed by an increase in dopamine levels.<sup id="cite_ref-Barron_66-2" class="reference"><a href="#cite_note-Barron-66"><span>[</span>66<span>]</span></a></sup> Arthropods are an exception, though. In these species&#160;— insects, crustaceans, etc.&#160;— dopamine has an aversive effect, and reward is instead mediated by <a href="/wiki/Octopamine" title="Octopamine">octopamine</a>, a neurotransmitter that is not found in vertebrates but is thought to be closely related to <a href="/wiki/Norepinephrine" title="Norepinephrine">norepinephrine</a>. In insects, dopamine increases aversion learning for olfactory stimuli as well as visual stimuli, and reduces approach learning for stimuli that are followed by rewards. It also improves recall for aversive memories and reduces recall for positive memories.<sup id="cite_ref-Barron_66-3" class="reference"><a href="#cite_note-Barron-66"><span>[</span>66<span>]</span></a></sup> The origin of the striking reversal between dopamine's effects in arthropods versus all other types of animals has not been explained.</p>
<h3><span class="mw-headline" id="Plants">Plants</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Dopamine&amp;action=edit&amp;section=21" title="Edit section: Plants">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Bananas_white_background.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/1/1c/Bananas_white_background.jpg/220px-Bananas_white_background.jpg" width="220" height="147" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/1/1c/Bananas_white_background.jpg/330px-Bananas_white_background.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/1/1c/Bananas_white_background.jpg/440px-Bananas_white_background.jpg 2x" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Bananas_white_background.jpg" class="internal" title="Enlarge"><img src="//bits.wikimedia.org/static-1.23wmf19/skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Dopamine can be found in the <a href="/wiki/Banana_peel" title="Banana peel">peel</a> and fruit pulp of <a href="/wiki/Bananas" title="Bananas" class="mw-redirect">bananas</a></div>
</div>
</div>
<p>Many plants synthesize dopamine to varying degrees, including a variety of food plants. The highest concentrations have been observed in bananas&#160;— the fruit pulp of red and yellow bananas contains dopamine at levels of 40 to 50 parts per million by weight. Potatoes, avocados, broccoli, and <a href="/wiki/Brussels_sprout" title="Brussels sprout">Brussels sprouts</a> may also contain dopamine at levels of 1 part per million or more; oranges, tomatoes, spinach, beans, and other plants contain measurable concentrations less than 1 part per million.<sup id="cite_ref-Kulma_67-0" class="reference"><a href="#cite_note-Kulma-67"><span>[</span>67<span>]</span></a></sup> The dopamine in plants is synthesized from the amino acid tyrosine, by biochemical mechanisms similar to those that animals use. It can be metabolized in a number of ways, producing <a href="/wiki/Melanin" title="Melanin">melanin</a> and a variety of alkaloids as byproducts.<sup id="cite_ref-Kulma_67-1" class="reference"><a href="#cite_note-Kulma-67"><span>[</span>67<span>]</span></a></sup> The functions of plant catecholamines have not been clearly established, but there is evidence that they play a role in the response to stressors such as bacterial infection, act as growth-promoting factors in some situations, and modify the way that sugars are metabolized. The receptors that mediate these actions have not yet been identified, nor have the intracellular mechanisms that they activate.<sup id="cite_ref-Kulma_67-2" class="reference"><a href="#cite_note-Kulma-67"><span>[</span>67<span>]</span></a></sup></p>
<p>Dopamine consumed in food cannot act on the brain, because it cannot cross the <a href="/wiki/Blood%E2%80%93brain_barrier" title="Blood–brain barrier">blood–brain barrier</a>. However, there are also a variety of plants that contain <a href="/wiki/L-DOPA" title="L-DOPA">L-DOPA</a>, the metabolic precursor of dopamine.<sup id="cite_ref-Ingle_68-0" class="reference"><a href="#cite_note-Ingle-68"><span>[</span>68<span>]</span></a></sup> The highest concentrations are found in the leaves and bean pods of plants of the genus <i><a href="/wiki/Mucuna" title="Mucuna">Mucuna</a></i>, especially in <i><a href="/wiki/Mucuna_pruriens" title="Mucuna pruriens">Mucuna pruriens</a></i> (velvet beans), which have been used as a source for L-DOPA as a drug.<sup id="cite_ref-69" class="reference"><a href="#cite_note-69"><span>[</span>69<span>]</span></a></sup> Another plant containing substantial amounts of L-DOPA is <i><a href="/wiki/Vicia_faba" title="Vicia faba">Vicia faba</a></i>, the plant that produces fava beans (also known as "broad beans"). The level of L-DOPA in the beans, however, is much lower than in the pod shells and other parts of the plant.<sup id="cite_ref-70" class="reference"><a href="#cite_note-70"><span>[</span>70<span>]</span></a></sup> The seeds of <i><a href="/wiki/Cassia_(legume)" title="Cassia (legume)" class="mw-redirect">Cassia</a></i> and <i><a href="/wiki/Bauhinia" title="Bauhinia">Bauhinia</a></i> trees also contain substantial amounts of L-DOPA.<sup id="cite_ref-Ingle_68-1" class="reference"><a href="#cite_note-Ingle-68"><span>[</span>68<span>]</span></a></sup></p>
<p>In the marine green alga <a href="/wiki/Ulvaria_(alga)" title="Ulvaria (alga)"><i>Ulvaria obscura</i></a>, which is a major component of some <a href="/wiki/Algal_bloom" title="Algal bloom">algal blooms</a>, dopamine is present in very high concentrations, estimated at 4.4% of dry weight. There is evidence that this dopamine functions as an anti-<a href="/wiki/Herbivore" title="Herbivore">herbivore</a> defense, reducing consumption by snails and <a href="/wiki/Isopoda" title="Isopoda">isopods</a>.<sup id="cite_ref-pmid16489461_71-0" class="reference"><a href="#cite_note-pmid16489461-71"><span>[</span>71<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="As_a_precursor_for_melanin">As a precursor for melanin</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Dopamine&amp;action=edit&amp;section=22" title="Edit section: As a precursor for melanin">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a href="/wiki/Melanin" title="Melanin">Melanins</a> are a family of dark-pigmented substances that are found in a wide range of organisms. Their physical properties make them difficult to work with experimentally, and consequently a number of aspects of their biochemistry are not well understood. Chemically they are closely related to dopamine, and there is a type of melanin, known as "dopamine-melanin", that can be synthesized by oxidation of dopamine via the enzyme <a href="/wiki/Tyrosinase" title="Tyrosinase">tyrosinase</a>.<sup id="cite_ref-72" class="reference"><a href="#cite_note-72"><span>[</span>72<span>]</span></a></sup> The melanin that darkens human skin is not of this type: it is synthesized by a pathway that uses <a href="/wiki/L-DOPA" title="L-DOPA">L-DOPA</a> as a precursor but not dopamine. However, there is substantial evidence that the "neuromelanin" that gives a dark color to the brain's <a href="/wiki/Substantia_nigra" title="Substantia nigra">substantia nigra</a> is at least in part dopamine-melanin.<sup id="cite_ref-73" class="reference"><a href="#cite_note-73"><span>[</span>73<span>]</span></a></sup></p>
<p>Dopamine-derived melanin probably appears in at least some other biological systems as well. Some of the dopamine in plants is likely to be used as a precursor for dopamine-melanin.<sup id="cite_ref-74" class="reference"><a href="#cite_note-74"><span>[</span>74<span>]</span></a></sup> The complex patterns that appear on butterfly wings, as well as black-and-white stripes on the bodies of insect larvae, are also thought to be caused by spatially structured accumulations of dopamine-melanin.<sup id="cite_ref-75" class="reference"><a href="#cite_note-75"><span>[</span>75<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Pharmacology">Pharmacology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Dopamine&amp;action=edit&amp;section=23" title="Edit section: Pharmacology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<h3><span class="mw-headline" id="Dopamine_as_an_injectable_drug">Dopamine as an injectable drug</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Dopamine&amp;action=edit&amp;section=24" title="Edit section: Dopamine as an injectable drug">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Under the trade names <b>Intropin</b>, <b>Dopastat</b>, <b>Revimine</b>, or other names, dopamine can be used as a <a href="/wiki/Drug" title="Drug">drug</a> in <a href="/wiki/Injection_(medicine)" title="Injection (medicine)">injectable</a> form. It is most commonly used in the treatment of severe <a href="/wiki/Hypotension" title="Hypotension">hypotension</a>, <a href="/wiki/Bradycardia" title="Bradycardia">bradycardia</a> (slow heart rate), <a href="/wiki/Shock_(circulatory)" title="Shock (circulatory)">circulatory shock</a>, or <a href="/wiki/Cardiac_arrest" title="Cardiac arrest">cardiac arrest</a>, especially in newborn infants. Its effects, depending on dosage, include an increase in sodium excretion by the kidneys, an increase in urine output, an increase in heart rate, and an increase in blood pressure. At a "cardiac dose" of 5 to 10 μg/kg/min, dopamine acts through the <a href="/wiki/Sympathetic_nervous_system" title="Sympathetic nervous system">sympathetic nervous system</a> to increase heart muscle contraction force and heart rate, thereby increasing cardiac output and blood pressure. At a "pressor dose" of 10 to 20 μg/kg/min, dopamine also causes <a href="/wiki/Vasoconstriction" title="Vasoconstriction">vasoconstriction</a> that further increases blood pressure, but can produce negative side effects such as an impairment of kidney function and <a href="/wiki/Cardiac_arrhythmias" title="Cardiac arrhythmias" class="mw-redirect">cardiac arrhythmias</a>.<sup id="cite_ref-BryantKnights2010_76-0" class="reference"><a href="#cite_note-BryantKnights2010-76"><span>[</span>76<span>]</span></a></sup><sup id="cite_ref-77" class="reference"><a href="#cite_note-77"><span>[</span>77<span>]</span></a></sup> Older literature also describes a so-called "renal dose" of 2 to 5 μg/kg/min thought to improve kidney function without other consequences, but recent reviews have concluded that doses at this low level are not clinically effective and may sometimes be harmful.<sup id="cite_ref-78" class="reference"><a href="#cite_note-78"><span>[</span>78<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="L-DOPA">L-DOPA</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Dopamine&amp;action=edit&amp;section=25" title="Edit section: L-DOPA">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a href="/wiki/L-DOPA" title="L-DOPA">Levodopa</a> is a dopamine precursor used in various forms to treat <a href="/wiki/Parkinson%27s_disease" title="Parkinson's disease">Parkinson's disease</a> and dopa-responsive <a href="/wiki/Dystonia" title="Dystonia">dystonia</a>. It is typically co-administered with an inhibitor of peripheral decarboxylation (DDC, <a href="/wiki/Aromatic-L-amino-acid_decarboxylase" title="Aromatic-L-amino-acid decarboxylase" class="mw-redirect">dopa decarboxylase</a>), such as <a href="/wiki/Carbidopa" title="Carbidopa">carbidopa</a> or <a href="/wiki/Benserazide" title="Benserazide">benserazide</a>. Inhibitors of alternative metabolic route for dopamine by <a href="/wiki/Catechol-O-methyl_transferase" title="Catechol-O-methyl transferase">catechol-O-methyl transferase</a> are also used. These include <a href="/wiki/Entacapone" title="Entacapone">entacapone</a> and <a href="/wiki/Tolcapone" title="Tolcapone">tolcapone</a>.</p>
<h3><span class="mw-headline" id="Psychomotor_stimulants">Psychomotor stimulants</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Dopamine&amp;action=edit&amp;section=26" title="Edit section: Psychomotor stimulants">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright">
<div class="thumbinner" style="width:542px;">
<div style="clear: both; font-weight: bold; text-align: center; background-color: #F0F8FF">
<p>Pharmacodynamics of amphetamine enantiomers in a dopamine neuron</p>
</div>
<div style="position:relative; width:540px; height:685px; overflow:hidden; border:solid #ccc 1px; background-color:white;">
<div style="left:0px; top:0px; width:540px; position:absolute"><a href="/wiki/File:TAAR1_Dopamine.svg" class="image"><img alt="A pharmacodynamic model of amphetamine and TAAR1" src="//upload.wikimedia.org/wikipedia/commons/thumb/1/10/TAAR1_Dopamine.svg/540px-TAAR1_Dopamine.svg.png" width="540" height="685" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/1/10/TAAR1_Dopamine.svg/810px-TAAR1_Dopamine.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/1/10/TAAR1_Dopamine.svg/1080px-TAAR1_Dopamine.svg.png 2x" /></a></div>
<div style="text-align:center; font-size:13px; line-height:110%;">
<div id="annotation_190x45" style="position:absolute; left:190px; top:45px; line-height:110%"><span style="background-color:transparent; color:black"><span style="background-color:transparent;">via <b><a href="/wiki/Aromatic_L-amino_acid_decarboxylase" title="Aromatic L-amino acid decarboxylase">AADC</a></b></span></span></div>
</div>
</div>
<div class="thumbcaption" style="clear:left">Amphetamine enters the presynaptic neuron across the neuronal membrane or through <abbr title="dopamine transporter">DAT</abbr>. Once inside, it binds to <abbr title="trace amine-associated receptor 1">TAAR1</abbr> or enters synaptic vesicles through <abbr title="vesicular monoamine transporter 2">VMAT2</abbr>. When amphetamine binds to TAAR1, it reduces dopamine receptor firing rate and triggers <a href="/wiki/Protein_kinase_A" title="Protein kinase A">protein kinase A</a> (PKA) and <a href="/wiki/Protein_kinase_C" title="Protein kinase C">protein kinase C</a> (PKC) signaling, resulting in DAT phosphorylation. <span class="nowrap">PKC-phosphorylated</span> DAT operates in reverse, while <span class="nowrap">PKA-phosphorylated</span> DAT withdraws into the presynaptic neuron and ceases transport. When amphetamine enters the synaptic vesicles through VMAT2, dopamine is released into the cytosol (yellow-orange area).</div>
</div>
</div>
<p>Cocaine and <a href="/wiki/Substituted_amphetamine" title="Substituted amphetamine">substituted amphetamines</a> both increase dopamine neuronal activity; however, they do so by very different mechanisms. Cocaine is a <a href="/wiki/Dopamine_transporter" title="Dopamine transporter">dopamine transporter</a> and <a href="/wiki/Norepinephrine_transporter" title="Norepinephrine transporter">norepinephrine transporter</a> blocker. It non-competitively inhibits dopamine reuptake, resulting in increased dopamine concentrations in the synaptic cleft. Like cocaine, substituted amphetamines increase the concentration of dopamine in the <a href="/wiki/Synaptic_cleft" title="Synaptic cleft" class="mw-redirect">synaptic cleft</a>, but by a different, more complex mechanism (see image).<sup id="cite_ref-Miller_79-0" class="reference"><a href="#cite_note-Miller-79"><span>[</span>79<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Antipsychotic_drugs">Antipsychotic drugs</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Dopamine&amp;action=edit&amp;section=27" title="Edit section: Antipsychotic drugs">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>A range of drugs that reduce dopamine activity have been found useful in the treatment of <a href="/wiki/Schizophrenia" title="Schizophrenia">schizophrenia</a> and other disorders that produce <a href="/wiki/Psychosis" title="Psychosis">psychosis</a>. These <a href="/wiki/Antipsychotic" title="Antipsychotic">antipsychotic</a> drugs are also sometimes known as neuroleptics or "major tranquilizers", in contrast to "minor tranquilizers" such as <a href="/wiki/Diazepam" title="Diazepam">Valium</a> that are used to treat anxiety or sleep disorders. These drugs have a broadly suppressive effect on most types of active behavior, and particularly reduce the delusional and agitated behavior characteristic of overt psychosis. The introduction of the first widely used antipsychotic drug, <a href="/wiki/Chlorpromazine" title="Chlorpromazine">chlorpromazine</a> (Thorazine), in the 1950s, led to the release of many schizophrenia patients from institutions in the years that followed.</p>
<p>Even so, the widespread use of antipsychotic drugs has long been controversial. There are several reasons for this. First, these drugs are perceived as very aversive by people who have to take them, because they produce a general dullness of thought and suppress the ability to experience pleasure.<sup id="cite_ref-fn2_80-0" class="reference"><a href="#cite_note-fn2-80"><span>[</span>80<span>]</span></a></sup> Second, it is difficult to show that they act specifically against psychotic behaviors rather than merely suppressing all types of active behavior. Third, they can produce a range of serious side effects, including weight gain, diabetes, fatigue, sexual dysfunction, hormonal changes, and a type of movement disorder known as <a href="/wiki/Tardive_dyskinesia" title="Tardive dyskinesia">tardive dyskinesia</a>. Some of these side effects may continue long after the cessation of drug use, or even permanently.</p>
<p>The first drugs introduced specifically for the treatment of psychosis all had strong direct effects on multiple aspects of dopamine function. Drugs of this type are known as "typical antipsychotics". Because of the problems they cause, there has been wide interest in newer types of drugs known as "atypical antipsychotics" or "second-generation antipsychotics", which aim to target the specific types of dopamine receptors involved in psychosis, and thereby reduce psychotic symptoms without producing as many undesirable side effects. There remains substantial dispute, however, about how much of an improvement in the patient experience these drugs produce.</p>
<h3><span class="mw-headline" id="Toxicity">Toxicity</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Dopamine&amp;action=edit&amp;section=28" title="Edit section: Toxicity">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The LD<sub>50</sub>, or dose which is expected to be lethal in 50% of the population, has been found to be: 59&#160;mg/kg (mouse; administered <a href="/wiki/Intravenously" title="Intravenously" class="mw-redirect">intravenously</a>); 950&#160;mg/kg (mouse; administered <a href="/wiki/Intraperitoneally" title="Intraperitoneally" class="mw-redirect">intraperitoneally</a>); 163&#160;mg/kg (rat; administered intraperitoneally); 79&#160;mg/kg (dog; administered intravenously).<sup id="cite_ref-81" class="reference"><a href="#cite_note-81"><span>[</span>81<span>]</span></a></sup></p>
<p><b><big>Binding profile of dopamine</big></b><sup id="cite_ref-82" class="reference"><a href="#cite_note-82"><span>[</span>82<span>]</span></a></sup></p>
<table class="wikitable">
<tr>
<th>Macromolecule</th>
<th>K<sub>i</sub> (nM)</th>
</tr>
<tr>
<td><a href="/wiki/5-HT1A_receptor" title="5-HT1A receptor">5-HT<sub>1A</sub></a></td>
<td>8248</td>
</tr>
<tr>
<td><a href="/wiki/5-HT7_receptor" title="5-HT7 receptor">5-HT<sub>7</sub></a></td>
<td>&gt;10000</td>
</tr>
<tr>
<td><a href="/wiki/Dopamine_D1_receptor" title="Dopamine D1 receptor" class="mw-redirect">D<sub>1</sub></a></td>
<td>130</td>
</tr>
<tr>
<td><a href="/wiki/Dopamine_D2_receptor" title="Dopamine D2 receptor" class="mw-redirect">D<sub>2</sub></a></td>
<td>598</td>
</tr>
<tr>
<td><a href="/wiki/Dopamine_D3_receptor" title="Dopamine D3 receptor" class="mw-redirect">D<sub>3</sub></a></td>
<td>32.5</td>
</tr>
<tr>
<td><a href="/wiki/Dopamine_D4_receptor" title="Dopamine D4 receptor" class="mw-redirect">D<sub>4</sub></a></td>
<td>182.6</td>
</tr>
<tr>
<td><a href="/wiki/Dopamine_D5_receptor" title="Dopamine D5 receptor" class="mw-redirect">D<sub>5</sub></a></td>
<td>228</td>
</tr>
<tr>
<td><a href="/wiki/Dopamine_transporter" title="Dopamine transporter">DAT</a></td>
<td>67</td>
</tr>
<tr>
<td><a href="/wiki/Norepinephrine_transporter" title="Norepinephrine transporter">NET</a></td>
<td>323</td>
</tr>
<tr>
<td><a href="/wiki/TAAR1" title="TAAR1">TAAR1</a></td>
<td>422</td>
</tr>
</table>
<h2><span class="mw-headline" id="Biochemical_mechanisms">Biochemical mechanisms</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Dopamine&amp;action=edit&amp;section=29" title="Edit section: Biochemical mechanisms">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Structurally, dopamine belongs to the <a href="/wiki/Catecholamine" title="Catecholamine">catecholamine</a> and <a href="/wiki/Phenethylamine" title="Phenethylamine">phenethylamine</a> classes. In biological systems, dopamine is synthesized in brain cells and adrenal cells from the precursor <a href="/wiki/L-DOPA" title="L-DOPA">L-DOPA</a>. In brain cells, it is transported to <a href="/wiki/Chemical_synapse" title="Chemical synapse">synaptic</a> sites and packaged into vesicles for release, which occurs during synaptic transmission. After release, free dopamine is either reabsorbed into the presynaptic terminal for reuse, or broken down by the enzymes <a href="/wiki/Monoamine_oxidase" title="Monoamine oxidase">monoamine oxidase</a> or COMT, producing a variety of degradation metabolites.</p>
<h3><span class="mw-headline" id="Biosynthesis">Biosynthesis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Dopamine&amp;action=edit&amp;section=30" title="Edit section: Biosynthesis">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Dopamine is <a href="/wiki/Biosynthesis" title="Biosynthesis">synthesized</a> in a restricted set of cell types, mainly <a href="/wiki/Neuron" title="Neuron">neurons</a> and cells in the <a href="/wiki/Adrenal_medulla" title="Adrenal medulla">medulla</a> of the <a href="/wiki/Adrenal_gland" title="Adrenal gland">adrenal glands</a>. This is the <a href="/wiki/Metabolic_pathway" title="Metabolic pathway">metabolic pathway</a>:</p>
<ul>
<li><small>L</small>-Phenylalanine → <small>L</small>-Tyrosine → <small>L</small>-DOPA → Dopamine</li>
</ul>
<p>Thus the direct precursor of dopamine is <a href="/wiki/L-DOPA" title="L-DOPA">L-DOPA</a>, but this itself can be synthesized from the essential amino acid <a href="/wiki/Phenylalanine" title="Phenylalanine">phenylalanine</a> or the non-essential amino acid <a href="/wiki/Tyrosine" title="Tyrosine">tyrosine</a>. These amino acids are found in nearly every protein and as such are provided from ingestion of protein-containing food, with tyrosine being the most common. Although dopamine itself is also found in many types of food, it is incapable of crossing the <a href="/wiki/Blood%E2%80%93brain_barrier" title="Blood–brain barrier">blood–brain barrier</a> that surrounds and protects the brain. It must therefore be synthesized inside the brain in order to perform its neural actions.</p>
<p><small>L</small>-Phenylalanine is converted into <small>L</small>-tyrosine by the enzyme <a href="/wiki/Phenylalanine_hydroxylase" title="Phenylalanine hydroxylase">phenylalanine hydroxylase</a> (PAH), with molecular <a href="/wiki/Oxygen" title="Oxygen">oxygen</a> (O<sub>2</sub>) and <a href="/wiki/Tetrahydrobiopterin" title="Tetrahydrobiopterin">tetrahydrobiopterin</a> (THB) as <a href="/wiki/Cofactor_(biochemistry)" title="Cofactor (biochemistry)">cofactors</a>. <small>L</small>-Tyrosine is converted into <small>L</small>-DOPA by the enzyme <a href="/wiki/Tyrosine_hydroxylase" title="Tyrosine hydroxylase">tyrosine hydroxylase</a> (TH), with <a href="/wiki/Tetrahydrobiopterin" title="Tetrahydrobiopterin">tetrahydrobiopterin</a> (THB), O<sub>2</sub>, and <a href="/wiki/Ferrous" title="Ferrous">ferrous</a> <a href="/wiki/Iron" title="Iron">iron</a> (Fe<sup>2+</sup>) as cofactors. <small>L</small>-DOPA is converted into dopamine by the enzyme <a href="/wiki/Aromatic_L-amino_acid_decarboxylase" title="Aromatic L-amino acid decarboxylase">aromatic <small>L</small>-amino acid decarboxylase</a> (AAAD; also known as DOPA decarboxylase (DDC)), with <a href="/wiki/Pyridoxal_phosphate" title="Pyridoxal phosphate">pyridoxal phosphate</a> (PLP) as the cofactor.</p>
<p>Dopamine itself is also used as precursor in the synthesis of the neurotransmitters <a href="/wiki/Norepinephrine" title="Norepinephrine">norepinephrine</a> and <a href="/wiki/Epinephrine" title="Epinephrine">epinephrine</a>. Dopamine is converted into norepinephrine by the enzyme <a href="/wiki/Dopamine_beta_hydroxylase" title="Dopamine beta hydroxylase" class="mw-redirect">dopamine β-hydroxylase</a> (DBH), with O<sub>2</sub> and <a href="/wiki/Ascorbic_acid" title="Ascorbic acid"><small>L</small>-ascorbic acid</a> as cofactors. Norepinephrine is converted into epinephrine by the enzyme <a href="/wiki/Phenylethanolamine_N-methyltransferase" title="Phenylethanolamine N-methyltransferase">phenylethanolamine <i>N</i>-methyltransferase</a> (PNMT) with <a href="/wiki/S-Adenosyl_methionine" title="S-Adenosyl methionine"><i>S</i>-adenosyl-<small>L</small>-methionine</a> (SAMe) as the cofactor.</p>
<p>It should be noted that some of the cofactors also require their own synthesis. Deficiency in any required amino acid or cofactor will result in subsequent dopamine, norepinephrine, and epinephrine biosynthesis impairment and deficiency.</p>
<center>
<div class="thumb tnone">
<div class="thumbinner" style="width:592px;">
<div style="position:relative; width:590px; height:600px; overflow:hidden; border:solid #ccc 1px; background-color:white;">
<div style="left:5px; top:0px; width:580px; position:absolute"><a href="/wiki/File:Catecholamine_and_trace_amine_biosynthesis.png" class="image"><img alt="Graphic of trace amine and catecholamine metabolism" src="//upload.wikimedia.org/wikipedia/commons/thumb/6/6a/Catecholamine_and_trace_amine_biosynthesis.png/580px-Catecholamine_and_trace_amine_biosynthesis.png" width="580" height="595" srcset="//upload.wikimedia.org/wikipedia/commons/6/6a/Catecholamine_and_trace_amine_biosynthesis.png 1.5x, //upload.wikimedia.org/wikipedia/commons/6/6a/Catecholamine_and_trace_amine_biosynthesis.png 2x" /></a></div>
<div style="text-align:center; font-size:14px; line-height:110%;">
<div id="annotation_40x60" style="position:absolute; left:40px; top:60px; line-height:110%"><span style="background-color:transparent; color:black"><span style="background-color:transparent;"><a href="/wiki/L-Phenylalanine" title="L-Phenylalanine" class="mw-redirect">L-Phenylalanine</a></span></span></div>
<div id="annotation_50x250" style="position:absolute; left:50px; top:250px; line-height:110%"><span style="background-color:transparent;"><a href="/wiki/L-Tyrosine" title="L-Tyrosine" class="mw-redirect">L-Tyrosine</a></span></div>
<div id="annotation_60x410" style="position:absolute; left:60px; top:410px; line-height:110%"><span style="background-color:transparent;"><a href="/wiki/L-Dopa" title="L-Dopa" class="mw-redirect">L-Dopa</a></span></div>
<div id="annotation_50x565" style="position:absolute; left:50px; top:565px; line-height:110%"><span style="background-color:transparent;"><a href="/wiki/Epinephrine" title="Epinephrine">Epinephrine</a></span></div>
<div id="annotation_245x60" style="position:absolute; left:245px; top:60px; line-height:110%"><span style="background-color:transparent;"><a href="/wiki/Phenethylamine" title="Phenethylamine">Phenethylamine</a></span></div>
<div id="annotation_245x250" style="position:absolute; left:245px; top:250px; line-height:110%"><span style="background-color:transparent;"><a href="/wiki/Tyramine" title="Tyramine"><i>p</i>-Tyramine</a></span></div>
<div id="annotation_245x410" style="position:absolute; left:245px; top:410px; line-height:110%"><span style="background-color:transparent;"><strong class="selflink">Dopamine</strong></span></div>
<div id="annotation_245x565" style="position:absolute; left:245px; top:565px; line-height:110%"><span style="background-color:transparent;"><a href="/wiki/Norepinephrine" title="Norepinephrine">Norepinephrine</a></span></div>
<div id="annotation_405x60" style="position:absolute; left:405px; top:60px; line-height:110%"><span style="background-color:transparent;"><a href="/wiki/N-Methylphenethylamine" title="N-Methylphenethylamine"><i>N</i>-Methylphenethylamine</a></span></div>
<div id="annotation_440x150" style="position:absolute; left:440px; top:150px; line-height:110%"><span style="background-color:transparent;"><a href="/wiki/N-Methyltyramine" title="N-Methyltyramine"><i>N</i>-Methyltyramine</a></span></div>
<div id="annotation_440x295" style="position:absolute; left:440px; top:295px; line-height:110%"><span style="background-color:transparent;"><a href="/wiki/Octopamine" title="Octopamine"><i>p</i>-Octopamine</a></span></div>
<div id="annotation_445x445" style="position:absolute; left:445px; top:445px; line-height:110%"><span style="background-color:transparent;"><a href="/wiki/Synephrine" title="Synephrine">Synephrine</a></span></div>
<div id="annotation_425x565" style="position:absolute; left:425px; top:565px; line-height:110%"><span style="background-color:transparent;"><a href="/wiki/3-Methoxytyramine" title="3-Methoxytyramine">3-Methoxytyramine</a></span></div>
<div id="annotation_170x18" style="position:absolute; left:170px; top:18px; line-height:110%"><span style="background-color:transparent;"><a href="/wiki/Aromatic_L-amino_acid_decarboxylase" title="Aromatic L-amino acid decarboxylase">AADC</a></span></div>
<div id="annotation_170x205" style="position:absolute; left:170px; top:205px; line-height:110%"><span style="background-color:transparent;"><a href="/wiki/Aromatic_L-amino_acid_decarboxylase" title="Aromatic L-amino acid decarboxylase">AADC</a></span></div>
<div id="annotation_170x370" style="position:absolute; left:170px; top:370px; line-height:110%"><span style="background-color:transparent;"><a href="/wiki/Aromatic_L-amino_acid_decarboxylase" title="Aromatic L-amino acid decarboxylase">AADC</a></span></div>
<div id="annotation_425x345" style="position:absolute; left:425px; top:345px; line-height:110%"><span style="background-color:transparent;"><a href="/wiki/Phenylethanolamine_N-methyltransferase" title="Phenylethanolamine N-methyltransferase">PNMT</a></span></div>
<div id="annotation_380x18" style="position:absolute; left:380px; top:18px; line-height:110%"><span style="background-color:transparent;"><a href="/wiki/Phenylethanolamine_N-methyltransferase" title="Phenylethanolamine N-methyltransferase">PNMT</a></span></div>
<div id="annotation_165x528" style="position:absolute; left:165px; top:528px; line-height:110%"><span style="background-color:transparent;"><a href="/wiki/Phenylethanolamine_N-methyltransferase" title="Phenylethanolamine N-methyltransferase">PNMT</a></span></div>
<div id="annotation_360x170" style="position:absolute; left:360px; top:170px; line-height:110%"><span style="background-color:transparent;"><a href="/wiki/Phenylethanolamine_N-methyltransferase" title="Phenylethanolamine N-methyltransferase">PNMT</a></span></div>
<div id="annotation_56x130" style="position:absolute; left:56px; top:130px; line-height:110%"><span style="background-color:transparent;"><a href="/wiki/Biopterin-dependent_aromatic_amino_acid_hydroxylase" title="Biopterin-dependent aromatic amino acid hydroxylase">AAAH</a></span></div>
<div id="annotation_56x305" style="position:absolute; left:56px; top:305px; line-height:110%"><span style="background-color:transparent;"><a href="/wiki/Biopterin-dependent_aromatic_amino_acid_hydroxylase" title="Biopterin-dependent aromatic amino acid hydroxylase">AAAH</a></span></div>
<div id="annotation_325x460" style="position:absolute; left:325px; top:460px; line-height:110%"><span style="background-color:transparent;"><a href="/wiki/Catechol_O-methyltransferase" title="Catechol O-methyltransferase" class="mw-redirect">COMT</a></span></div>
<div id="annotation_235x460" style="position:absolute; left:235px; top:460px; line-height:110%"><span style="background-color:transparent;"><a href="/wiki/Dopamine_beta_hydroxylase" title="Dopamine beta hydroxylase" class="mw-redirect">DBH</a></span></div>
<div id="annotation_365x250" style="position:absolute; left:365px; top:250px; line-height:110%"><span style="background-color:transparent;"><a href="/wiki/Dopamine_beta_hydroxylase" title="Dopamine beta hydroxylase" class="mw-redirect">DBH</a></span></div>
</div>
</div>
<div class="thumbcaption" style="clear:left">This is the biosynthesis of catecholamines, including dopamine, as well as phenethylaminergic trace amines from the amino acid phenylalanine. Abbreviations used:<br />
<span class="nowrap">DBH: Dopamine β-hydroxylase;</span><br />
<span class="nowrap">AADC:Aromatic L-amino acid decarboxylase;</span><br />
<span class="nowrap">AAAH: (Biopterin-dependent) aromatic amino acid hydroxylase;</span><br />
<span class="nowrap">COMT: Catechol O-methyltransferase;</span><br />
<span class="nowrap">PNMT: Phenylethanolamine N-methyltransferase</span></div>
</div>
</div>
</center>
<p><br /></p>
<h3><span class="mw-headline" id="Storage.2C_release.2C_and_reuptake">Storage, release, and reuptake</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Dopamine&amp;action=edit&amp;section=31" title="Edit section: Storage, release, and reuptake">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Inside the brain dopamine functions as a <a href="/wiki/Neurotransmitter" title="Neurotransmitter">neurotransmitter</a>, and is controlled by a set of mechanisms that are common to all neurotransmitters. After synthesis, dopamine is transported from the <a href="/wiki/Cytosol" title="Cytosol">cytosol</a><sup class="Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (November 2013)">citation needed</span></a></i>]</sup> into <a href="/wiki/Vesicle_(biology_and_chemistry)" title="Vesicle (biology and chemistry)">synaptic vesicles</a> by the <a href="/wiki/Vesicular_monoamine_transporter_2" title="Vesicular monoamine transporter 2">vesicular monoamine transporter 2</a> (VMAT2). Dopamine is stored in and remains in these vesicles until an <a href="/wiki/Action_potential" title="Action potential">action potential</a> occurs and causes the contents of the vesicles to be ejected into the <a href="/wiki/Chemical_synapse" title="Chemical synapse">synaptic cleft</a>.</p>
<p>Once in the synapse, dopamine binds to and activates <a href="/wiki/Dopamine_receptor" title="Dopamine receptor">dopamine receptors</a>, which can be located either on <a href="/wiki/Chemical_synapse" title="Chemical synapse">postsynaptic</a> target cells or on the membrane of the dopamine-releasing cell itself (i.e., <a href="/wiki/Autoreceptor" title="Autoreceptor">autoreceptors</a>).</p>
<p>After an action potential, the dopamine molecules quickly become unbound from their receptors. They are then absorbed back into the presynaptic cell, via <a href="/wiki/Reuptake" title="Reuptake">reuptake</a> mediated either by the high-affinity <a href="/wiki/Dopamine_transporter" title="Dopamine transporter">dopamine transporter</a> (DAT) or by the low-affinity <a href="/wiki/Plasma_membrane_monoamine_transporter" title="Plasma membrane monoamine transporter">plasma membrane monoamine transporter</a> (PMAT). Once back in the cytosol, dopamine is subsequently repackaged into vesicles by VMAT2, making it available for future release.</p>
<h3><span class="mw-headline" id="Degradation">Degradation</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Dopamine&amp;action=edit&amp;section=32" title="Edit section: Degradation">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright">
<div class="thumbinner" style="width:402px;"><a href="/wiki/File:Dopamine_degradation.svg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/e/e7/Dopamine_degradation.svg/400px-Dopamine_degradation.svg.png" width="400" height="383" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/e/e7/Dopamine_degradation.svg/600px-Dopamine_degradation.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/e7/Dopamine_degradation.svg/800px-Dopamine_degradation.svg.png 2x" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Dopamine_degradation.svg" class="internal" title="Enlarge"><img src="//bits.wikimedia.org/static-1.23wmf19/skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Dopamine degradation</div>
</div>
</div>
<p>Dopamine is broken down into inactive metabolites by a set of enzymes, <a href="/wiki/Monoamine_oxidase" title="Monoamine oxidase">monoamine oxidase</a> (MAO), <a href="/wiki/Aldehyde_dehydrogenase" title="Aldehyde dehydrogenase">aldehyde dehydrogenase</a> (ALDH), and <a href="/wiki/Catechol-O-methyl_transferase" title="Catechol-O-methyl transferase">catechol-<i>O</i>-methyl transferase</a> (COMT), acting in sequence. Both <a href="/wiki/Protein_isoform" title="Protein isoform">isoforms</a> of MAO, <a href="/wiki/Monoamine_oxidase_A" title="Monoamine oxidase A">MAO-A</a> and <a href="/wiki/Monoamine_oxidase_B" title="Monoamine oxidase B">MAO-B</a>, are equally effective.</p>
<p>The metabolites produced by these processes are:</p>
<ul>
<li>DOPAL (<a href="/wiki/3,4-Dihydroxyphenylacetaldehyde" title="3,4-Dihydroxyphenylacetaldehyde">3,4-Dihydroxyphenylacetaldehyde</a>)</li>
<li>DOPAC (<a href="/wiki/3,4-Dihydroxyphenylacetic_acid" title="3,4-Dihydroxyphenylacetic acid">3,4-Dihydroxyphenylacetic acid</a>)</li>
<li>DOPET (3,4-dihydroxyphenylethanol, also known as <a href="/wiki/Hydroxytyrosol" title="Hydroxytyrosol">Hydroxytyrosol</a>)</li>
<li>MOPET (3-methoxy-4-hydroxyphenylethanol, also known as <a href="/wiki/Homovanillyl_alcohol" title="Homovanillyl alcohol">Homovanillyl alcohol</a>)</li>
<li>3-MT (<a href="/wiki/3-Methoxytyramine" title="3-Methoxytyramine">3-Methoxytyramine</a>)</li>
<li>HVA (<a href="/wiki/Homovanillic_acid" title="Homovanillic acid">Homovanillic acid</a>)</li>
</ul>
<p>All of these are intermediate metabolites except MOPET and HVA, which are filtered from the bloodstream by the kidneys and then excreted in the urine.</p>
<p>The specific reactions that make up these pathways are:</p>
<ul>
<li>Dopamine → DOPAL, mediated by MAO</li>
<li>DOPAL → DOPAC, mediated by <a href="/wiki/Aldehyde_dehydrogenase" title="Aldehyde dehydrogenase">ALDH</a></li>
<li>DOPAL → DOPET, mediated by <a href="/wiki/Aldose_reductase" title="Aldose reductase">aldose reductase</a> (minor pathway)</li>
<li>DOPAC → HVA, mediated by COMT</li>
<li>DOPET → MOPET, mediated by COMT</li>
<li>Dopamine → 3-MT, mediated by COMT</li>
<li>3-MT → HVA, mediated by MAO</li>
</ul>
<p>In most areas of the brain, including the <a href="/wiki/Striatum" title="Striatum">striatum</a> and <a href="/wiki/Basal_ganglia" title="Basal ganglia">basal ganglia</a>, dopamine is inactivated by reuptake via the DAT, then enzymatic breakdown by MAO into DOPAC. In the <a href="/wiki/Prefrontal_cortex" title="Prefrontal cortex">prefrontal cortex</a>, however, there are very few DAT proteins, and dopamine is inactivated instead by reuptake via the <a href="/wiki/Norepinephrine_transporter" title="Norepinephrine transporter">norepinephrine transporter</a> (NET), presumably on neighboring norepinephrine neurons, then enzymatic breakdown by COMT into 3-MT.<sup id="cite_ref-pmid11784783_83-0" class="reference"><a href="#cite_note-pmid11784783-83"><span>[</span>83<span>]</span></a></sup> The DAT pathway is roughly an order of magnitude faster than the NET pathway: in mice, dopamine concentrations decay with a half-life of 200 milliseconds in the <a href="/wiki/Caudate_nucleus" title="Caudate nucleus">caudate nucleus</a> (which uses the DAT pathway) versus 2,000 milliseconds in the prefrontal cortex.<sup id="cite_ref-pmid17881525_84-0" class="reference"><a href="#cite_note-pmid17881525-84"><span>[</span>84<span>]</span></a></sup> Dopamine that is not broken down by enzymes is repackaged into vesicles for future release.</p>
<h2><span class="mw-headline" id="Chemistry">Chemistry</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Dopamine&amp;action=edit&amp;section=33" title="Edit section: Chemistry">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tnone" style="width: 644px; margin: 0 auto;">
<div class="thumbinner">
<div style="float: left; margin: 1px; width: 252px">
<div class="thumbimage"><a href="/wiki/File:Dopamine2.svg" class="image"><img alt="Dopamine structure" src="//upload.wikimedia.org/wikipedia/commons/thumb/6/6c/Dopamine2.svg/250px-Dopamine2.svg.png" width="250" height="116" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/6/6c/Dopamine2.svg/375px-Dopamine2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/6c/Dopamine2.svg/500px-Dopamine2.svg.png 2x" /></a></div>
<div class="thumbcaption" style="clear:left">Dopamine structure</div>
</div>
<div style="float: left; margin: 1px; width: 258px">
<div class="thumbimage"><a href="/wiki/File:Fenyloetyloamina.svg" class="image"><img alt="Phenethylamine structure" src="//upload.wikimedia.org/wikipedia/commons/thumb/f/fe/Fenyloetyloamina.svg/256px-Fenyloetyloamina.svg.png" width="256" height="116" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/f/fe/Fenyloetyloamina.svg/384px-Fenyloetyloamina.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/f/fe/Fenyloetyloamina.svg/512px-Fenyloetyloamina.svg.png 2x" /></a></div>
<div class="thumbcaption" style="clear:left">Phenethylamine structure</div>
</div>
<div style="float: left; margin: 1px; width: 119px">
<div class="thumbimage"><a href="/wiki/File:Brenzcatechin.svg" class="image"><img alt="Catechol structure" src="//upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Brenzcatechin.svg/117px-Brenzcatechin.svg.png" width="117" height="116" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Brenzcatechin.svg/176px-Brenzcatechin.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Brenzcatechin.svg/234px-Brenzcatechin.svg.png 2x" /></a></div>
<div class="thumbcaption" style="clear:left">Catechol structure</div>
</div>
</div>
</div>
<p>Chemically, a dopamine molecule consists of a <a href="/wiki/Catechol" title="Catechol">catechol</a> structure (a <a href="/wiki/Benzene" title="Benzene">benzene</a> ring with two <a href="/wiki/Hydroxyl" title="Hydroxyl">hydroxyl</a> side groups) with one <a href="/wiki/Amine" title="Amine">amine</a> group attached. As such, dopamine is the simplest possible <a href="/wiki/Catecholamine" title="Catecholamine">catecholamine</a>, a family that also includes the <a href="/wiki/Neurotransmitter" title="Neurotransmitter">neurotransmitters</a> <a href="/wiki/Norepinephrine" title="Norepinephrine">norepinephrine</a> and <a href="/wiki/Epinephrine" title="Epinephrine">epinephrine</a>. The presence of a benzene ring with an attached amine group makes it a <a href="/wiki/Phenethylamine" title="Phenethylamine">phenethylamine</a>, a family that includes numerous psychoactive drugs.</p>
<p>Dopamine, like most <a href="/wiki/Amine" title="Amine">amines</a>, is an <a href="/wiki/Organic_base" title="Organic base">organic base</a>. At neutral or acidic pH levels it is generally <a href="/wiki/Protonation" title="Protonation">protonated</a>. The protonated form is highly water-soluble and relatively stable, though it is capable of oxidizing if exposed to oxygen or other oxidants. At basic pH levels, dopamine becomes deprotonated. In this <a href="/wiki/Free_base" title="Free base">free base</a> form it is less soluble and also highly reactive and easily oxidized. Because of this pH-dependence, dopamine is supplied for chemical or pharmaceutical use in the form of dopamine hydochloride, that is, the <a href="/wiki/Hydrochloride" title="Hydrochloride">hydrochloride</a> salt that is created when dopamine is combined with hydrochloric acid. In dry form, dopamine hydrochloride is a fine colorless powder. When dissolved in distilled water it gives a solution that is mildly acidic and therefore relatively stable. It cannot, however, be combined with alkaline solutions such as a <a href="/wiki/Bicarbonate" title="Bicarbonate">bicarbonate</a> buffer without being rendered inactive.</p>
<h3><span class="mw-headline" id="Oxidation">Oxidation</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Dopamine&amp;action=edit&amp;section=34" title="Edit section: Oxidation">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Dopamine in the body is normally broken down by oxidation catalyzed by the enzyme <a href="/wiki/Monoamine_oxidase" title="Monoamine oxidase">monoamine oxidase</a>. However, dopamine is also capable of <a href="/wiki/Autoxidation" title="Autoxidation">autoxidation</a>, that is, direct reaction with oxygen, yielding <a href="/wiki/Quinone" title="Quinone">quinones</a> plus various <a href="/wiki/Radical_(chemistry)" title="Radical (chemistry)">free radicals</a> as products.<sup id="cite_ref-Sulzer_85-0" class="reference"><a href="#cite_note-Sulzer-85"><span>[</span>85<span>]</span></a></sup> The rate of autoxidation can be increased by the presence of ferrous iron or other factors. The ability of dopamine autoxidation to produce quinones and free radicals makes it a potent cell toxin, and there is evidence that this mechanism may contribute to cell loss that occurs in <a href="/wiki/Parkinson%27s_disease" title="Parkinson's disease">Parkinson's disease</a> or other conditions.<sup id="cite_ref-86" class="reference"><a href="#cite_note-86"><span>[</span>86<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Polydopamine"><span id="Polydopamine"></span> Polydopamine</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Dopamine&amp;action=edit&amp;section=35" title="Edit section: Polydopamine">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Research motivated by mussel adhesive proteins led to the discovery in 2007 that a wide variety of materials, if placed in a solution of dopamine at slightly basic pH, will become coated with a layer of polymerized dopamine, often referred to as <b>polydopamine</b>.<sup id="cite_ref-87" class="reference"><a href="#cite_note-87"><span>[</span>87<span>]</span></a></sup><sup id="cite_ref-Dreyer_88-0" class="reference"><a href="#cite_note-Dreyer-88"><span>[</span>88<span>]</span></a></sup> This polymerized dopamine forms by a spontaneous oxidation reaction, and is formally a type of <a href="/wiki/Melanin" title="Melanin">melanin</a>.<sup id="cite_ref-Lynge_89-0" class="reference"><a href="#cite_note-Lynge-89"><span>[</span>89<span>]</span></a></sup> Synthesis usually involves reaction of dopamine hydrochloride with <a href="/wiki/Tris" title="Tris">Tris</a> as a base in water. The structure of polydopamine is unknown.<sup id="cite_ref-Dreyer_88-1" class="reference"><a href="#cite_note-Dreyer-88"><span>[</span>88<span>]</span></a></sup></p>
<p>Polydopamine coatings can form on objects ranging in size from nanoparticles to large surfaces. Polydopamine layers have chemical properties that have the potential to be extremely useful, and numerous studies have examined their possible applications. At the simplest level, they can be used for protection against damage by light, or to form capsules for drug delivery. At a more sophisticated level, their adhesive properties may make them useful as substrates for biosensors or other biologically active macromolecules.<sup id="cite_ref-Lynge_89-1" class="reference"><a href="#cite_note-Lynge-89"><span>[</span>89<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="History">History</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Dopamine&amp;action=edit&amp;section=36" title="Edit section: History">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="rellink relarticle mainarticle">Main article: <a href="/wiki/History_of_catecholamine_research" title="History of catecholamine research">History of catecholamine research</a></div>
<p>Dopamine was first synthesized in 1910 by <a href="/wiki/George_Barger" title="George Barger">George Barger</a> and <a href="/w/index.php?title=James_Ewens&amp;action=edit&amp;redlink=1" class="new" title="James Ewens (page does not exist)">James Ewens</a> at <a href="/wiki/Wellcome_Trust" title="Wellcome Trust">Wellcome</a> Laboratories in London, England.<sup id="cite_ref-90" class="reference"><a href="#cite_note-90"><span>[</span>90<span>]</span></a></sup> It was named dopamine because it is a <a href="/wiki/Monoamine" title="Monoamine" class="mw-redirect">monoamine</a> whose <a href="/wiki/Precursor_chemical" title="Precursor chemical" class="mw-redirect">precursor</a> in the Barger-Ewens synthesis is 3,4-<i>d</i>ihydr<i>o</i>xy<i>p</i>henyl<i>a</i>lanine (levodopamine or <a href="/wiki/L-DOPA" title="L-DOPA">L-DOPA</a>). Dopamine's function as a neurotransmitter was first recognized in 1958 by <a href="/wiki/Arvid_Carlsson" title="Arvid Carlsson">Arvid Carlsson</a> and <a href="/wiki/Nils-%C3%85ke_Hillarp" title="Nils-Åke Hillarp">Nils-Åke Hillarp</a> at the Laboratory for Chemical Pharmacology of the National Heart Institute of <a href="/wiki/Sweden" title="Sweden">Sweden</a>.<sup id="cite_ref-pmid11165672_91-0" class="reference"><a href="#cite_note-pmid11165672-91"><span>[</span>91<span>]</span></a></sup> Carlsson was awarded the 2000 <a href="/wiki/Nobel_Prize_in_Physiology_or_Medicine" title="Nobel Prize in Physiology or Medicine">Nobel Prize in Physiology or Medicine</a> for showing that dopamine is not only a precursor of <a href="/wiki/Norepinephrine" title="Norepinephrine">norepinephrine</a> (noradrenaline) and <a href="/wiki/Epinephrine" title="Epinephrine">epinephrine</a> (adrenaline), but also a neurotransmitter.</p>
<h2><span class="mw-headline" id="See_also">See also</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Dopamine&amp;action=edit&amp;section=37" title="Edit section: See also">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="div-col columns column-count column-count-3" style="-moz-column-count: 3; -webkit-column-count: 3; column-count: 3;">
<ul>
<li><a href="/wiki/Substance_use_disorder" title="Substance use disorder">Addiction</a></li>
<li><a href="/wiki/Amphetamine" title="Amphetamine">Amphetamine</a></li>
<li><a href="/wiki/Antipsychotic" title="Antipsychotic">Antipsychotic</a></li>
<li><a href="/wiki/Catecholamine" title="Catecholamine">Catecholamine</a></li>
<li><a href="/wiki/Catechol-O-methyl_transferase" title="Catechol-O-methyl transferase">Catechol-O-methyl transferase</a></li>
<li><a href="/wiki/Classical_conditioning" title="Classical conditioning">Classical conditioning</a></li>
<li><a href="/wiki/Cocaine" title="Cocaine">Cocaine</a></li>
<li><a href="/wiki/Depression_(mood)" title="Depression (mood)">Depression</a></li>
<li><a href="/wiki/Dopamine_hypothesis_of_schizophrenia" title="Dopamine hypothesis of schizophrenia">Dopamine hypothesis of schizophrenia</a></li>
<li><a href="/wiki/Dopamine_reuptake_inhibitor" title="Dopamine reuptake inhibitor">Dopamine reuptake inhibitor</a></li>
<li><a href="/wiki/Epinine" title="Epinine" class="mw-redirect">Epinine</a> (N-methyldopamine)</li>
<li><a href="/wiki/Limbic_system" title="Limbic system">Limbic system</a></li>
<li><a href="/wiki/Methylphenidate" title="Methylphenidate">Methylphenidate</a></li>
<li><a href="/wiki/N,N-Dimethyldopamine" title="N,N-Dimethyldopamine">N,N-Dimethyldopamine</a></li>
<li><a href="/wiki/Neurotransmitter" title="Neurotransmitter">Neurotransmitter</a></li>
<li><a href="/wiki/Operant_conditioning" title="Operant conditioning">Operant conditioning</a></li>
<li><a href="/wiki/Parkinson%27s_disease" title="Parkinson's disease">Parkinson's disease</a></li>
<li><a href="/wiki/Prolactinoma" title="Prolactinoma">Prolactinoma</a></li>
<li><a href="/wiki/Schizophrenia" title="Schizophrenia">Schizophrenia</a></li>
<li><a href="/wiki/Selegiline" title="Selegiline">Selegiline</a></li>
<li><a href="/wiki/Serotonin" title="Serotonin">Serotonin</a></li>
</ul>
</div>
<h2><span class="mw-headline" id="References">References</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Dopamine&amp;action=edit&amp;section=38" title="Edit section: References">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="reflist columns references-column-width" style="-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;">
<ol class="references">
<li id="cite_note-SchultzAnnRev-1"><span class="mw-cite-backlink"><b><a href="#cite_ref-SchultzAnnRev_1-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Schultz W (2007). "Multiple dopamine functions at different time courses". <i>Annu. Rev. Neurosci.</i> <b>30</b>: 259–88. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1146%2Fannurev.neuro.28.061604.135722">10.1146/annurev.neuro.28.061604.135722</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17600522">17600522</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Multiple+dopamine+functions+at+different+time+courses&amp;rft.aulast=Schultz+W&amp;rft.au=Schultz+W&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1146%2Fannurev.neuro.28.061604.135722&amp;rft_id=info%3Apmid%2F17600522&amp;rft.jtitle=Annu.+Rev.+Neurosci.&amp;rft.pages=259%E2%80%9388&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=30" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-2"><span class="mw-cite-backlink"><b><a href="#cite_ref-2">^</a></b></span> <span class="reference-text"><span class="citation journal">A. Dahlström and K. Fuxe (1964). "Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons". <i>Acta physiologica Scandinavica. Supplementum</i> <b>232</b>: 1–55. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/14229500">14229500</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Evidence+for+the+existence+of+monoamine-containing+neurons+in+the+central+nervous+system.+I.+Demonstration+of+monoamines+in+the+cell+bodies+of+brain+stem+neurons&amp;rft.au=A.+Dahlstr%C3%B6m+and+K.+Fuxe&amp;rft.aulast=A.+Dahlstr%C3%B6m+and+K.+Fuxe&amp;rft.date=1964&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F14229500&amp;rft.jtitle=Acta+physiologica+Scandinavica.+Supplementum&amp;rft.pages=1%E2%80%9355&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=232" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Bjorklund-3"><span class="mw-cite-backlink">^ <a href="#cite_ref-Bjorklund_3-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Bjorklund_3-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Björklund A, Dunnett SB (May 2007). "Dopamine neuron systems in the brain: an update". <i>Trends Neurosci.</i> <b>30</b> (5): 194–202. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2Fj.tins.2007.03.006">10.1016/j.tins.2007.03.006</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17408759">17408759</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Dopamine+neuron+systems+in+the+brain%3A+an+update&amp;rft.au=Bj%C3%B6rklund+A%2C+Dunnett+SB&amp;rft.aulast=Bj%C3%B6rklund+A%2C+Dunnett+SB&amp;rft.date=May+2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.tins.2007.03.006&amp;rft_id=info%3Apmid%2F17408759&amp;rft.issue=5&amp;rft.jtitle=Trends+Neurosci.&amp;rft.pages=194%E2%80%93202&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=30" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-4"><span class="mw-cite-backlink"><b><a href="#cite_ref-4">^</a></b></span> <span class="reference-text"><span class="citation journal">Christine CW, Aminoff MJ (September 2004). "Clinical differentiation of parkinsonian syndromes: prognostic and therapeutic relevance". <i>Am. J. Med.</i> <b>117</b> (6): 412–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2Fj.amjmed.2004.03.032">10.1016/j.amjmed.2004.03.032</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15380498">15380498</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Clinical+differentiation+of+parkinsonian+syndromes%3A+prognostic+and+therapeutic+relevance&amp;rft.au=Christine+CW%2C+Aminoff+MJ&amp;rft.aulast=Christine+CW%2C+Aminoff+MJ&amp;rft.date=September+2004&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.amjmed.2004.03.032&amp;rft_id=info%3Apmid%2F15380498&amp;rft.issue=6&amp;rft.jtitle=Am.+J.+Med.&amp;rft.pages=412%E2%80%939&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=117" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-DeLong-5"><span class="mw-cite-backlink"><b><a href="#cite_ref-DeLong_5-0">^</a></b></span> <span class="reference-text"><span class="citation journal">DeLong M, Wichmann T (April 2010). "Changing views of basal ganglia circuits and circuit disorders". <i>Clin EEG Neurosci</i> <b>41</b> (2): 61–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1177%2F155005941004100204">10.1177/155005941004100204</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20521487">20521487</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Changing+views+of+basal+ganglia+circuits+and+circuit+disorders&amp;rft.au=DeLong+M%2C+Wichmann+T&amp;rft.aulast=DeLong+M%2C+Wichmann+T&amp;rft.date=April+2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1177%2F155005941004100204&amp;rft_id=info%3Apmid%2F20521487&amp;rft.issue=2&amp;rft.jtitle=Clin+EEG+Neurosci&amp;rft.pages=61%E2%80%937&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=41" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-6"><span class="mw-cite-backlink"><b><a href="#cite_ref-6">^</a></b></span> <span class="reference-text"><span class="citation journal">Robbins TW, Arnsten AF. (2009). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2863127">"The neuropsychopharmacology of fronto-executive function: monoaminergic modulation"</a>. <i>Annu Rev Neurosci.</i> <b>32</b>: 267–87. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1146%2Fannurev.neuro.051508.135535">10.1146/annurev.neuro.051508.135535</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2863127">2863127</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19555290">19555290</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=The+neuropsychopharmacology+of+fronto-executive+function%3A+monoaminergic+modulation&amp;rft.aulast=Robbins+TW%2C+Arnsten+AF.&amp;rft.au=Robbins+TW%2C+Arnsten+AF.&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2863127&amp;rft_id=info%3Adoi%2F10.1146%2Fannurev.neuro.051508.135535&amp;rft_id=info%3Apmc%2F2863127&amp;rft_id=info%3Apmid%2F19555290&amp;rft.jtitle=Annu+Rev+Neurosci.&amp;rft.pages=267%E2%80%9387&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=32" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-7"><span class="mw-cite-backlink"><b><a href="#cite_ref-7">^</a></b></span> <span class="reference-text"><span class="citation journal">Paulus W, Schomburg ED (June 2006). "Dopamine and the spinal cord in restless legs syndrome: does spinal cord physiology reveal a basis for augmentation?". <i>Sleep Med Rev</i> <b>10</b> (3): 185–96. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2Fj.smrv.2006.01.004">10.1016/j.smrv.2006.01.004</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16762808">16762808</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Dopamine+and+the+spinal+cord+in+restless+legs+syndrome%3A+does+spinal+cord+physiology+reveal+a+basis+for+augmentation%3F&amp;rft.aulast=Paulus+W%2C+Schomburg+ED&amp;rft.au=Paulus+W%2C+Schomburg+ED&amp;rft.date=June+2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.smrv.2006.01.004&amp;rft_id=info%3Apmid%2F16762808&amp;rft.issue=3&amp;rft.jtitle=Sleep+Med+Rev&amp;rft.pages=185%E2%80%9396&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=10" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-prolactininhibition-8"><span class="mw-cite-backlink">^ <a href="#cite_ref-prolactininhibition_8-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-prolactininhibition_8-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Ben-Jonathan N, Hnasko R (2001). <a rel="nofollow" class="external text" href="http://edrv.endojournals.org/cgi/reprint/22/6/724.pdf">"Dopamine as a Prolactin (PRL) Inhibitor"</a> (PDF). <i>Endocrine Reviews</i> <b>22</b> (6): 724–763. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1210%2Fer.22.6.724">10.1210/er.22.6.724</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11739329">11739329</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Dopamine+as+a+Prolactin+%28PRL%29+Inhibitor&amp;rft.au=Ben-Jonathan+N%2C+Hnasko+R&amp;rft.aulast=Ben-Jonathan+N%2C+Hnasko+R&amp;rft.date=2001&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fedrv.endojournals.org%2Fcgi%2Freprint%2F22%2F6%2F724.pdf&amp;rft_id=info%3Adoi%2F10.1210%2Fer.22.6.724&amp;rft_id=info%3Apmid%2F11739329&amp;rft.issue=6&amp;rft.jtitle=Endocrine+Reviews&amp;rft.pages=724%E2%80%93763&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=22" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-9"><span class="mw-cite-backlink"><b><a href="#cite_ref-9">^</a></b></span> <span class="reference-text"><span class="citation journal">Witkovsky P (January 2004). "Dopamine and retinal function". <i>Doc Ophthalmol</i> <b>108</b> (1): 17–40. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1023%2FB%3ADOOP.0000019487.88486.0a">10.1023/B:DOOP.0000019487.88486.0a</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15104164">15104164</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Dopamine+and+retinal+function&amp;rft.aulast=Witkovsky+P&amp;rft.au=Witkovsky+P&amp;rft.date=January+2004&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1023%2FB%3ADOOP.0000019487.88486.0a&amp;rft_id=info%3Apmid%2F15104164&amp;rft.issue=1&amp;rft.jtitle=Doc+Ophthalmol&amp;rft.pages=17%E2%80%9340&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=108" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Eisenhofer-10"><span class="mw-cite-backlink">^ <a href="#cite_ref-Eisenhofer_10-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Eisenhofer_10-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Eisenhofer_10-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Eisenhofer G, Kopin IJ, Goldstein DS (September 2004). <a rel="nofollow" class="external text" href="http://intl.pharmrev.org/content/56/3/331.full">"Catecholamine metabolism: a contemporary view with implications for physiology and medicine"</a>. <i>Pharmacol. Rev.</i> <b>56</b> (3): 331–49. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1124%2Fpr.56.3.1">10.1124/pr.56.3.1</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15317907">15317907</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Catecholamine+metabolism%3A+a+contemporary+view+with+implications+for+physiology+and+medicine&amp;rft.au=Eisenhofer+G%2C+Kopin+IJ%2C+Goldstein+DS&amp;rft.aulast=Eisenhofer+G%2C+Kopin+IJ%2C+Goldstein+DS&amp;rft.date=September+2004&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fintl.pharmrev.org%2Fcontent%2F56%2F3%2F331.full&amp;rft_id=info%3Adoi%2F10.1124%2Fpr.56.3.1&amp;rft_id=info%3Apmid%2F15317907&amp;rft.issue=3&amp;rft.jtitle=Pharmacol.+Rev.&amp;rft.pages=331%E2%80%9349&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=56" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Missale-11"><span class="mw-cite-backlink"><b><a href="#cite_ref-Missale_11-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Missale C, Nash SR, Robinson SW, Jaber M, Caron MG (1998). "Dopamine receptors: from structure to function". <i>Physiol. Rev.</i> <b>78</b> (1): 189–225. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9457173">9457173</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Dopamine+receptors%3A+from+structure+to+function&amp;rft.aulast=Missale+C%2C+Nash+SR%2C+Robinson+SW%2C+Jaber+M%2C+Caron+MG&amp;rft.au=Missale+C%2C+Nash+SR%2C+Robinson+SW%2C+Jaber+M%2C+Caron+MG&amp;rft.date=1998&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F9457173&amp;rft.issue=1&amp;rft.jtitle=Physiol.+Rev.&amp;rft.pages=189%E2%80%93225&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=78" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Buttarelli-12"><span class="mw-cite-backlink">^ <a href="#cite_ref-Buttarelli_12-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Buttarelli_12-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Buttarelli FR, Fanciulli A, Pellicano C, Pontieri FE (June 2011). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3131719">"The dopaminergic system in peripheral blood lymphocytes: from physiology to pharmacology and potential applications to neuropsychiatric disorders"</a>. <i>Curr Neuropharmacol</i> <b>9</b> (2): 278–88. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.2174%2F157015911795596612">10.2174/157015911795596612</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3131719">3131719</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22131937">22131937</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=The+dopaminergic+system+in+peripheral+blood+lymphocytes%3A+from+physiology+to+pharmacology+and+potential+applications+to+neuropsychiatric+disorders&amp;rft.au=Buttarelli+FR%2C+Fanciulli+A%2C+Pellicano+C%2C+Pontieri+FE&amp;rft.aulast=Buttarelli+FR%2C+Fanciulli+A%2C+Pellicano+C%2C+Pontieri+FE&amp;rft.date=June+2011&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3131719&amp;rft_id=info%3Adoi%2F10.2174%2F157015911795596612&amp;rft_id=info%3Apmc%2F3131719&amp;rft_id=info%3Apmid%2F22131937&amp;rft.issue=2&amp;rft.jtitle=Curr+Neuropharmacol&amp;rft.pages=278%E2%80%9388&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=9" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid10636479-13"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid10636479_13-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Basu S, Dasgupta PS (2000). "Dopamine, a neurotransmitter, influences the immune system". <i>J. Neuroimmunol.</i> <b>102</b> (2): 113–24. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2FS0165-5728%2899%2900176-9">10.1016/S0165-5728(99)00176-9</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10636479">10636479</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Dopamine%2C+a+neurotransmitter%2C+influences+the+immune+system&amp;rft.au=Basu+S%2C+Dasgupta+PS&amp;rft.aulast=Basu+S%2C+Dasgupta+PS&amp;rft.date=2000&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0165-5728%2899%2900176-9&amp;rft_id=info%3Apmid%2F10636479&amp;rft.issue=2&amp;rft.jtitle=J.+Neuroimmunol.&amp;rft.pages=113%E2%80%9324&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=102" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid19896530-14"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19896530_14-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Sarkar C, Basu B, Chakroborty D, Dasgupta PS, Basu S (2010). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2856781">"The immunoregulatory role of dopamine: an update"</a>. <i>Brain Behav. Immun.</i> <b>24</b> (4): 525–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2Fj.bbi.2009.10.015">10.1016/j.bbi.2009.10.015</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2856781">2856781</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19896530">19896530</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=The+immunoregulatory+role+of+dopamine%3A+an+update&amp;rft.aulast=Sarkar+C%2C+Basu+B%2C+Chakroborty+D%2C+Dasgupta+PS%2C+Basu+S&amp;rft.au=Sarkar+C%2C+Basu+B%2C+Chakroborty+D%2C+Dasgupta+PS%2C+Basu+S&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2856781&amp;rft_id=info%3Adoi%2F10.1016%2Fj.bbi.2009.10.015&amp;rft_id=info%3Apmc%2F2856781&amp;rft_id=info%3Apmid%2F19896530&amp;rft.issue=4&amp;rft.jtitle=Brain+Behav.+Immun.&amp;rft.pages=525%E2%80%938&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=24" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid11566894-15"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid11566894_15-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Carey RM (September 2001). "Theodore Cooper Lecture: Renal dopamine system: paracrine regulator of sodium homeostasis and blood pressure". <i>Hypertension</i> <b>38</b> (3): 297–302. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1161%2Fhy0901.096422">10.1161/hy0901.096422</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11566894">11566894</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Theodore+Cooper+Lecture%3A+Renal+dopamine+system%3A+paracrine+regulator+of+sodium+homeostasis+and+blood+pressure&amp;rft.au=Carey+RM&amp;rft.aulast=Carey+RM&amp;rft.date=September+2001&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1161%2Fhy0901.096422&amp;rft_id=info%3Apmid%2F11566894&amp;rft.issue=3&amp;rft.jtitle=Hypertension&amp;rft.pages=297%E2%80%93302&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=38" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Rubi-16"><span class="mw-cite-backlink">^ <a href="#cite_ref-Rubi_16-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Rubi_16-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Rubí B, Maechler P (December 2010). <a rel="nofollow" class="external text" href="http://endo.endojournals.org/content/151/12/5570.long">"Minireview: new roles for peripheral dopamine on metabolic control and tumor growth: let's seek the balance"</a>. <i>Endocrinology</i> <b>151</b> (12): 5570–81. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1210%2Fen.2010-0745">10.1210/en.2010-0745</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21047943">21047943</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Minireview%3A+new+roles+for+peripheral+dopamine+on+metabolic+control+and+tumor+growth%3A+let%27s+seek+the+balance&amp;rft.aulast=Rub%C3%AD+B%2C+Maechler+P&amp;rft.au=Rub%C3%AD+B%2C+Maechler+P&amp;rft.date=December+2010&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fendo.endojournals.org%2Fcontent%2F151%2F12%2F5570.long&amp;rft_id=info%3Adoi%2F10.1210%2Fen.2010-0745&amp;rft_id=info%3Apmid%2F21047943&amp;rft.issue=12&amp;rft.jtitle=Endocrinology&amp;rft.pages=5570%E2%80%9381&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=151" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-17"><span class="mw-cite-backlink"><b><a href="#cite_ref-17">^</a></b></span> <span class="reference-text"><span class="citation journal">Grace AA, (1991). "Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the eitiology of schizophrenia". <i>Neuroscience</i> <b>41</b> (1): 1–24. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2F0306-4522%2891%2990196-U">10.1016/0306-4522(91)90196-U</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/1676137">1676137</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Phasic+versus+tonic+dopamine+release+and+the+modulation+of+dopamine+system+responsivity%3A+A+hypothesis+for+the+eitiology+of+schizophrenia&amp;rft.au=Grace+AA%2C&amp;rft.aulast=Grace+AA%2C&amp;rft.date=1991&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2F0306-4522%2891%2990196-U&amp;rft_id=info%3Apmid%2F1676137&amp;rft.issue=1&amp;rft.jtitle=Neuroscience&amp;rft.pages=1%E2%80%9324&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=41" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-18"><span class="mw-cite-backlink"><b><a href="#cite_ref-18">^</a></b></span> <span class="reference-text"><span class="citation journal">Grace AA, Bunney BS (1984). <a rel="nofollow" class="external text" href="http://www.jneurosci.org/cgi/reprint/4/11/2866">"The control of firing pattern in nigral dopamine neurons: single spike firing"</a> (PDF). <i>Journal of Neuroscience</i> <b>4</b> (11): 2866–2876. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/6150070">6150070</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=The+control+of+firing+pattern+in+nigral+dopamine+neurons%3A+single+spike+firing&amp;rft.au=Grace+AA%2C+Bunney+BS&amp;rft.aulast=Grace+AA%2C+Bunney+BS&amp;rft.date=1984&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.jneurosci.org%2Fcgi%2Freprint%2F4%2F11%2F2866&amp;rft_id=info%3Apmid%2F6150070&amp;rft.issue=11&amp;rft.jtitle=Journal+of+Neuroscience&amp;rft.pages=2866%E2%80%932876&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=4" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-19"><span class="mw-cite-backlink"><b><a href="#cite_ref-19">^</a></b></span> <span class="reference-text"><span class="citation journal">Grace AA, Bunney BS (1984). <a rel="nofollow" class="external text" href="http://www.jneurosci.org/cgi/reprint/4/11/2877">"The control of firing pattern in nigral dopamine neurons: burst firing"</a> (PDF). <i>Journal of Neuroscience</i> <b>4</b> (11): 28677–2890. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/6150071">6150071</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=The+control+of+firing+pattern+in+nigral+dopamine+neurons%3A+burst+firing&amp;rft.au=Grace+AA%2C+Bunney+BS&amp;rft.aulast=Grace+AA%2C+Bunney+BS&amp;rft.date=1984&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.jneurosci.org%2Fcgi%2Freprint%2F4%2F11%2F2877&amp;rft_id=info%3Apmid%2F6150071&amp;rft.issue=11&amp;rft.jtitle=Journal+of+Neuroscience&amp;rft.pages=28677%E2%80%932890&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=4" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-20"><span class="mw-cite-backlink"><b><a href="#cite_ref-20">^</a></b></span> <span class="reference-text"><span class="citation journal">Calabresi P, Picconi B, Tozzi A, Di Filippo M (May 2007). "Dopamine-mediated regulation of corticostriatal synaptic plasticity". <i>Trends Neurosci.</i> <b>30</b> (5): 211–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2Fj.tins.2007.03.001">10.1016/j.tins.2007.03.001</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17367873">17367873</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Dopamine-mediated+regulation+of+corticostriatal+synaptic+plasticity&amp;rft.au=Calabresi+P%2C+Picconi+B%2C+Tozzi+A%2C+Di+Filippo+M&amp;rft.aulast=Calabresi+P%2C+Picconi+B%2C+Tozzi+A%2C+Di+Filippo+M&amp;rft.date=May+2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.tins.2007.03.001&amp;rft_id=info%3Apmid%2F17367873&amp;rft.issue=5&amp;rft.jtitle=Trends+Neurosci.&amp;rft.pages=211%E2%80%939&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=30" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-fn5-21"><span class="mw-cite-backlink">^ <a href="#cite_ref-fn5_21-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-fn5_21-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Arias-Carrión O, Pöppel E (2007). "Dopamine, learning and reward-seeking behavior". <i>Act Neurobiol Exp</i> <b>67</b> (4): 481–488.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Dopamine%2C+learning+and+reward-seeking+behavior&amp;rft.au=Arias-Carri%C3%B3n+O%2C+P%C3%B6ppel+E&amp;rft.aulast=Arias-Carri%C3%B3n+O%2C+P%C3%B6ppel+E&amp;rft.date=2007&amp;rft.genre=article&amp;rft.issue=4&amp;rft.jtitle=Act+Neurobiol+Exp&amp;rft.pages=481%E2%80%93488&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=67" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Wise-22"><span class="mw-cite-backlink">^ <a href="#cite_ref-Wise_22-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Wise_22-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Wise RA (1996). "Addictive drugs and brain stimulation reward". <i>Annu. Rev. Neurosci.</i> <b>19</b>: 319–40. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1146%2Fannurev.ne.19.030196.001535">10.1146/annurev.ne.19.030196.001535</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8833446">8833446</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Addictive+drugs+and+brain+stimulation+reward&amp;rft.aulast=Wise+RA&amp;rft.au=Wise+RA&amp;rft.date=1996&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1146%2Fannurev.ne.19.030196.001535&amp;rft_id=info%3Apmid%2F8833446&amp;rft.jtitle=Annu.+Rev.+Neurosci.&amp;rft.pages=319%E2%80%9340&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=19" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Schultz-23"><span class="mw-cite-backlink">^ <a href="#cite_ref-Schultz_23-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Schultz_23-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Schultz W (2002). "Getting formal with dopamine and reward". <i>Neuron</i> <b>36</b> (2): 241–263. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2FS0896-6273%2802%2900967-4">10.1016/S0896-6273(02)00967-4</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12383780">12383780</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Getting+formal+with+dopamine+and+reward&amp;rft.aulast=Schultz+W&amp;rft.au=Schultz+W&amp;rft.date=2002&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0896-6273%2802%2900967-4&amp;rft_id=info%3Apmid%2F12383780&amp;rft.issue=2&amp;rft.jtitle=Neuron&amp;rft.pages=241%E2%80%93263&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=36" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Matsumoto-24"><span class="mw-cite-backlink">^ <a href="#cite_ref-Matsumoto_24-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Matsumoto_24-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Matsumoto_24-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Matsumoto_24-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Matsumoto M, Hikosaka O. (2009). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2739096">"Two types of dopamine neuron distinctly convey positive and negative motivational signals"</a>. <i>Nature</i> <b>459</b> (7248): 837–41. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1038%2Fnature08028">10.1038/nature08028</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2739096">2739096</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19448610">19448610</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Two+types+of+dopamine+neuron+distinctly+convey+positive+and+negative+motivational+signals&amp;rft.aulast=Matsumoto+M%2C+Hikosaka+O.&amp;rft.au=Matsumoto+M%2C+Hikosaka+O.&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2739096&amp;rft_id=info%3Adoi%2F10.1038%2Fnature08028&amp;rft_id=info%3Apmc%2F2739096&amp;rft_id=info%3Apmid%2F19448610&amp;rft.issue=7248&amp;rft.jtitle=Nature&amp;rft.pages=837%E2%80%9341&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=459" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Williams-25"><span class="mw-cite-backlink"><b><a href="#cite_ref-Williams_25-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Williams SM, Goldman-Rakic PS. (1998). "Widespread origin of the primate mesofrontal dopamine system". <i>Cereb Cortex.</i> <b>8</b> (4): 321–45. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1093%2Fcercor%2F8.4.321">10.1093/cercor/8.4.321</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9651129">9651129</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Widespread+origin+of+the+primate+mesofrontal+dopamine+system&amp;rft.aulast=Williams+SM%2C+Goldman-Rakic+PS.&amp;rft.au=Williams+SM%2C+Goldman-Rakic+PS.&amp;rft.date=1998&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1093%2Fcercor%2F8.4.321&amp;rft_id=info%3Apmid%2F9651129&amp;rft.issue=4&amp;rft.jtitle=Cereb+Cortex.&amp;rft.pages=321%E2%80%9345&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=8" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Deutch-26"><span class="mw-cite-backlink"><b><a href="#cite_ref-Deutch_26-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Deutch AY, Roth RH. (1990). "The determinants of stress-induced activation of the prefrontal cortical dopamine system". <i>Prog Brain Res</i>. Progress in Brain Research <b>85</b>: 367–402. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2FS0079-6123%2808%2962691-6">10.1016/S0079-6123(08)62691-6</a>. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/9780444811240" title="Special:BookSources/9780444811240">9780444811240</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/2094906">2094906</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=The+determinants+of+stress-induced+activation+of+the+prefrontal+cortical+dopamine+system&amp;rft.au=Deutch+AY%2C+Roth+RH.&amp;rft.aulast=Deutch+AY%2C+Roth+RH.&amp;rft.date=1990&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0079-6123%2808%2962691-6&amp;rft_id=info%3Apmid%2F2094906&amp;rft.isbn=9780444811240&amp;rft.jtitle=Prog+Brain+Res.&amp;rft.pages=367%E2%80%93402&amp;rft.series=Progress+in+Brain+Research&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=85" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Brozoski-27"><span class="mw-cite-backlink"><b><a href="#cite_ref-Brozoski_27-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Brozoski TJ, Brown RM, Rosvold HE, Goldman PS. (1979). "Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey". <i>Science</i> <b>205</b> (4409): 929–32. <a href="/wiki/Bibcode" title="Bibcode">Bibcode</a>:<a rel="nofollow" class="external text" href="http://adsabs.harvard.edu/abs/1979Sci...205..929B">1979Sci...205..929B</a>. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1126%2Fscience.112679">10.1126/science.112679</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/112679">112679</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Cognitive+deficit+caused+by+regional+depletion+of+dopamine+in+prefrontal+cortex+of+rhesus+monkey&amp;rft.au=Brozoski+TJ%2C+Brown+RM%2C+Rosvold+HE%2C+Goldman+PS.&amp;rft.aulast=Brozoski+TJ%2C+Brown+RM%2C+Rosvold+HE%2C+Goldman+PS.&amp;rft.date=1979&amp;rft.genre=article&amp;rft_id=info%3Abibcode%2F1979Sci...205..929B&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.112679&amp;rft_id=info%3Apmid%2F112679&amp;rft.issue=4409&amp;rft.jtitle=Science&amp;rft.pages=929%E2%80%9332&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=205" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Arnsten-28"><span class="mw-cite-backlink"><b><a href="#cite_ref-Arnsten_28-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Arnsten AF, Wang MJ, Paspalas CD. (2012). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3488343">"Neuromodulation of thought: flexibilities and vulnerabilities in prefrontal cortical network synapses"</a>. <i>Neuron</i> <b>76</b> (1): 223–39. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2Fj.neuron.2012.08.038">10.1016/j.neuron.2012.08.038</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3488343">3488343</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23040817">23040817</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Neuromodulation+of+thought%3A+flexibilities+and+vulnerabilities+in+prefrontal+cortical+network+synapses&amp;rft.au=Arnsten+AF%2C+Wang+MJ%2C+Paspalas+CD.&amp;rft.aulast=Arnsten+AF%2C+Wang+MJ%2C+Paspalas+CD.&amp;rft.date=2012&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3488343&amp;rft_id=info%3Adoi%2F10.1016%2Fj.neuron.2012.08.038&amp;rft_id=info%3Apmc%2F3488343&amp;rft_id=info%3Apmid%2F23040817&amp;rft.issue=1&amp;rft.jtitle=Neuron&amp;rft.pages=223%E2%80%9339&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=76" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Vijayraghavan-29"><span class="mw-cite-backlink"><b><a href="#cite_ref-Vijayraghavan_29-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Vijayraghavan S, Wang M, Birnbaum SG, Williams GV, Arnsten AF. (2007). "Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory". <i>Nat Neurosci.</i> <b>10</b> (3): 376–84. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1038%2Fnn1846">10.1038/nn1846</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17277774">17277774</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Inverted-U+dopamine+D1+receptor+actions+on+prefrontal+neurons+engaged+in+working+memory&amp;rft.aulast=Vijayraghavan+S%2C+Wang+M%2C+Birnbaum+SG%2C+Williams+GV%2C+Arnsten+AF.&amp;rft.au=Vijayraghavan+S%2C+Wang+M%2C+Birnbaum+SG%2C+Williams+GV%2C+Arnsten+AF.&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1038%2Fnn1846&amp;rft_id=info%3Apmid%2F17277774&amp;rft.issue=3&amp;rft.jtitle=Nat+Neurosci.&amp;rft.pages=376%E2%80%9384&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=10" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Wang-30"><span class="mw-cite-backlink"><b><a href="#cite_ref-Wang_30-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Wang M, Vijayraghavan S, Goldman-Rakic PS. (2004). "Selective D2 receptor actions on the functional circuitry of working memory". <i>Science</i> <b>303</b> (5659): 853–6. <a href="/wiki/Bibcode" title="Bibcode">Bibcode</a>:<a rel="nofollow" class="external text" href="http://adsabs.harvard.edu/abs/2004Sci...303..853W">2004Sci...303..853W</a>. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1126%2Fscience.1091162">10.1126/science.1091162</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/14764884">14764884</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Selective+D2+receptor+actions+on+the+functional+circuitry+of+working+memory&amp;rft.aulast=Wang+M%2C+Vijayraghavan+S%2C+Goldman-Rakic+PS.&amp;rft.au=Wang+M%2C+Vijayraghavan+S%2C+Goldman-Rakic+PS.&amp;rft.date=2004&amp;rft.genre=article&amp;rft_id=info%3Abibcode%2F2004Sci...303..853W&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.1091162&amp;rft_id=info%3Apmid%2F14764884&amp;rft.issue=5659&amp;rft.jtitle=Science&amp;rft.pages=853%E2%80%936&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=303" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid17988927-31"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid17988927_31-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Merims D, Giladi N (2008). <a rel="nofollow" class="external text" href="http://linkinghub.elsevier.com/retrieve/pii/S1353-8020(07)00208-8">"Dopamine dysregulation syndrome, addiction and behavioral changes in Parkinson's disease"</a>. <i>Parkinsonism &amp; Related Disorders</i> <b>14</b> (4): 273–80. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2Fj.parkreldis.2007.09.007">10.1016/j.parkreldis.2007.09.007</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17988927">17988927</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Dopamine+dysregulation+syndrome%2C+addiction+and+behavioral+changes+in+Parkinson%27s+disease&amp;rft.aulast=Merims+D%2C+Giladi+N&amp;rft.au=Merims+D%2C+Giladi+N&amp;rft.date=2008&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1353-8020%2807%2900208-8&amp;rft_id=info%3Adoi%2F10.1016%2Fj.parkreldis.2007.09.007&amp;rft_id=info%3Apmid%2F17988927&amp;rft.issue=4&amp;rft.jtitle=Parkinsonism+%26+Related+Disorders&amp;rft.pages=273%E2%80%9380&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=14" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-32"><span class="mw-cite-backlink"><b><a href="#cite_ref-32">^</a></b></span> <span class="reference-text"><span class="citation journal">Wu J, Xiao H, Sun H, Zou L, Zhu LQ. (2012). "Role of dopamine receptors in ADHD: a systematic meta-analysis". <i>Mol Neurobiol.</i> <b>45</b>: 605–20.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Role+of+dopamine+receptors+in+ADHD%3A+a+systematic+meta-analysis&amp;rft.aulast=Wu+J%2C+Xiao+H%2C+Sun+H%2C+Zou+L%2C+Zhu+LQ.&amp;rft.au=Wu+J%2C+Xiao+H%2C+Sun+H%2C+Zou+L%2C+Zhu+LQ.&amp;rft.date=2012&amp;rft.genre=article&amp;rft.jtitle=Mol+Neurobiol.&amp;rft.pages=605%E2%80%9320&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=45" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-33"><span class="mw-cite-backlink"><b><a href="#cite_ref-33">^</a></b></span> <span class="reference-text"><span class="citation journal">Berridge CW, Devilbiss DM. (2011). "Psychostimulants as cognitive enhancers: the prefrontal cortex, catecholamines, and attention-deficit/hyperactivity disorder". <i>Biol Psychiatry</i> <b>69</b> (12): e101–11.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Psychostimulants+as+cognitive+enhancers%3A+the+prefrontal+cortex%2C+catecholamines%2C+and+attention-deficit%2Fhyperactivity+disorder&amp;rft.au=Berridge+CW%2C+Devilbiss+DM.&amp;rft.aulast=Berridge+CW%2C+Devilbiss+DM.&amp;rft.date=2011&amp;rft.genre=article&amp;rft.issue=12&amp;rft.jtitle=Biol+Psychiatry&amp;rft.pages=e101%E2%80%9311&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=69" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Nestler.2C_Hyman.2C_and_Malenka_2-34"><span class="mw-cite-backlink">^ <a href="#cite_ref-Nestler.2C_Hyman.2C_and_Malenka_2_34-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Nestler.2C_Hyman.2C_and_Malenka_2_34-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Nestler.2C_Hyman.2C_and_Malenka_2_34-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Nestler.2C_Hyman.2C_and_Malenka_2_34-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Hyman SE, Malenka RC, Nestler EJ (2006). "Neural mechanisms of addiction: the role of reward-related learning and memory". <i>Annu. Rev. Neurosci.</i> <b>29</b>: 565–598. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1146%2Fannurev.neuro.29.051605.113009">10.1146/annurev.neuro.29.051605.113009</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16776597">16776597</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Neural+mechanisms+of+addiction%3A+the+role+of+reward-related+learning+and+memory&amp;rft.au=Hyman+SE%2C+Malenka+RC%2C+Nestler+EJ&amp;rft.aulast=Hyman+SE%2C+Malenka+RC%2C+Nestler+EJ&amp;rft.date=2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1146%2Fannurev.neuro.29.051605.113009&amp;rft_id=info%3Apmid%2F16776597&amp;rft.jtitle=Annu.+Rev.+Neurosci.&amp;rft.pages=565%26ndash%3B598&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=29" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Nestler-35"><span class="mw-cite-backlink">^ <a href="#cite_ref-Nestler_35-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Nestler_35-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Nestler_35-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Nestler_35-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Nestler_35-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Nestler_35-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Nestler_35-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Nestler_35-7"><sup><i><b>h</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Nestler EJ (December 2012). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3569166">"Transcriptional mechanisms of drug addiction"</a>. <i>Clin. Psychopharmacol. Neurosci.</i> <b>10</b> (3): 136–143. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.9758%2Fcpn.2012.10.3.136">10.9758/cpn.2012.10.3.136</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3569166">3569166</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23430970">23430970</a>. "ΔFosB has been linked directly to several addiction-related behaviors&#160;...&#160; Importantly, genetic or viral overexpression of ΔJunD, a dominant negative mutant of JunD which antagonizes ΔFosB- and other AP-1-mediated transcriptional activity, in the NAc or OFC blocks these key effects of drug exposure14,22–24. This indicates that ΔFosB is both necessary and sufficient for many of the changes wrought in the brain by chronic drug exposure. ΔFosB is also induced in D1-type NAc MSNs by chronic consumption of several natural rewards, including sucrose, high fat food, sex, wheel running, where it promotes that consumption14,26–30. This implicates ΔFosB in the regulation of natural rewards under normal conditions and perhaps during pathological addictive-like states."</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Transcriptional+mechanisms+of+drug+addiction&amp;rft.aulast=Nestler+EJ&amp;rft.au=Nestler+EJ&amp;rft.date=December+2012&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3569166&amp;rft_id=info%3Adoi%2F10.9758%2Fcpn.2012.10.3.136&amp;rft_id=info%3Apmc%2F3569166&amp;rft_id=info%3Apmid%2F23430970&amp;rft.issue=3&amp;rft.jtitle=Clin.+Psychopharmacol.+Neurosci.&amp;rft.pages=136%26ndash%3B143&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=10" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Malenka_2009_04-36"><span class="mw-cite-backlink"><b><a href="#cite_ref-Malenka_2009_04_36-0">^</a></b></span> <span class="reference-text"><span class="citation book">Malenka RC, Nestler EJ, Hyman SE (2009). "Chapter 15: Reinforcement and addictive disorders". In Sydor A, Brown RY. <i>Molecular Neuropharmacology: A Foundation for Clinical Neuroscience</i> (2nd ed.). New York: McGraw-Hill Medical. pp.&#160;384–385. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/9780071481274" title="Special:BookSources/9780071481274">9780071481274</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Molecular+Neuropharmacology%3A+A+Foundation+for+Clinical+Neuroscience&amp;rft.aulast=Malenka+RC%2C+Nestler+EJ%2C+Hyman+SE&amp;rft.au=Malenka+RC%2C+Nestler+EJ%2C+Hyman+SE&amp;rft.btitle=Chapter+15%3A+Reinforcement+and+addictive+disorders&amp;rft.date=2009&amp;rft.edition=2nd&amp;rft.genre=bookitem&amp;rft.isbn=9780071481274&amp;rft.pages=384%26ndash%3B385&amp;rft.place=New+York&amp;rft.pub=McGraw-Hill+Medical&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid11207397-37"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid11207397_37-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Jääskeläinen SK, Rinne JO, Forssell H, Tenovuo O, Kaasinen V, Sonninen P, Bergman J (2001). "Role of the dopaminergic system in chronic pain&#160;– a fluorodopa-PET study". <i>Pain</i> <b>90</b> (3): 257–60. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2FS0304-3959%2800%2900409-7">10.1016/S0304-3959(00)00409-7</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11207397">11207397</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Role+of+the+dopaminergic+system+in+chronic+pain%26nbsp%3B%E2%80%93+a+fluorodopa-PET+study&amp;rft.au=J%C3%A4%C3%A4skel%C3%A4inen+SK%2C+Rinne+JO%2C+Forssell+H%2C+Tenovuo+O%2C+Kaasinen+V%2C+Sonninen+P%2C+Bergman+J&amp;rft.aulast=J%C3%A4%C3%A4skel%C3%A4inen+SK%2C+Rinne+JO%2C+Forssell+H%2C+Tenovuo+O%2C+Kaasinen+V%2C+Sonninen+P%2C+Bergman+J&amp;rft.date=2001&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0304-3959%2800%2900409-7&amp;rft_id=info%3Apmid%2F11207397&amp;rft.issue=3&amp;rft.jtitle=Pain&amp;rft.pages=257%E2%80%9360&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=90" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid18457535-38"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid18457535_38-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Wood PB (2008). "Role of central dopamine in pain and analgesia". <i>Expert Rev Neurother</i> <b>8</b> (5): 781–97. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1586%2F14737175.8.5.781">10.1586/14737175.8.5.781</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18457535">18457535</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Role+of+central+dopamine+in+pain+and+analgesia&amp;rft.aulast=Wood+PB&amp;rft.au=Wood+PB&amp;rft.date=2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1586%2F14737175.8.5.781&amp;rft_id=info%3Apmid%2F18457535&amp;rft.issue=5&amp;rft.jtitle=Expert+Rev+Neurother&amp;rft.pages=781%E2%80%9397&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=8" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-39"><span class="mw-cite-backlink"><b><a href="#cite_ref-39">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.innovations-report.com/html/reports/life_sciences/report-52499.html">"Disruption of gene interaction linked to schizophrenia"</a>. St. Jude Children's Research Hospital<span class="reference-accessdate">. Retrieved 6 July 2006</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.btitle=Disruption+of+gene+interaction+linked+to+schizophrenia&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.innovations-report.com%2Fhtml%2Freports%2Flife_sciences%2Freport-52499.html&amp;rft.pub=St.+Jude+Children%27s+Research+Hospital&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid9050120-40"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid9050120_40-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Maas JW, Bowden CL, Miller AL, Javors MA, Funderburg LG, Berman N, Weintraub ST (1997). "Schizophrenia, psychosis, and cerebral spinal fluid homovanillic acid concentrations". <i>Schizophr Bull</i> <b>23</b> (1): 147–54. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1093%2Fschbul%2F23.1.147">10.1093/schbul/23.1.147</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9050120">9050120</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Schizophrenia%2C+psychosis%2C+and+cerebral+spinal+fluid+homovanillic+acid+concentrations&amp;rft.aulast=Maas+JW%2C+Bowden+CL%2C+Miller+AL%2C+Javors+MA%2C+Funderburg+LG%2C+Berman+N%2C+Weintraub+ST&amp;rft.au=Maas+JW%2C+Bowden+CL%2C+Miller+AL%2C+Javors+MA%2C+Funderburg+LG%2C+Berman+N%2C+Weintraub+ST&amp;rft.date=1997&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1093%2Fschbul%2F23.1.147&amp;rft_id=info%3Apmid%2F9050120&amp;rft.issue=1&amp;rft.jtitle=Schizophr+Bull&amp;rft.pages=147%E2%80%9354&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=23" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-41"><span class="mw-cite-backlink"><b><a href="#cite_ref-41">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="http://www.williams.edu/imput/synapse/pages/IIIB5.htm">http://www.williams.edu/imput/synapse/pages/IIIB5.htm</a></span></li>
<li id="cite_note-pmid7475902-42"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid7475902_42-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Durcan MJ, Rigdon GC, Norman MH, Morgan PF (1995). "Is clozapine selective for the dopamine D4 receptor?". <i>Life Sci.</i> <b>57</b> (18): PL275–83. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2F0024-3205%2895%2902151-8">10.1016/0024-3205(95)02151-8</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/7475902">7475902</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Is+clozapine+selective+for+the+dopamine+D4+receptor%3F&amp;rft.au=Durcan+MJ%2C+Rigdon+GC%2C+Norman+MH%2C+Morgan+PF&amp;rft.aulast=Durcan+MJ%2C+Rigdon+GC%2C+Norman+MH%2C+Morgan+PF&amp;rft.date=1995&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2F0024-3205%2895%2902151-8&amp;rft_id=info%3Apmid%2F7475902&amp;rft.issue=18&amp;rft.jtitle=Life+Sci.&amp;rft.pages=PL275%E2%80%9383&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=57" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-43"><span class="mw-cite-backlink"><b><a href="#cite_ref-43">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://webcache.googleusercontent.com/search?q=cache:b3pkrTPLeT0J:www.stopmethinflorida.org/documents/Methamphetamine101.ppt+www.stopmethinflorida.org/documents/Methamphetamine101.ppt&amp;cd=1&amp;hl=en&amp;ct=clnk&amp;gl"><i>Methamphetamine 101</i></a></span></li>
<li id="cite_note-pmid2884687-44"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid2884687_44-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Lieberman JA, Kane JM, Alvir J (1987). "Provocative tests with psychostimulant drugs in schizophrenia". <i>Psychopharmacology (Berl.)</i> <b>91</b> (4): 415–33. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1007%2FBF00216006">10.1007/BF00216006</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/2884687">2884687</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Provocative+tests+with+psychostimulant+drugs+in+schizophrenia&amp;rft.aulast=Lieberman+JA%2C+Kane+JM%2C+Alvir+J&amp;rft.au=Lieberman+JA%2C+Kane+JM%2C+Alvir+J&amp;rft.date=1987&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2FBF00216006&amp;rft_id=info%3Apmid%2F2884687&amp;rft.issue=4&amp;rft.jtitle=Psychopharmacology+%28Berl.%29&amp;rft.pages=415%E2%80%9333&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=91" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Cardinal_2011_diagnosis_psychosis-45"><span class="mw-cite-backlink"><b><a href="#cite_ref-Cardinal_2011_diagnosis_psychosis_45-0">^</a></b></span> <span class="reference-text">Cardinal, R.N. &amp; Bullmore, E.T., <i>The Diagnosis of Psychosis</i>, <a href="/wiki/Cambridge_University_Press" title="Cambridge University Press">Cambridge University Press</a>, 2011, <a href="/wiki/Special:BookSources/9780521164849" class="internal mw-magiclink-isbn">ISBN 978-0-521-16484-9</a></span></li>
<li id="cite_note-pmid10063482-46"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid10063482_46-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Jentsch JD, Roth RH (1999). "The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia". <i>Neuropsychopharmacology</i> <b>20</b> (3): 201–25. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2FS0893-133X%2898%2900060-8">10.1016/S0893-133X(98)00060-8</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10063482">10063482</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=The+neuropsychopharmacology+of+phencyclidine%3A+from+NMDA+receptor+hypofunction+to+the+dopamine+hypothesis+of+schizophrenia&amp;rft.au=Jentsch+JD%2C+Roth+RH&amp;rft.aulast=Jentsch+JD%2C+Roth+RH&amp;rft.date=1999&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0893-133X%2898%2900060-8&amp;rft_id=info%3Apmid%2F10063482&amp;rft.issue=3&amp;rft.jtitle=Neuropsychopharmacology&amp;rft.pages=201%E2%80%9325&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=20" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid9754841-47"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid9754841_47-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Abi-Saab WM, D'Souza DC, Moghaddam B, Krystal JH (1998). "The NMDA antagonist model for schizophrenia: promise and pitfalls". <i>Pharmacopsychiatry</i>. 31 Suppl 2: 104–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1055%2Fs-2007-979354">10.1055/s-2007-979354</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9754841">9754841</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=The+NMDA+antagonist+model+for+schizophrenia%3A+promise+and+pitfalls&amp;rft.au=Abi-Saab+WM%2C+D%27Souza+DC%2C+Moghaddam+B%2C+Krystal+JH&amp;rft.aulast=Abi-Saab+WM%2C+D%27Souza+DC%2C+Moghaddam+B%2C+Krystal+JH&amp;rft.date=1998&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1055%2Fs-2007-979354&amp;rft_id=info%3Apmid%2F9754841&amp;rft.jtitle=Pharmacopsychiatry&amp;rft.pages=104%E2%80%939&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=31+Suppl+2" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-48"><span class="mw-cite-backlink"><b><a href="#cite_ref-48">^</a></b></span> <span class="reference-text"><span class="citation journal">Galani VJ, Rana DG (2011). "Depression and antidepressants with dopamine hypothesis-A review". <i>IJPFR</i> <b>1</b> (2): 45–60.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Depression+and+antidepressants+with+dopamine+hypothesis-A+review&amp;rft.au=Galani+VJ%2C+Rana+DG&amp;rft.aulast=Galani+VJ%2C+Rana+DG&amp;rft.date=2011&amp;rft.genre=article&amp;rft.issue=2&amp;rft.jtitle=IJPFR&amp;rft.pages=45%E2%80%9360&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=1" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid5116991-49"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid5116991_49-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Benkert O, Renz A, Marano C, Matussek N (October 1971). "Altered tyrosine daytime plasma levels in endogenous depressive patients". <i>Arch. Gen. Psychiatry</i> <b>25</b> (4): 359–63. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1001%2Farchpsyc.1971.01750160071013">10.1001/archpsyc.1971.01750160071013</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/5116991">5116991</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Altered+tyrosine+daytime+plasma+levels+in+endogenous+depressive+patients&amp;rft.au=Benkert+O%2C+Renz+A%2C+Marano+C%2C+Matussek+N&amp;rft.aulast=Benkert+O%2C+Renz+A%2C+Marano+C%2C+Matussek+N&amp;rft.date=October+1971&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1001%2Farchpsyc.1971.01750160071013&amp;rft_id=info%3Apmid%2F5116991&amp;rft.issue=4&amp;rft.jtitle=Arch.+Gen.+Psychiatry&amp;rft.pages=359%E2%80%9363&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=25" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-50"><span class="mw-cite-backlink"><b><a href="#cite_ref-50">^</a></b></span> <span class="reference-text"><span class="citation journal">Birkmayer W, Linauer W, Storung D (1970). "Tyrosin and tryptophan- metabolisms in depression patients". <i>Arch Psychiar Nervenkr</i> <b>213</b> (4): 377–387. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1007%2FBF00341554">10.1007/BF00341554</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Tyrosin+and+tryptophan-+metabolisms+in+depression+patients&amp;rft.au=Birkmayer+W%2C+Linauer+W%2C+Storung+D&amp;rft.aulast=Birkmayer+W%2C+Linauer+W%2C+Storung+D&amp;rft.date=1970&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2FBF00341554&amp;rft.issue=4&amp;rft.jtitle=Arch+Psychiar+Nervenkr&amp;rft.pages=377%E2%80%93387&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=213" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid5796265-51"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid5796265_51-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Bowers MB, Heninger GR, Gerbode F (1969). "Cerebrospinal fluid 5-hydroxyindoleactiic acid and homovanillic acid in psychiatric patients". <i>Int J Neuropharmacol</i> <b>8</b> (3): 255–62. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2F0028-3908%2869%2990046-X">10.1016/0028-3908(69)90046-X</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/5796265">5796265</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Cerebrospinal+fluid+5-hydroxyindoleactiic+acid+and+homovanillic+acid+in+psychiatric+patients&amp;rft.au=Bowers+MB%2C+Heninger+GR%2C+Gerbode+F&amp;rft.aulast=Bowers+MB%2C+Heninger+GR%2C+Gerbode+F&amp;rft.date=1969&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2F0028-3908%2869%2990046-X&amp;rft_id=info%3Apmid%2F5796265&amp;rft.issue=3&amp;rft.jtitle=Int+J+Neuropharmacol&amp;rft.pages=255%E2%80%9362&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=8" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid18371940-52"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid18371940_52-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Xiang L, Szebeni K, Szebeni A, Klimek V, Stockmeier CA, Karolewicz B, Kalbfleisch J, Ordway GA (May 2008). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2577810">"Dopamine receptor gene expression in human amygdaloid nuclei: elevated D4 receptor mRNA in major depression"</a>. <i>Brain Res.</i> <b>1207</b>: 214–24. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2Fj.brainres.2008.02.009">10.1016/j.brainres.2008.02.009</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2577810">2577810</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18371940">18371940</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Dopamine+receptor+gene+expression+in+human+amygdaloid+nuclei%3A+elevated+D4+receptor+mRNA+in+major+depression&amp;rft.aulast=Xiang+L%2C+Szebeni+K%2C+Szebeni+A%2C+Klimek+V%2C+Stockmeier+CA%2C+Karolewicz+B%2C+Kalbfleisch+J%2C+Ordway+GA&amp;rft.au=Xiang+L%2C+Szebeni+K%2C+Szebeni+A%2C+Klimek+V%2C+Stockmeier+CA%2C+Karolewicz+B%2C+Kalbfleisch+J%2C+Ordway+GA&amp;rft.date=May+2008&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2577810&amp;rft_id=info%3Adoi%2F10.1016%2Fj.brainres.2008.02.009&amp;rft_id=info%3Apmc%2F2577810&amp;rft_id=info%3Apmid%2F18371940&amp;rft.jtitle=Brain+Res.&amp;rft.pages=214%E2%80%9324&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=1207" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid8866721-53"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid8866721_53-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Carlson JN, Visker KE, Nielsen DM, Keller RW, Glick SD (1996). "Chronic antidepressant drug treatment reduces turning behavior and increases dopamine levels in the medial prefrontal cortex". <i>Brain Res.</i> <b>707</b> (1): 122–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2F0006-8993%2895%2901341-5">10.1016/0006-8993(95)01341-5</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8866721">8866721</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Chronic+antidepressant+drug+treatment+reduces+turning+behavior+and+increases+dopamine+levels+in+the+medial+prefrontal+cortex&amp;rft.au=Carlson+JN%2C+Visker+KE%2C+Nielsen+DM%2C+Keller+RW%2C+Glick+SD&amp;rft.aulast=Carlson+JN%2C+Visker+KE%2C+Nielsen+DM%2C+Keller+RW%2C+Glick+SD&amp;rft.date=1996&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2F0006-8993%2895%2901341-5&amp;rft_id=info%3Apmid%2F8866721&amp;rft.issue=1&amp;rft.jtitle=Brain+Res.&amp;rft.pages=122%E2%80%936&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=707" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid9888623-54"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid9888623_54-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Ainsworth K, Smith SE, Zetterström TS, Pei Q, Franklin M, Sharp T (December 1998). "Effect of antidepressant drugs on dopamine D1 and D2 receptor expression and dopamine release in the nucleus accumbens of the rat". <i>Psychopharmacology (Berl.)</i> <b>140</b> (4): 470–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1007%2Fs002130050791">10.1007/s002130050791</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9888623">9888623</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Effect+of+antidepressant+drugs+on+dopamine+D1+and+D2+receptor+expression+and+dopamine+release+in+the+nucleus+accumbens+of+the+rat&amp;rft.au=Ainsworth+K%2C+Smith+SE%2C+Zetterstr%C3%B6m+TS%2C+Pei+Q%2C+Franklin+M%2C+Sharp+T&amp;rft.aulast=Ainsworth+K%2C+Smith+SE%2C+Zetterstr%C3%B6m+TS%2C+Pei+Q%2C+Franklin+M%2C+Sharp+T&amp;rft.date=December+1998&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2Fs002130050791&amp;rft_id=info%3Apmid%2F9888623&amp;rft.issue=4&amp;rft.jtitle=Psychopharmacology+%28Berl.%29&amp;rft.pages=470%E2%80%937&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=140" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid2901126-55"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid2901126_55-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Meltzer LT, Wiley JN, Williams AE, Heffner TG (1988). "Evidence for postsynaptic dopamine agonist effects of B-HT 920 in the presence of the dopamine D-1 agonist SKF 38393". <i>Psychopharmacology (Berl.)</i> <b>95</b> (3): 329–32. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1007%2FBF00181942">10.1007/BF00181942</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/2901126">2901126</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Evidence+for+postsynaptic+dopamine+agonist+effects+of+B-HT+920+in+the+presence+of+the+dopamine+D-1+agonist+SKF+38393&amp;rft.aulast=Meltzer+LT%2C+Wiley+JN%2C+Williams+AE%2C+Heffner+TG&amp;rft.au=Meltzer+LT%2C+Wiley+JN%2C+Williams+AE%2C+Heffner+TG&amp;rft.date=1988&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2FBF00181942&amp;rft_id=info%3Apmid%2F2901126&amp;rft.issue=3&amp;rft.jtitle=Psychopharmacology+%28Berl.%29&amp;rft.pages=329%E2%80%9332&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=95" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid2482026-56"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid2482026_56-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Nomikos GG, Damsma G, Wenkstern D, Fibiger HC (1989). "Acute effects of bupropion on extracellular dopamine concentrations in rat striatum and nucleus accumbens studied by in vivo microdialysis". <i>Neuropsychopharmacology</i> <b>2</b> (4): 273–9. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/2482026">2482026</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Acute+effects+of+bupropion+on+extracellular+dopamine+concentrations+in+rat+striatum+and+nucleus+accumbens+studied+by+in+vivo+microdialysis&amp;rft.aulast=Nomikos+GG%2C+Damsma+G%2C+Wenkstern+D%2C+Fibiger+HC&amp;rft.au=Nomikos+GG%2C+Damsma+G%2C+Wenkstern+D%2C+Fibiger+HC&amp;rft.date=1989&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F2482026&amp;rft.issue=4&amp;rft.jtitle=Neuropsychopharmacology&amp;rft.pages=273%E2%80%939&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=2" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Tye_2012_537-541-57"><span class="mw-cite-backlink">^ <a href="#cite_ref-Tye_2012_537-541_57-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Tye_2012_537-541_57-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Deisseroth, Julie J.; Mirzabekov, Warden, Ferenczi, Tsai, Finkelstein, kim, Adhikari, Thompson, Andalman, Gunaydin, Witten &amp; Deisseroth (2012). "Dopamine neurons modulate neural encoding and expression of depression-related behaviour". <i>Nature</i> <b>493</b> (7433): 537–541. <a href="/wiki/Bibcode" title="Bibcode">Bibcode</a>:<a rel="nofollow" class="external text" href="http://adsabs.harvard.edu/abs/2013Natur.493..537T">2013Natur.493..537T</a>. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1038%2Fnature11740">10.1038/nature11740</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23235822">23235822</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Dopamine+neurons+modulate+neural+encoding+and+expression+of+depression-related+behaviour&amp;rft.au=Deisseroth%2C+Julie+J.&amp;rft.aufirst=Julie+J.&amp;rft.aulast=Deisseroth&amp;rft.au=Mirzabekov%2C+Warden%2C+Ferenczi%2C+Tsai%2C+Finkelstein%2C+kim%2C+Adhikari%2C+Thompson%2C+Andalman%2C+Gunaydin%2C+Witten+%26+Deisseroth&amp;rft.date=2012&amp;rft.genre=article&amp;rft_id=info%3Abibcode%2F2013Natur.493..537T&amp;rft_id=info%3Adoi%2F10.1038%2Fnature11740&amp;rft_id=info%3Apmid%2F23235822&amp;rft.issue=7433&amp;rft.jtitle=Nature&amp;rft.pages=537%E2%80%93541&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=493" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid23235832-58"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid23235832_58-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Chaudhury D, Walsh JJ, Friedman AK, Juarez B, Ku SM, Koo JW, Ferguson D, Tsai HC, Pomeranz L, Christoffel DJ, Nectow AR, Ekstrand M, Domingos A, Mazei-Robison MS, Mouzon E, Lobo MK, Neve RL, Friedman JM, Russo SJ, Deisseroth K, Nestler EJ, Han MH (2013). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3554860">"Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons"</a>. <i>Nature</i> <b>493</b> (7433): 532–6. <a href="/wiki/Bibcode" title="Bibcode">Bibcode</a>:<a rel="nofollow" class="external text" href="http://adsabs.harvard.edu/abs/2013Natur.493..532C">2013Natur.493..532C</a>. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1038%2Fnature11713">10.1038/nature11713</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3554860">3554860</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23235832">23235832</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Rapid+regulation+of+depression-related+behaviours+by+control+of+midbrain+dopamine+neurons&amp;rft.au=Chaudhury+D%2C+Walsh+JJ%2C+Friedman+AK%2C+Juarez+B%2C+Ku+SM%2C+Koo+JW%2C+Ferguson+D%2C+Tsai+HC%2C+Pomeranz+L%2C+Christoffel+DJ%2C+Nectow+AR%2C+Ekstrand+M%2C+Domingos+A%2C+Mazei-Robison+MS%2C+Mouzon+E%2C+Lobo+MK%2C+Neve+RL%2C+Friedman+JM%2C+Russo+SJ%2C+Deisseroth+K%2C+Nestler+EJ%2C+Han+MH&amp;rft.aulast=Chaudhury+D%2C+Walsh+JJ%2C+Friedman+AK%2C+Juarez+B%2C+Ku+SM%2C+Koo+JW%2C+Ferguson+D%2C+Tsai+HC%2C+Pomeranz+L%2C+Christoffel+DJ%2C+Nectow+AR%2C+Ekstrand+M%2C+Domingos+A%2C+Mazei-Robison+MS%2C+Mouzon+E%2C+Lobo+MK%2C+Neve+RL%2C+Friedman+JM%2C+Russo+SJ%2C+Deisseroth+K%2C+Nestler+EJ%2C+Han+MH&amp;rft.date=2013&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3554860&amp;rft_id=info%3Abibcode%2F2013Natur.493..532C&amp;rft_id=info%3Adoi%2F10.1038%2Fnature11713&amp;rft_id=info%3Apmc%2F3554860&amp;rft_id=info%3Apmid%2F23235832&amp;rft.issue=7433&amp;rft.jtitle=Nature&amp;rft.pages=532%E2%80%936&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=493" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid2378927-59"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid2378927_59-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Muscat R, Sampson D, Willner P (1990). "Dopaminergic mechanism of imipramine action in an animal model of depression". <i>Biol. Psychiatry</i> <b>28</b> (3): 223–30. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2F0006-3223%2890%2990577-O">10.1016/0006-3223(90)90577-O</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/2378927">2378927</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Dopaminergic+mechanism+of+imipramine+action+in+an+animal+model+of+depression&amp;rft.aulast=Muscat+R%2C+Sampson+D%2C+Willner+P&amp;rft.au=Muscat+R%2C+Sampson+D%2C+Willner+P&amp;rft.date=1990&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2F0006-3223%2890%2990577-O&amp;rft_id=info%3Apmid%2F2378927&amp;rft.issue=3&amp;rft.jtitle=Biol.+Psychiatry&amp;rft.pages=223%E2%80%9330&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=28" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-60"><span class="mw-cite-backlink"><b><a href="#cite_ref-60">^</a></b></span> <span class="reference-text"><span class="citation book">Roshchina VV (2010). "Evolutionary considerations of neurotransmitters in microbial, plant, and animal cells". In Lyte M, Primrose PEPE. <i>Microbial Endocrinology</i>. New York: Springer. pp.&#160;17–52. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-1-4419-5576-0" title="Special:BookSources/978-1-4419-5576-0">978-1-4419-5576-0</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Microbial+Endocrinology&amp;rft.aulast=Roshchina+VV&amp;rft.au=Roshchina+VV&amp;rft.btitle=Evolutionary+considerations+of+neurotransmitters+in+microbial%2C+plant%2C+and+animal+cells&amp;rft.date=2010&amp;rft.genre=bookitem&amp;rft.isbn=978-1-4419-5576-0&amp;rft.pages=17%E2%80%9352&amp;rft.place=New+York&amp;rft.pub=Springer&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-61"><span class="mw-cite-backlink"><b><a href="#cite_ref-61">^</a></b></span> <span class="reference-text"><span class="citation journal">Iyer LM, Aravind L, Coon SL, Klein DC, Koonin EV (July 2004). "Evolution of cell-cell signaling in animals: did late horizontal gene transfer from bacteria have a role?". <i>Trends Genet.</i> <b>20</b> (7): 292–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2Fj.tig.2004.05.007">10.1016/j.tig.2004.05.007</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15219393">15219393</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Evolution+of+cell-cell+signaling+in+animals%3A+did+late+horizontal+gene+transfer+from+bacteria+have+a+role%3F&amp;rft.au=Iyer+LM%2C+Aravind+L%2C+Coon+SL%2C+Klein+DC%2C+Koonin+EV&amp;rft.aulast=Iyer+LM%2C+Aravind+L%2C+Coon+SL%2C+Klein+DC%2C+Koonin+EV&amp;rft.date=July+2004&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.tig.2004.05.007&amp;rft_id=info%3Apmid%2F15219393&amp;rft.issue=7&amp;rft.jtitle=Trends+Genet.&amp;rft.pages=292%E2%80%939&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=20" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-62"><span class="mw-cite-backlink"><b><a href="#cite_ref-62">^</a></b></span> <span class="reference-text"><span class="citation journal">Liu H, Mishima Y, Fujiwara T, Nagai H, Kitazawa A, Mine Y, <i>et al.</i> (2004). "Isolation of Araguspongine M, a new stereoisomer of an Araguspongine/Xestospongin alkaloid, and dopamine from the marine sponge <i>Neopetrosia exigua</i> collected in Palau". <i>Marine Drugs</i> <b>2</b> (4): 154–163. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.3390%2Fmd204154">10.3390/md204154</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Isolation+of+Araguspongine+M%2C+a+new+stereoisomer+of+an+Araguspongine%2FXestospongin+alkaloid%2C+and+dopamine+from+the+marine+sponge+%27%27Neopetrosia+exigua%27%27+collected+in+Palau&amp;rft.aulast=Liu+H%2C+Mishima+Y%2C+Fujiwara+T%2C+Nagai+H%2C+Kitazawa+A%2C+Mine+Y%2C+%27%27et+al.%27%27&amp;rft.au=Liu+H%2C+Mishima+Y%2C+Fujiwara+T%2C+Nagai+H%2C+Kitazawa+A%2C+Mine+Y%2C+%27%27et+al.%27%27&amp;rft.date=2004&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.3390%2Fmd204154&amp;rft.issue=4&amp;rft.jtitle=Marine+Drugs&amp;rft.pages=154%E2%80%93163&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=2" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-63"><span class="mw-cite-backlink"><b><a href="#cite_ref-63">^</a></b></span> <span class="reference-text"><span class="citation journal">Kass-Simon G, Pierobon P (January 2007). "Cnidarian chemical neurotransmission, an updated overview". <i>Comp. Biochem. Physiol., Part a Mol. Integr. Physiol.</i> <b>146</b> (1): 9–25. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2Fj.cbpa.2006.09.008">10.1016/j.cbpa.2006.09.008</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17101286">17101286</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Cnidarian+chemical+neurotransmission%2C+an+updated+overview&amp;rft.au=Kass-Simon+G%2C+Pierobon+P&amp;rft.aulast=Kass-Simon+G%2C+Pierobon+P&amp;rft.date=January+2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.cbpa.2006.09.008&amp;rft_id=info%3Apmid%2F17101286&amp;rft.issue=1&amp;rft.jtitle=Comp.+Biochem.+Physiol.%2C+Part+a+Mol.+Integr.+Physiol.&amp;rft.pages=9%E2%80%9325&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=146" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-64"><span class="mw-cite-backlink"><b><a href="#cite_ref-64">^</a></b></span> <span class="reference-text"><span class="citation journal">Cottrell GA (January 1967). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1557178">"Occurrence of dopamine and noradrenaline in the nervous tissue of some invertebrate species"</a>. <i>Br J Pharmacol Chemother</i> <b>29</b> (1): 63–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1111%2Fj.1476-5381.1967.tb01939.x">10.1111/j.1476-5381.1967.tb01939.x</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1557178">1557178</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19108240">19108240</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Occurrence+of+dopamine+and+noradrenaline+in+the+nervous+tissue+of+some+invertebrate+species&amp;rft.au=Cottrell+GA&amp;rft.aulast=Cottrell+GA&amp;rft.date=January+1967&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1557178&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1476-5381.1967.tb01939.x&amp;rft_id=info%3Apmc%2F1557178&amp;rft_id=info%3Apmid%2F19108240&amp;rft.issue=1&amp;rft.jtitle=Br+J+Pharmacol+Chemother&amp;rft.pages=63%E2%80%939&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=29" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-65"><span class="mw-cite-backlink"><b><a href="#cite_ref-65">^</a></b></span> <span class="reference-text"><span class="citation journal">Kindt KS, Quast KB, Giles AC, <i>et al.</i> (August 2007). "Dopamine mediates context-dependent modulation of sensory plasticity in C. elegans". <i>Neuron</i> <b>55</b> (4): 662–76. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2Fj.neuron.2007.07.023">10.1016/j.neuron.2007.07.023</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17698017">17698017</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Dopamine+mediates+context-dependent+modulation+of+sensory+plasticity+in+C.+elegans&amp;rft.au=Kindt+KS%2C+Quast+KB%2C+Giles+AC%2C+%27%27et+al.%27%27&amp;rft.aulast=Kindt+KS%2C+Quast+KB%2C+Giles+AC%2C+%27%27et+al.%27%27&amp;rft.date=August+2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.neuron.2007.07.023&amp;rft_id=info%3Apmid%2F17698017&amp;rft.issue=4&amp;rft.jtitle=Neuron&amp;rft.pages=662%E2%80%9376&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=55" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Barron-66"><span class="mw-cite-backlink">^ <a href="#cite_ref-Barron_66-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Barron_66-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Barron_66-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Barron_66-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Barron AB, Søvik E, Cornish JL (2010). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2967375">"The roles of dopamine and related compounds in reward-seeking behavior across animal phyla"</a>. <i>Front Behav Neurosci</i> <b>4</b>: 163. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.3389%2Ffnbeh.2010.00163">10.3389/fnbeh.2010.00163</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2967375">2967375</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21048897">21048897</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=The+roles+of+dopamine+and+related+compounds+in+reward-seeking+behavior+across+animal+phyla&amp;rft.au=Barron+AB%2C+S%C3%B8vik+E%2C+Cornish+JL&amp;rft.aulast=Barron+AB%2C+S%C3%B8vik+E%2C+Cornish+JL&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2967375&amp;rft_id=info%3Adoi%2F10.3389%2Ffnbeh.2010.00163&amp;rft_id=info%3Apmc%2F2967375&amp;rft_id=info%3Apmid%2F21048897&amp;rft.jtitle=Front+Behav+Neurosci&amp;rft.pages=163&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=4" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Kulma-67"><span class="mw-cite-backlink">^ <a href="#cite_ref-Kulma_67-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Kulma_67-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Kulma_67-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Kulma A, Szopa J (2007). "Catecholamines are active compounds in plants". <i>Plant Science</i> <b>172</b> (3): 433–440. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2Fj.plantsci.2006.10.013">10.1016/j.plantsci.2006.10.013</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Catecholamines+are+active+compounds+in+plants&amp;rft.au=Kulma+A%2C+Szopa+J&amp;rft.aulast=Kulma+A%2C+Szopa+J&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.plantsci.2006.10.013&amp;rft.issue=3&amp;rft.jtitle=Plant+Science&amp;rft.pages=433%E2%80%93440&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=172" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Ingle-68"><span class="mw-cite-backlink">^ <a href="#cite_ref-Ingle_68-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Ingle_68-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Ingle PK (2003). <a rel="nofollow" class="external text" href="http://nopr.niscair.res.in/bitstream/123456789/12261/1/NPR%202%283%29%20126-133.pdf">"L-DOPA bearing plants"</a> (PDF). <i>Natural Product Radiance</i> <b>2</b>: 126–133<span class="reference-accessdate">. Retrieved 3 February 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=L-DOPA+bearing+plants&amp;rft.au=Ingle+PK&amp;rft.aulast=Ingle+PK&amp;rft.date=2003&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fnopr.niscair.res.in%2Fbitstream%2F123456789%2F12261%2F1%2FNPR%25202%25283%2529%2520126-133.pdf&amp;rft.jtitle=Natural+Product+Radiance&amp;rft.pages=126%E2%80%93133&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=2" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-69"><span class="mw-cite-backlink"><b><a href="#cite_ref-69">^</a></b></span> <span class="reference-text"><span class="citation journal">Wichers HJ, Visser JF, Huizing HJ, Pras N (1993). "Occurrence of L-DOPA and dopamine in plants and cell cultures of <i>Mucuna pruriens</i> and effects of 2, 4-d and NaCl on these compounds". <i>Plant Cell, Tissue and Organ Culture</i> <b>33</b> (3): 259–264. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1007%2FBF02319010">10.1007/BF02319010</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Occurrence+of+L-DOPA+and+dopamine+in+plants+and+cell+cultures+of+%27%27Mucuna+pruriens%27%27+and+effects+of+2%2C+4-d+and+NaCl+on+these+compounds&amp;rft.aulast=Wichers+HJ%2C+Visser+JF%2C+Huizing+HJ%2C+Pras+N&amp;rft.au=Wichers+HJ%2C+Visser+JF%2C+Huizing+HJ%2C+Pras+N&amp;rft.date=1993&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2FBF02319010&amp;rft.issue=3&amp;rft.jtitle=Plant+Cell%2C+Tissue+and+Organ+Culture&amp;rft.pages=259%E2%80%93264&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=33" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-70"><span class="mw-cite-backlink"><b><a href="#cite_ref-70">^</a></b></span> <span class="reference-text"><span class="citation journal">Longo R (1974). "Distribution of L-dopa and related amino acid in <i>Vicia</i>". <i>Phytochemistry</i> <b>13</b>: 167–171. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2FS0031-9422%2800%2991287-1">10.1016/S0031-9422(00)91287-1</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Distribution+of+L-dopa+and+related+amino+acid+in+%27%27Vicia%27%27&amp;rft.aulast=Longo+R&amp;rft.au=Longo+R&amp;rft.date=1974&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0031-9422%2800%2991287-1&amp;rft.jtitle=Phytochemistry&amp;rft.pages=167%E2%80%93171&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=13" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid16489461-71"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid16489461_71-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Van Alstyne KL, Nelson AV, Vyvyan JR, Cancilla DA (June 2006). "Dopamine functions as an antiherbivore defense in the temperate green alga <i>Ulvaria obscure</i>". <i>Oecologia</i> <b>148</b> (2): 304–11. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1007%2Fs00442-006-0378-3">10.1007/s00442-006-0378-3</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16489461">16489461</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Dopamine+functions+as+an+antiherbivore+defense+in+the+temperate+green+alga+%27%27Ulvaria+obscure%27%27&amp;rft.aulast=Van+Alstyne+KL%2C+Nelson+AV%2C+Vyvyan+JR%2C+Cancilla+DA&amp;rft.au=Van+Alstyne+KL%2C+Nelson+AV%2C+Vyvyan+JR%2C+Cancilla+DA&amp;rft.date=June+2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2Fs00442-006-0378-3&amp;rft_id=info%3Apmid%2F16489461&amp;rft.issue=2&amp;rft.jtitle=Oecologia&amp;rft.pages=304%E2%80%9311&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=148" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-72"><span class="mw-cite-backlink"><b><a href="#cite_ref-72">^</a></b></span> <span class="reference-text"><span class="citation journal">Simon JD, Peles D, Wakamatsu K, Ito S (October 2009). "Current challenges in understanding melanogenesis: bridging chemistry, biological control, morphology, and function". <i>Pigment Cell Melanoma Res</i> <b>22</b> (5): 563–79. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1111%2Fj.1755-148X.2009.00610.x">10.1111/j.1755-148X.2009.00610.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19627559">19627559</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Current+challenges+in+understanding+melanogenesis%3A+bridging+chemistry%2C+biological+control%2C+morphology%2C+and+function&amp;rft.aulast=Simon+JD%2C+Peles+D%2C+Wakamatsu+K%2C+Ito+S&amp;rft.au=Simon+JD%2C+Peles+D%2C+Wakamatsu+K%2C+Ito+S&amp;rft.date=October+2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1755-148X.2009.00610.x&amp;rft_id=info%3Apmid%2F19627559&amp;rft.issue=5&amp;rft.jtitle=Pigment+Cell+Melanoma+Res&amp;rft.pages=563%E2%80%9379&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=22" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-73"><span class="mw-cite-backlink"><b><a href="#cite_ref-73">^</a></b></span> <span class="reference-text"><span class="citation journal">Fedorow H, Tribl F, Halliday G, Gerlach M, Riederer P, Double KL (February 2005). "Neuromelanin in human dopamine neurons: comparison with peripheral melanins and relevance to Parkinson's disease". <i>Prog. Neurobiol.</i> <b>75</b> (2): 109–24. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2Fj.pneurobio.2005.02.001">10.1016/j.pneurobio.2005.02.001</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15784302">15784302</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Neuromelanin+in+human+dopamine+neurons%3A+comparison+with+peripheral+melanins+and+relevance+to+Parkinson%27s+disease&amp;rft.au=Fedorow+H%2C+Tribl+F%2C+Halliday+G%2C+Gerlach+M%2C+Riederer+P%2C+Double+KL&amp;rft.aulast=Fedorow+H%2C+Tribl+F%2C+Halliday+G%2C+Gerlach+M%2C+Riederer+P%2C+Double+KL&amp;rft.date=February+2005&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.pneurobio.2005.02.001&amp;rft_id=info%3Apmid%2F15784302&amp;rft.issue=2&amp;rft.jtitle=Prog.+Neurobiol.&amp;rft.pages=109%E2%80%9324&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=75" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-74"><span class="mw-cite-backlink"><b><a href="#cite_ref-74">^</a></b></span> <span class="reference-text"><span class="citation journal">Andrews RS, Pridham JB (1967). "Melanins from DOPA-containing plants". <i>Phytochemistry</i> <b>6</b> (1): 13–18. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2F0031-9422%2867%2985002-7">10.1016/0031-9422(67)85002-7</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Melanins+from+DOPA-containing+plants&amp;rft.au=Andrews+RS%2C+Pridham+JB&amp;rft.aulast=Andrews+RS%2C+Pridham+JB&amp;rft.date=1967&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2F0031-9422%2867%2985002-7&amp;rft.issue=1&amp;rft.jtitle=Phytochemistry&amp;rft.pages=13%E2%80%9318&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=6" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-75"><span class="mw-cite-backlink"><b><a href="#cite_ref-75">^</a></b></span> <span class="reference-text"><span class="citation journal">Beldade P, Brakefield PM (June 2002). "The genetics and evo-devo of butterfly wing patterns". <i>Nature Reviews Genetics</i> <b>3</b> (6): 442–52. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1038%2Fnrg818">10.1038/nrg818</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12042771">12042771</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=The+genetics+and+evo-devo+of+butterfly+wing+patterns&amp;rft.au=Beldade+P%2C+Brakefield+PM&amp;rft.aulast=Beldade+P%2C+Brakefield+PM&amp;rft.date=June+2002&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1038%2Fnrg818&amp;rft_id=info%3Apmid%2F12042771&amp;rft.issue=6&amp;rft.jtitle=Nature+Reviews+Genetics&amp;rft.pages=442%E2%80%9352&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=3" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-BryantKnights2010-76"><span class="mw-cite-backlink"><b><a href="#cite_ref-BryantKnights2010_76-0">^</a></b></span> <span class="reference-text"><span class="citation book">Bronwen Jean Bryant; Kathleen Mary Knights (15 November 2009). <a rel="nofollow" class="external text" href="http://books.google.com/books?id=TQV6sLzYsOYC&amp;pg=PA119"><i>Pharmacology for Health Professionals</i></a> (2nd ed.). Elsevier Australia. p.&#160;192. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-7295-3929-6" title="Special:BookSources/978-0-7295-3929-6">978-0-7295-3929-6</a><span class="reference-accessdate">. Retrieved 9 June 2011</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.au=Bronwen+Jean+Bryant&amp;rft.au=Kathleen+Mary+Knights&amp;rft.aulast=Bronwen+Jean+Bryant&amp;rft.btitle=Pharmacology+for+Health+Professionals&amp;rft.date=15+November+2009&amp;rft.edition=2nd&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DTQV6sLzYsOYC%26pg%3DPA119&amp;rft.isbn=978-0-7295-3929-6&amp;rft.pages=192&amp;rft.pub=Elsevier+Australia&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-77"><span class="mw-cite-backlink"><b><a href="#cite_ref-77">^</a></b></span> <span class="reference-text"><span class="citation journal">de Backer D, Biston P, Devriendt J, <i>et al.</i> (2010). "Comparison of Dopamine and Norepinephrine in the Treatment of Shock". <i>New Engl. J. Med.</i> <b>362</b> (9): 779–789. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1056%2FNEJMoa0907118">10.1056/NEJMoa0907118</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20200382">20200382</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Comparison+of+Dopamine+and+Norepinephrine+in+the+Treatment+of+Shock&amp;rft.au=de+Backer+D%2C+Biston+P%2C+Devriendt+J%2C+%27%27et+al.%27%27&amp;rft.aulast=de+Backer+D%2C+Biston+P%2C+Devriendt+J%2C+%27%27et+al.%27%27&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa0907118&amp;rft_id=info%3Apmid%2F20200382&amp;rft.issue=9&amp;rft.jtitle=New+Engl.+J.+Med.&amp;rft.pages=779%E2%80%93789&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=362" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-78"><span class="mw-cite-backlink"><b><a href="#cite_ref-78">^</a></b></span> <span class="reference-text"><span class="citation journal">Karthik S, Lisbon A (2006). "Low-dose dopamine in the intensive care unit". <i>Semin Dial</i> <b>19</b> (6): 465–71. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1111%2Fj.1525-139X.2006.00208.x">10.1111/j.1525-139X.2006.00208.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17150046">17150046</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Low-dose+dopamine+in+the+intensive+care+unit&amp;rft.au=Karthik+S%2C+Lisbon+A&amp;rft.aulast=Karthik+S%2C+Lisbon+A&amp;rft.date=2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1525-139X.2006.00208.x&amp;rft_id=info%3Apmid%2F17150046&amp;rft.issue=6&amp;rft.jtitle=Semin+Dial&amp;rft.pages=465%E2%80%9371&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=19" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Miller-79"><span class="mw-cite-backlink"><b><a href="#cite_ref-Miller_79-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Miller, GM (January 2011). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3005101">"The emerging role of trace amine-associated receptor 1 in the functional regulation of monoamine transporters and dopaminergic activity"</a>. <i>Journal of Neurochemistry</i> <b>116</b> (2): 164–76. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1111%2Fj.1471-4159.2010.07109.x">10.1111/j.1471-4159.2010.07109.x</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3005101">3005101</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21073468">21073468</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=The+emerging+role+of+trace+amine-associated+receptor+1+in+the+functional+regulation+of+monoamine+transporters+and+dopaminergic+activity&amp;rft.aufirst=GM&amp;rft.aulast=Miller&amp;rft.au=Miller%2C+GM&amp;rft.date=January+2011&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3005101&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1471-4159.2010.07109.x&amp;rft_id=info%3Apmc%2F3005101&amp;rft_id=info%3Apmid%2F21073468&amp;rft.issue=2&amp;rft.jtitle=Journal+of+Neurochemistry&amp;rft.pages=164%E2%80%9376&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=116" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-fn2-80"><span class="mw-cite-backlink"><b><a href="#cite_ref-fn2_80-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Lambert M, Schimmelmann B, Karow A, Naber D (2003). "Subjective well-being and initial dysphoric reaction under antipsychotic drugs&#160;– concepts, measurement and clinical relevance". <i>Pharmacopsychiatry</i> <b>36</b> (Suppl 3): S181–90. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1055%2Fs-2003-45128">10.1055/s-2003-45128</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/14677077">14677077</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Subjective+well-being+and+initial+dysphoric+reaction+under+antipsychotic+drugs%26nbsp%3B%E2%80%93+concepts%2C+measurement+and+clinical+relevance&amp;rft.au=Lambert+M%2C+Schimmelmann+B%2C+Karow+A%2C+Naber+D&amp;rft.aulast=Lambert+M%2C+Schimmelmann+B%2C+Karow+A%2C+Naber+D&amp;rft.date=2003&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1055%2Fs-2003-45128&amp;rft_id=info%3Apmid%2F14677077&amp;rft.issue=Suppl+3&amp;rft.jtitle=Pharmacopsychiatry&amp;rft.pages=S181%E2%80%9390&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=36" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-81"><span class="mw-cite-backlink"><b><a href="#cite_ref-81">^</a></b></span> <span class="reference-text">R. J. Lewis (Ed.) (2004), Sax's Dangerous Properties of Industrial Materials, 11th Ed., p. 1552, Wiley &amp; Sons, Hoboken, NJ.</span></li>
<li id="cite_note-82"><span class="mw-cite-backlink"><b><a href="#cite_ref-82">^</a></b></span> <span class="reference-text"><span class="citation web">Roth, BL; Driscol, J (12 January 2011). <a rel="nofollow" class="external text" href="http://pdsp.med.unc.edu/pdsp.php">"PDSP K<sub>i</sub> Database"</a>. <i>Psychoactive Drug Screening Program (PDSP)</i>. University of North Carolina at Chapel Hill and the United States National Institute of Mental Health<span class="reference-accessdate">. Retrieved 15 November 2013</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=PDSP+K%3Csub%3Ei%3C%2Fsub%3E+Database&amp;rft.aulast=Roth%2C+BL%3B+Driscol%2C+J&amp;rft.au=Roth%2C+BL%3B+Driscol%2C+J&amp;rft.date=12+January+2011&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fpdsp.med.unc.edu%2Fpdsp.php&amp;rft.jtitle=Psychoactive+Drug+Screening+Program+%28PDSP%29&amp;rft.pub=University+of+North+Carolina+at+Chapel+Hill+and+the+United+States+National+Institute+of+Mental+Health&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid11784783-83"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid11784783_83-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Morón JA, Brockington A, Wise RA, Rocha BA, Hope BT (2002). <a rel="nofollow" class="external text" href="http://www.jneurosci.org/content/22/2/389.full.pdf">"Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines"</a>. <i>J. Neurosci.</i> <b>22</b> (2): 389–95. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11784783">11784783</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Dopamine+uptake+through+the+norepinephrine+transporter+in+brain+regions+with+low+levels+of+the+dopamine+transporter%3A+evidence+from+knock-out+mouse+lines&amp;rft.aulast=Mor%C3%B3n+JA%2C+Brockington+A%2C+Wise+RA%2C+Rocha+BA%2C+Hope+BT&amp;rft.au=Mor%C3%B3n+JA%2C+Brockington+A%2C+Wise+RA%2C+Rocha+BA%2C+Hope+BT&amp;rft.date=2002&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.jneurosci.org%2Fcontent%2F22%2F2%2F389.full.pdf&amp;rft_id=info%3Apmid%2F11784783&amp;rft.issue=2&amp;rft.jtitle=J.+Neurosci.&amp;rft.pages=389%E2%80%9395&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=22" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid17881525-84"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid17881525_84-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Yavich L, Forsberg MM, Karayiorgou M, Gogos JA, Männistö PT (2007). "Site-specific role of catechol-O-methyltransferase in dopamine overflow within prefrontal cortex and dorsal striatum". <i>J. Neurosci.</i> <b>27</b> (38): 10196–209. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1523%2FJNEUROSCI.0665-07.2007">10.1523/JNEUROSCI.0665-07.2007</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17881525">17881525</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Site-specific+role+of+catechol-O-methyltransferase+in+dopamine+overflow+within+prefrontal+cortex+and+dorsal+striatum&amp;rft.aulast=Yavich+L%2C+Forsberg+MM%2C+Karayiorgou+M%2C+Gogos+JA%2C+M%C3%A4nnist%C3%B6+PT&amp;rft.au=Yavich+L%2C+Forsberg+MM%2C+Karayiorgou+M%2C+Gogos+JA%2C+M%C3%A4nnist%C3%B6+PT&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1523%2FJNEUROSCI.0665-07.2007&amp;rft_id=info%3Apmid%2F17881525&amp;rft.issue=38&amp;rft.jtitle=J.+Neurosci.&amp;rft.pages=10196%E2%80%93209&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=27" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Sulzer-85"><span class="mw-cite-backlink"><b><a href="#cite_ref-Sulzer_85-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Sulzer D, Zecca L (February 2000). "Intraneuronal dopamine-quinone synthesis: a review". <i>Neurotox Res</i> <b>1</b> (3): 181–95. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1007%2FBF03033289">10.1007/BF03033289</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12835101">12835101</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Intraneuronal+dopamine-quinone+synthesis%3A+a+review&amp;rft.aulast=Sulzer+D%2C+Zecca+L&amp;rft.au=Sulzer+D%2C+Zecca+L&amp;rft.date=February+2000&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2FBF03033289&amp;rft_id=info%3Apmid%2F12835101&amp;rft.issue=3&amp;rft.jtitle=Neurotox+Res&amp;rft.pages=181%E2%80%9395&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=1" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-86"><span class="mw-cite-backlink"><b><a href="#cite_ref-86">^</a></b></span> <span class="reference-text"><span class="citation journal">Miyazaki I, Asanuma M (June 2008). <a rel="nofollow" class="external text" href="http://www.lib.okayama-u.ac.jp/www/acta/pdf/62_3_141.pdf">"Dopaminergic neuron-specific oxidative stress caused by dopamine itself"</a> (PDF). <i>Acta Med. Okayama</i> <b>62</b> (3): 141–50. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18596830">18596830</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Dopaminergic+neuron-specific+oxidative+stress+caused+by+dopamine+itself&amp;rft.aulast=Miyazaki+I%2C+Asanuma+M&amp;rft.au=Miyazaki+I%2C+Asanuma+M&amp;rft.date=June+2008&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.lib.okayama-u.ac.jp%2Fwww%2Facta%2Fpdf%2F62_3_141.pdf&amp;rft_id=info%3Apmid%2F18596830&amp;rft.issue=3&amp;rft.jtitle=Acta+Med.+Okayama&amp;rft.pages=141%E2%80%9350&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=62" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-87"><span class="mw-cite-backlink"><b><a href="#cite_ref-87">^</a></b></span> <span class="reference-text"><i>Mussel-Inspired Surface Chemistry for Multifunctional Coatings</i> Haeshin Lee, Shara M. Dellatore, William M. Miller, Phillip B. Messersmith Science 19 October 2007: Vol. 318 no. 5849 pp.&#160;426–430 <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1126%2Fscience.1147241">10.1126/science.1147241</a></span></li>
<li id="cite_note-Dreyer-88"><span class="mw-cite-backlink">^ <a href="#cite_ref-Dreyer_88-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Dreyer_88-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><i>Perspectives on poly(dopamine)</i> Daniel R. Dreyer, Daniel J. Miller, Benny D. Freeman, Donald R. Paul and Christopher W. Bielawski Chem" <i>Sci</i> 2013, Advance Article <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1039%2FC3SC51501J">10.1039/C3SC51501J</a></span></li>
<li id="cite_note-Lynge-89"><span class="mw-cite-backlink">^ <a href="#cite_ref-Lynge_89-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Lynge_89-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Lynge ME, van der Westen R, Postma A, Städler B; Van Der Westen; Postma; Städler (December 2011). <a rel="nofollow" class="external text" href="http://www.researchgate.net/publication/51742922_Polydopamine--a_nature-inspired_polymer_coating_for_biomedical_science/file/d912f50318c9e0c7bb.pdf">"Polydopamine—a nature-inspired polymer coating for biomedical science"</a>. <i>Nanoscale</i> <b>3</b> (12): 4916–28. <a href="/wiki/Bibcode" title="Bibcode">Bibcode</a>:<a rel="nofollow" class="external text" href="http://adsabs.harvard.edu/abs/2011Nanos...3.4916L">2011Nanos...3.4916L</a>. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1039%2Fc1nr10969c">10.1039/c1nr10969c</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22024699">22024699</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Polydopamine%E2%80%94a+nature-inspired+polymer+coating+for+biomedical+science&amp;rft.aulast=Lynge+ME%2C+van+der+Westen+R%2C+Postma+A%2C+St%C3%A4dler+B&amp;rft.au=Lynge+ME%2C+van+der+Westen+R%2C+Postma+A%2C+St%C3%A4dler+B&amp;rft.au=Postma&amp;rft.au=St%C3%A4dler&amp;rft.au=Van+Der+Westen&amp;rft.date=December+2011&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.researchgate.net%2Fpublication%2F51742922_Polydopamine--a_nature-inspired_polymer_coating_for_biomedical_science%2Ffile%2Fd912f50318c9e0c7bb.pdf&amp;rft_id=info%3Abibcode%2F2011Nanos...3.4916L&amp;rft_id=info%3Adoi%2F10.1039%2Fc1nr10969c&amp;rft_id=info%3Apmid%2F22024699&amp;rft.issue=12&amp;rft.jtitle=Nanoscale&amp;rft.pages=4916%E2%80%9328&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=3" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-90"><span class="mw-cite-backlink"><b><a href="#cite_ref-90">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://movementdisorders.org/education/onlinecme/levodopa/print.pdf">Fahn, Stanley, "The History of Levodopa as it Pertains to Parkinson's disease," Movement Disorder Society's 10th International Congress of Parkinson's Disease and Movement Disorders on November 1, 2006, in Kyoto, Japan.</a></span></li>
<li id="cite_note-pmid11165672-91"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid11165672_91-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Benes FM (2001). "Carlsson and the discovery of dopamine". <i>Trends Pharmacol. Sci.</i> <b>22</b> (1): 46–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2FS0165-6147%2800%2901607-2">10.1016/S0165-6147(00)01607-2</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11165672">11165672</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopamine&amp;rft.atitle=Carlsson+and+the+discovery+of+dopamine&amp;rft.au=Benes+FM&amp;rft.aulast=Benes+FM&amp;rft.date=2001&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0165-6147%2800%2901607-2&amp;rft_id=info%3Apmid%2F11165672&amp;rft.issue=1&amp;rft.jtitle=Trends+Pharmacol.+Sci.&amp;rft.pages=46%E2%80%937&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=22" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
</ol>
</div>
<h2><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Dopamine&amp;action=edit&amp;section=39" title="Edit section: External links">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul>
<li><a rel="nofollow" class="external text" href="http://gmd.mpimp-golm.mpg.de/Spectrums/3ff8e16a-4797-4a9a-95de-3117a8f3a87c.aspx">Dopamine MS Spectrum</a></li>
</ul>
<table class="metadata mbox-small plainlinks" style="border:1px solid #aaa; background-color:#f9f9f9;">
<tr>
<td class="mbox-image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/f/f8/Wiktionary-logo-en.svg/37px-Wiktionary-logo-en.svg.png" width="37" height="40" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/f/f8/Wiktionary-logo-en.svg/55px-Wiktionary-logo-en.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/f/f8/Wiktionary-logo-en.svg/73px-Wiktionary-logo-en.svg.png 2x" /></td>
<td class="mbox-text plainlist" style="">Look up <i><b><a href="//en.wiktionary.org/wiki/Dopamine" class="extiw" title="wiktionary:Dopamine">Dopamine</a></b></i> in Wiktionary, the free dictionary.</td>
</tr>
</table>
<ul>
<li><a href="/wiki/DrugBank" title="DrugBank">DrugBank</a> <a rel="nofollow" class="external text" href="http://www.drugbank.ca/drugs/APRD00085">APRD00085</a></li>
<li><a rel="nofollow" class="external text" href="http://druginfo.nlm.nih.gov/drugportal/dpdirect.jsp?name=Dopamine">U.S. National Library of Medicine: Drug Information Portal – Dopamine</a></li>
<li><a rel="nofollow" class="external text" href="http://www.acb.org.uk/docs/NHLM/Dopamine.pdf">Dopamine: analyte monograph</a> – The Association for Clinical Biochemistry and Laboratory Medicine</li>
</ul>
<table cellspacing="0" class="navbox" style="border-spacing:0;">
<tr>
<td style="padding:2px;">
<table cellspacing="0" class="nowraplinks collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit;">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Neurotransmitters" title="Template:Neurotransmitters"><span title="View this template" style=";;background:none transparent;border:none;;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Neurotransmitters" title="Template talk:Neurotransmitters"><span title="Discuss this template" style=";;background:none transparent;border:none;;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Neurotransmitters&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%;"><a href="/wiki/Neurotransmitter" title="Neurotransmitter">Neurotransmitters</a></div>
</th>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Amino_acid" title="Amino acid">Amino acids</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Alanine" title="Alanine">Alanine</a></li>
<li><a href="/wiki/Aspartic_acid" title="Aspartic acid">Aspartate</a></li>
<li><a href="/wiki/Cycloserine" title="Cycloserine">Cycloserine</a></li>
<li><a href="/wiki/Dimethylglycine" title="Dimethylglycine">DMG</a></li>
<li><a href="/wiki/Gamma-Aminobutyric_acid" title="Gamma-Aminobutyric acid">GABA</a></li>
<li><a href="/wiki/Glutamic_acid" title="Glutamic acid">Glutamate</a></li>
<li><a href="/wiki/Glycine" title="Glycine">Glycine</a></li>
<li><a href="/wiki/Hypotaurine" title="Hypotaurine">Hypotaurine</a></li>
<li><a href="/wiki/Kynurenic_acid" title="Kynurenic acid">Kynurenic acid (Transtorine)</a></li>
<li><a href="/wiki/N-Acetylaspartylglutamic_acid" title="N-Acetylaspartylglutamic acid">NAAG (Spaglumic acid)</a></li>
<li><a href="/wiki/Sarcosine" title="Sarcosine">NMG (Sarcosine)</a></li>
<li><a href="/wiki/Serine" title="Serine">Serine</a></li>
<li><a href="/wiki/Taurine" title="Taurine">Taurine</a></li>
<li><a href="/wiki/Trimethylglycine" title="Trimethylglycine">TMG (Betaine)</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Endocannabinoid" title="Endocannabinoid" class="mw-redirect">Endocannabinoids</a></th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/2-Arachidonoylglycerol" title="2-Arachidonoylglycerol">2-AG</a></li>
<li><a href="/wiki/2-Arachidonyl_glyceryl_ether" title="2-Arachidonyl glyceryl ether">2-AGE (Noladin ether)</a></li>
<li><a href="/wiki/Anandamide" title="Anandamide">AEA (Anandamide)</a></li>
<li><a href="/wiki/N-Arachidonoyl_dopamine" title="N-Arachidonoyl dopamine">NADA</a></li>
<li><a href="/wiki/Virodhamine" title="Virodhamine">OAE (Virodhamine)</a></li>
<li><a href="/wiki/Oleamide" title="Oleamide">Oleamide</a></li>
<li><a href="/wiki/Palmitoylethanolamide" title="Palmitoylethanolamide">PEA (Palmitoylethanolamide)</a></li>
<li><a href="/wiki/RVD-Hp%CE%B1" title="RVD-Hpα">RVD-Hpα</a></li>
<li><a href="/wiki/Hemopressin" title="Hemopressin">Hp (Hemopressin)</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Gasotransmitter" title="Gasotransmitter">Gasotransmitters</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Carbon_monoxide" title="Carbon monoxide">Carbon monoxide</a></li>
<li><a href="/wiki/Hydrogen_sulfide" title="Hydrogen sulfide">Hydrogen sulfide</a></li>
<li><a href="/wiki/Nitric_oxide" title="Nitric oxide">Nitric oxide</a></li>
<li><a href="/wiki/Nitrous_oxide" title="Nitrous oxide">Nitrous oxide</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Monoamine_neurotransmitter" title="Monoamine neurotransmitter">Monoamines</a></th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;"><strong class="selflink">Dopamine</strong>
<ul>
<li><a href="/wiki/Epinephrine" title="Epinephrine">Epinephrine (Adrenaline)</a></li>
<li><a href="/wiki/Melatonin" title="Melatonin">Melatonin</a></li>
<li><a href="/wiki/N-Acetylserotonin" title="N-Acetylserotonin">NAS (Normelatonin)</a></li>
<li><a href="/wiki/Norepinephrine" title="Norepinephrine">Norepinephrine (Noradrenaline)</a></li>
<li><a href="/wiki/Serotonin" title="Serotonin">Serotonin (5-HT)</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Purine" title="Purine">Purines</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Adenosine" title="Adenosine">Adenosine</a></li>
<li><a href="/wiki/Adenosine_diphosphate" title="Adenosine diphosphate">ADP</a></li>
<li><a href="/wiki/Adenosine_monophosphate" title="Adenosine monophosphate">AMP</a></li>
<li><a href="/wiki/Adenosine_triphosphate" title="Adenosine triphosphate">ATP</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Trace_amine" title="Trace amine">Trace amines</a></th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/3-Iodothyronamine" title="3-Iodothyronamine">3-ITA</a></li>
<li><a href="/wiki/5-MeO-DMT" title="5-MeO-DMT">5-MeO-DMT</a></li>
<li><a href="/wiki/Bufotenin" title="Bufotenin">Bufotenin</a></li>
<li><a href="/wiki/Dimethyltryptamine" title="Dimethyltryptamine">DMT</a></li>
<li><a href="/wiki/Norfenefrine" title="Norfenefrine"><i>m</i>-Octopamine</a></li>
<li><a href="/wiki/Octopamine" title="Octopamine"><i>p</i>-Octopamine</a></li>
<li><a href="/wiki/Meta-Tyramine" title="Meta-Tyramine"><i>m</i>-Tyramine</a></li>
<li><a href="/wiki/Tyramine" title="Tyramine"><i>p</i>-Tyramine</a></li>
<li><a href="/wiki/N-Methyltryptamine" title="N-Methyltryptamine">NMT</a></li>
<li><a href="/wiki/Phenethylamine" title="Phenethylamine">Phenethylamine</a></li>
<li><a href="/wiki/Synephrine" title="Synephrine">Synephrine</a></li>
<li><a href="/wiki/Thyronamine" title="Thyronamine">Thyronamine</a></li>
<li><a href="/wiki/Tryptamine" title="Tryptamine">Tryptamine</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Others</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/1,4-Butanediol" title="1,4-Butanediol">1,4-BD</a></li>
<li><a href="/wiki/Acetylcholine" title="Acetylcholine">Acetylcholine</a></li>
<li><a href="/wiki/Gamma-Butyrolactone" title="Gamma-Butyrolactone">GBL</a></li>
<li><a href="/wiki/Gamma-Hydroxybutyric_acid" title="Gamma-Hydroxybutyric acid">GHB</a></li>
<li><a href="/wiki/Histamine" title="Histamine">Histamine</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<td colspan="2" class="navbox-list navbox-odd hlist" style="width:100%;padding:0px;">
<div style="padding:0em 0.25em;">See also <a href="/wiki/Template:Neuropeptides" title="Template:Neuropeptides">Template:<b>Neuropeptides</b></a></div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;;">
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px;background:transparent;color:inherit;;">
<div style="padding:0px;;">
<table cellspacing="0" class="navbox-columns-table" style="text-align:left;width:100%;">
<tr style="vertical-align:top;">
<td style="padding:0px;text-align:center;background:#efefef;;;text-align:center;background:LemonChiffon;;width:10em;">
<div>
<p><a href="/wiki/Template:Medicine_navs" title="Template:Medicine navs">M</a>: <a href="/wiki/Peripheral_nervous_system" title="Peripheral nervous system">PNS</a></p>
</div>
</td>
<td style="border-left:2px solid #fdfdfd;padding:0px;text-align:center;background:#efefef;;;text-align:center;background:white;;width:10em;">
<div>
<p><a href="/wiki/Template:Nervous_system" title="Template:Nervous system">anat</a> (<a href="/wiki/Template:Nervous_tissue" title="Template:Nervous tissue">h</a>/<a href="/wiki/Template:Cranial_nerves" title="Template:Cranial nerves">r</a>/<a href="/wiki/Template:Trigeminal_nerve" title="Template:Trigeminal nerve">t</a>/<a href="/wiki/Template:Cervical_plexus" title="Template:Cervical plexus">c</a>/<a href="/wiki/Template:Brachial_plexus" title="Template:Brachial plexus">b</a>/<a href="/wiki/Template:Lumbosacral_plexus" title="Template:Lumbosacral plexus">l</a>/<a href="/wiki/Template:Somatosensory_system" title="Template:Somatosensory system">s</a>/<a href="/wiki/Template:Autonomic_nervous_system" title="Template:Autonomic nervous system">a</a>)/<a href="/wiki/Template:Nervous_system_physiology" title="Template:Nervous system physiology">phys</a> (<a href="/wiki/Template:Reflex" title="Template:Reflex">r</a>)/<a href="/wiki/Template:Development_of_nervous_system" title="Template:Development of nervous system">devp</a>/<a href="/wiki/Template:Nerve_tissue_protein" title="Template:Nerve tissue protein">prot</a>/<a href="/wiki/Template:Neurotransmitter_transporters" title="Template:Neurotransmitter transporters">nttr</a>/<a href="/wiki/Template:Neurotransmitters" title="Template:Neurotransmitters">nttm</a>/<a href="/wiki/Template:Neurotrophins" title="Template:Neurotrophins">ntrp</a></p>
</div>
</td>
<td style="border-left:2px solid #fdfdfd;padding:0px;text-align:center;background:#efefef;;;text-align:center;background:silver;;width:10em;">
<div>
<p><a href="/wiki/Template:PNS_diseases_of_the_nervous_system" title="Template:PNS diseases of the nervous system">noco</a>/<a href="/wiki/Template:Autonomic_diseases" title="Template:Autonomic diseases">auto</a>/<a href="/wiki/Template:Congenital_malformations_and_deformations_of_nervous_system" title="Template:Congenital malformations and deformations of nervous system">cong</a>/<a href="/wiki/Template:Nervous_system_tumors" title="Template:Nervous system tumors">tumr</a>, <a href="/wiki/Template:Nervous_and_musculoskeletal_system_symptoms_and_signs" title="Template:Nervous and musculoskeletal system symptoms and signs">sysi</a>/<a href="/wiki/Template:Eponymous_medical_signs_for_nervous_system" title="Template:Eponymous medical signs for nervous system">epon</a>, <a href="/wiki/Template:Neurotrauma" title="Template:Neurotrauma">injr</a></p>
</div>
</td>
<td style="border-left:2px solid #fdfdfd;padding:0px;text-align:center;background:#efefef;;;text-align:center;background:#ccf;;width:10em;">
<div>
<p><a href="/wiki/Template:Neuro_procedures" title="Template:Neuro procedures">proc</a>, drug (<a href="/wiki/Template:Local_anesthetics" title="Template:Local anesthetics">N1B</a>)</p>
</div>
</td>
</tr>
</table>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>
<table cellspacing="0" class="navbox" style="border-spacing:0;">
<tr>
<td style="padding:2px;">
<table cellspacing="0" class="nowraplinks collapsible collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit;">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Dopaminergics" title="Template:Dopaminergics"><span title="View this template" style=";;background:none transparent;border:none;;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Dopaminergics" title="Template talk:Dopaminergics"><span title="Discuss this template" style=";;background:none transparent;border:none;;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Dopaminergics&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%;"><a href="/wiki/Dopaminergic" title="Dopaminergic">Dopaminergics</a></div>
</th>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<td colspan="2" class="navbox-list navbox-odd hlist" style="width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks collapsible collapsed navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="col" class="navbox-title" colspan="2" style=";background-color: LightYellow;"><span style="float:left;width:6em;">&#160;</span>
<div style="font-size:110%;"><a href="/wiki/Dopamine_receptor" title="Dopamine receptor">Receptor</a> <a href="/wiki/Ligand" title="Ligand">ligands</a></div>
</th>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Dopamine_receptor_agonist" title="Dopamine receptor agonist" class="mw-redirect">Agonists</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><i>Adamantanes</i>: <a href="/wiki/Amantadine" title="Amantadine">Amantadine</a></li>
<li><a href="/wiki/Memantine" title="Memantine">Memantine</a></li>
<li><a href="/wiki/Rimantadine" title="Rimantadine">Rimantadine</a>; <i>Aminotetralins</i>: <a href="/wiki/7-OH-DPAT" title="7-OH-DPAT">7-OH-DPAT</a></li>
<li><a href="/wiki/8-OH-PBZI" title="8-OH-PBZI">8-OH-PBZI</a></li>
<li><a href="/wiki/Rotigotine" title="Rotigotine">Rotigotine</a></li>
<li><a href="/wiki/UH-232" title="UH-232">UH-232</a>; <i>Benzazepines</i>: <a href="/wiki/6-Br-APB" title="6-Br-APB">6-Br-APB</a></li>
<li><a href="/wiki/Fenoldopam" title="Fenoldopam">Fenoldopam</a></li>
<li><a href="/wiki/SKF-38,393" title="SKF-38,393">SKF-38,393</a></li>
<li><a href="/wiki/SKF-77,434" title="SKF-77,434">SKF-77,434</a></li>
<li><a href="/wiki/SKF-81,297" title="SKF-81,297">SKF-81,297</a></li>
<li><a href="/wiki/SKF-82,958" title="SKF-82,958">SKF-82,958</a></li>
<li><a href="/wiki/SKF-83,959" title="SKF-83,959">SKF-83,959</a>; <i>Ergolines</i>: <a href="/wiki/Bromocriptine" title="Bromocriptine">Bromocriptine</a></li>
<li><a href="/wiki/Cabergoline" title="Cabergoline">Cabergoline</a></li>
<li><a href="/wiki/Dihydroergocryptine" title="Dihydroergocryptine">Dihydroergocryptine</a></li>
<li><a href="/wiki/Epicriptine" title="Epicriptine">Epicriptine</a></li>
<li><a href="/wiki/Lisuride" title="Lisuride">Lisuride</a></li>
<li><a href="/wiki/Lysergic_acid_diethylamide" title="Lysergic acid diethylamide">LSD</a></li>
<li><a href="/wiki/Pergolide" title="Pergolide">Pergolide</a>; <i>Dihydrexidine derivatives</i>: <a href="/wiki/2-OH-NPA" title="2-OH-NPA">2-OH-NPA</a></li>
<li><a href="/wiki/A-86,929" title="A-86,929" class="mw-redirect">A-86,929</a></li>
<li><a href="/wiki/Ciladopa" title="Ciladopa">Ciladopa</a></li>
<li><a href="/wiki/Dihydrexidine" title="Dihydrexidine">Dihydrexidine</a></li>
<li><a href="/wiki/Dinapsoline" title="Dinapsoline">Dinapsoline</a></li>
<li><a href="/wiki/Dinoxyline" title="Dinoxyline">Dinoxyline</a></li>
<li><a href="/wiki/Doxanthrine" title="Doxanthrine">Doxanthrine</a>; <i>Others</i>: <a href="/wiki/A-68,930" title="A-68,930" class="mw-redirect">A-68,930</a></li>
<li><a href="/wiki/A-77636" title="A-77636">A-77636</a></li>
<li><a href="/wiki/A-412,997" title="A-412,997">A-412,997</a></li>
<li><a href="/wiki/ABT-670" title="ABT-670">ABT-670</a></li>
<li><a href="/wiki/ABT-724" title="ABT-724">ABT-724</a></li>
<li><a href="/wiki/Aplindore" title="Aplindore">Aplindore</a></li>
<li><a href="/wiki/Apomorphine" title="Apomorphine">Apomorphine</a></li>
<li><a href="/wiki/Aripiprazole" title="Aripiprazole">Aripiprazole</a></li>
<li><a href="/wiki/Bifeprunox" title="Bifeprunox">Bifeprunox</a></li>
<li><a href="/wiki/BP-897" title="BP-897">BP-897</a></li>
<li><a href="/wiki/CY-208,243" title="CY-208,243">CY-208,243</a></li>
<li><a href="/wiki/Dizocilpine" title="Dizocilpine">Dizocilpine</a></li>
<li><a href="/wiki/Etilevodopa" title="Etilevodopa">Etilevodopa</a></li>
<li><a href="/wiki/Flibanserin" title="Flibanserin">Flibanserin</a></li>
<li><a href="/wiki/Ketamine" title="Ketamine">Ketamine</a></li>
<li><a href="/wiki/Melevodopa" title="Melevodopa">Melevodopa</a></li>
<li><a href="/wiki/Modafinil" title="Modafinil">Modafinil</a></li>
<li><a href="/wiki/Pardoprunox" title="Pardoprunox">Pardoprunox</a></li>
<li><a href="/wiki/Phencyclidine" title="Phencyclidine">Phencyclidine</a></li>
<li><a href="/wiki/PD-128,907" title="PD-128,907">PD-128,907</a></li>
<li><a href="/wiki/PD-168,077" title="PD-168,077">PD-168,077</a></li>
<li><a href="/wiki/PF-219,061" title="PF-219,061">PF-219,061</a></li>
<li><a href="/wiki/Piribedil" title="Piribedil">Piribedil</a></li>
<li><a href="/wiki/Pramipexole" title="Pramipexole">Pramipexole</a></li>
<li><a href="/wiki/Propylnorapomorphine" title="Propylnorapomorphine">Propylnorapomorphine</a></li>
<li><a href="/wiki/Pukateine" title="Pukateine">Pukateine</a></li>
<li><a href="/wiki/Quinagolide" title="Quinagolide">Quinagolide</a></li>
<li><a href="/wiki/Quinelorane" title="Quinelorane">Quinelorane</a></li>
<li><a href="/wiki/Quinpirole" title="Quinpirole">Quinpirole</a></li>
<li><a href="/wiki/RDS-127" title="RDS-127">RDS-127</a></li>
<li><a href="/wiki/Ro10-5824" title="Ro10-5824">Ro10-5824</a></li>
<li><a href="/wiki/Ropinirole" title="Ropinirole">Ropinirole</a></li>
<li><a href="/wiki/Rotigotine" title="Rotigotine">Rotigotine</a></li>
<li><a href="/wiki/Roxindole" title="Roxindole">Roxindole</a></li>
<li><a href="/wiki/Salvinorin_A" title="Salvinorin A">Salvinorin A</a></li>
<li><a href="/wiki/SKF-89,145" title="SKF-89,145">SKF-89,145</a></li>
<li><a href="/wiki/Sumanirole" title="Sumanirole">Sumanirole</a></li>
<li><a href="/wiki/Terguride" title="Terguride">Terguride</a></li>
<li><a href="/wiki/Umespirone" title="Umespirone">Umespirone</a></li>
<li><a href="/wiki/WAY-100,635" title="WAY-100,635">WAY-100,635</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Dopamine_receptor_antagonist" title="Dopamine receptor antagonist" class="mw-redirect">Antagonists</a></div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><i>Typical antipsychotics</i>: <a href="/wiki/Acepromazine" title="Acepromazine">Acepromazine</a></li>
<li><a href="/wiki/Azaperone" title="Azaperone">Azaperone</a></li>
<li><a href="/wiki/Benperidol" title="Benperidol">Benperidol</a></li>
<li><a href="/wiki/Bromperidol" title="Bromperidol">Bromperidol</a></li>
<li><a href="/wiki/Clopenthixol" title="Clopenthixol">Clopenthixol</a></li>
<li><a href="/wiki/Chlorpromazine" title="Chlorpromazine">Chlorpromazine</a></li>
<li><a href="/wiki/Chlorprothixene" title="Chlorprothixene">Chlorprothixene</a></li>
<li><a href="/wiki/Droperidol" title="Droperidol">Droperidol</a></li>
<li><a href="/wiki/Flupentixol" title="Flupentixol">Flupentixol</a></li>
<li><a href="/wiki/Fluphenazine" title="Fluphenazine">Fluphenazine</a></li>
<li><a href="/wiki/Fluspirilene" title="Fluspirilene">Fluspirilene</a></li>
<li><a href="/wiki/Haloperidol" title="Haloperidol">Haloperidol</a></li>
<li><a href="/wiki/Levosulpiride" title="Levosulpiride">Levosulpiride</a></li>
<li><a href="/wiki/Loxapine" title="Loxapine">Loxapine</a></li>
<li><a href="/wiki/Mesoridazine" title="Mesoridazine">Mesoridazine</a></li>
<li><a href="/wiki/Methotrimeprazine" title="Methotrimeprazine" class="mw-redirect">Methotrimeprazine</a></li>
<li><a href="/wiki/Nemonapride" title="Nemonapride">Nemonapride</a></li>
<li><a href="/wiki/Penfluridol" title="Penfluridol">Penfluridol</a></li>
<li><a href="/wiki/Perazine" title="Perazine">Perazine</a></li>
<li><a href="/wiki/Periciazine" title="Periciazine" class="mw-redirect">Periciazine</a></li>
<li><a href="/wiki/Perphenazine" title="Perphenazine">Perphenazine</a></li>
<li><a href="/wiki/Pimozide" title="Pimozide">Pimozide</a></li>
<li><a href="/wiki/Prochlorperazine" title="Prochlorperazine">Prochlorperazine</a></li>
<li><a href="/wiki/Promazine" title="Promazine">Promazine</a></li>
<li><a href="/wiki/Sulforidazine" title="Sulforidazine">Sulforidazine</a></li>
<li><a href="/wiki/Sulpiride" title="Sulpiride">Sulpiride</a></li>
<li><a href="/wiki/Sultopride" title="Sultopride">Sultopride</a></li>
<li><a href="/wiki/Thioridazine" title="Thioridazine">Thioridazine</a></li>
<li><a href="/wiki/Thiothixene" title="Thiothixene">Thiothixene</a></li>
<li><a href="/wiki/Trifluoperazine" title="Trifluoperazine">Trifluoperazine</a></li>
<li><a href="/wiki/Triflupromazine" title="Triflupromazine">Triflupromazine</a></li>
<li><a href="/wiki/Trifluperidol" title="Trifluperidol">Trifluperidol</a></li>
<li><a href="/wiki/Zuclopenthixol" title="Zuclopenthixol">Zuclopenthixol</a>; <i>Atypical antipsychotics</i>: <a href="/wiki/Amisulpride" title="Amisulpride">Amisulpride</a></li>
<li><a href="/wiki/Asenapine" title="Asenapine">Asenapine</a></li>
<li><a href="/wiki/Blonanserin" title="Blonanserin">Blonanserin</a></li>
<li><a href="/wiki/Cariprazine" title="Cariprazine">Cariprazine</a></li>
<li><a href="/wiki/Carpipramine" title="Carpipramine">Carpipramine</a></li>
<li><a href="/wiki/Clocapramine" title="Clocapramine">Clocapramine</a></li>
<li><a href="/wiki/Clorotepine" title="Clorotepine">Clorotepine</a></li>
<li><a href="/wiki/Clozapine" title="Clozapine">Clozapine</a></li>
<li><a href="/wiki/Gevotroline" title="Gevotroline">Gevotroline</a></li>
<li><a href="/wiki/Iloperidone" title="Iloperidone">Iloperidone</a></li>
<li><a href="/wiki/Lurasidone" title="Lurasidone">Lurasidone</a></li>
<li><a href="/wiki/Melperone" title="Melperone">Melperone</a></li>
<li><a href="/wiki/Molindone" title="Molindone">Molindone</a></li>
<li><a href="/wiki/Mosapramine" title="Mosapramine">Mosapramine</a></li>
<li><a href="/wiki/Olanzapine" title="Olanzapine">Olanzapine</a></li>
<li><a href="/wiki/Paliperidone" title="Paliperidone">Paliperidone</a></li>
<li><a href="/wiki/Perospirone" title="Perospirone">Perospirone</a></li>
<li><a href="/wiki/Piquindone" title="Piquindone">Piquindone</a></li>
<li><a href="/wiki/Quetiapine" title="Quetiapine">Quetiapine</a></li>
<li><a href="/wiki/Remoxipride" title="Remoxipride">Remoxipride</a></li>
<li><a href="/wiki/Risperidone" title="Risperidone">Risperidone</a></li>
<li><a href="/wiki/Sertindole" title="Sertindole">Sertindole</a></li>
<li><a href="/wiki/Tiospirone" title="Tiospirone">Tiospirone</a></li>
<li><a href="/wiki/Zicronapine" title="Zicronapine">Zicronapine</a></li>
<li><a href="/wiki/Ziprasidone" title="Ziprasidone">Ziprasidone</a></li>
<li><a href="/wiki/Zotepine" title="Zotepine">Zotepine</a>; <i>Antiemetics</i>: <a href="/wiki/AS-8112" title="AS-8112">AS-8112</a></li>
<li><a href="/wiki/Alizapride" title="Alizapride">Alizapride</a></li>
<li><a href="/wiki/Bromopride" title="Bromopride">Bromopride</a></li>
<li><a href="/wiki/Clebopride" title="Clebopride">Clebopride</a></li>
<li><a href="/wiki/Domperidone" title="Domperidone">Domperidone</a></li>
<li><a href="/wiki/Metoclopramide" title="Metoclopramide">Metoclopramide</a></li>
<li><a href="/wiki/Thiethylperazine" title="Thiethylperazine">Thiethylperazine</a>; <i>Others</i>: <a href="/wiki/Amoxapine" title="Amoxapine">Amoxapine</a></li>
<li><a href="/wiki/Buspirone" title="Buspirone">Buspirone</a></li>
<li><a href="/wiki/Butaclamol" title="Butaclamol">Butaclamol</a></li>
<li><a href="/wiki/Ecopipam" title="Ecopipam">Ecopipam</a></li>
<li><a href="/wiki/N-Ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline" title="N-Ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline">EEDQ</a></li>
<li><a href="/wiki/Eticlopride" title="Eticlopride">Eticlopride</a></li>
<li><a href="/wiki/Fananserin" title="Fananserin">Fananserin</a></li>
<li><a href="/wiki/Hydroxyzine" title="Hydroxyzine">Hydroxyzine</a></li>
<li><a href="/wiki/L-745,870" title="L-745,870">L-745,870</a></li>
<li><a href="/wiki/Nafadotride" title="Nafadotride">Nafadotride</a></li>
<li><a href="/wiki/Nuciferine" title="Nuciferine">Nuciferine</a></li>
<li><a href="/wiki/PNU-99,194" title="PNU-99,194">PNU-99,194</a></li>
<li><a href="/wiki/Raclopride" title="Raclopride">Raclopride</a></li>
<li><a href="/wiki/Sarizotan" title="Sarizotan">Sarizotan</a></li>
<li><a href="/wiki/SB-277,011-A" title="SB-277,011-A">SB-277,011-A</a></li>
<li><a href="/wiki/SCH-23,390" title="SCH-23,390" class="mw-redirect">SCH-23,390</a></li>
<li><a href="/wiki/SKF-83,959" title="SKF-83,959">SKF-83,959</a></li>
<li><a href="/wiki/Sonepiprazole" title="Sonepiprazole">Sonepiprazole</a></li>
<li><a href="/wiki/Spiperone" title="Spiperone">Spiperone</a></li>
<li><a href="/wiki/Spiroxatrine" title="Spiroxatrine">Spiroxatrine</a></li>
<li><a href="/wiki/Stepholidine" title="Stepholidine">Stepholidine</a></li>
<li><a href="/wiki/Tetrahydropalmatine" title="Tetrahydropalmatine">Tetrahydropalmatine</a></li>
<li><a href="/wiki/Tiapride" title="Tiapride">Tiapride</a></li>
<li><a href="/wiki/UH-232" title="UH-232">UH-232</a></li>
<li><a href="/wiki/Yohimbine" title="Yohimbine">Yohimbine</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<td colspan="2" class="navbox-list navbox-even hlist" style="width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks collapsible collapsed navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="col" class="navbox-title" colspan="2" style=";background-color: LightYellow;"><span style="float:left;width:6em;">&#160;</span>
<div style="font-size:110%;"><a href="/wiki/Dopamine_reuptake_inhibitor" title="Dopamine reuptake inhibitor">Reuptake inhibitors</a></div>
</th>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Plasmalemmal" title="Plasmalemmal" class="mw-redirect">Plasmalemmal</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Dopamine_transporter" title="Dopamine transporter">DAT</a> inhibitors</div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><i>Piperazines</i>: <a href="/wiki/DBL-583" title="DBL-583">DBL-583</a></li>
<li><a href="/wiki/GBR-12,935" title="GBR-12,935" class="mw-redirect">GBR-12,935</a></li>
<li><a href="/wiki/Nefazodone" title="Nefazodone">Nefazodone</a></li>
<li><a href="/wiki/Vanoxerine" title="Vanoxerine">Vanoxerine</a>; <i>Piperidines</i>: <a href="/wiki/Benocyclidine" title="Benocyclidine">BTCP</a></li>
<li><a href="/wiki/Desoxypipradrol" title="Desoxypipradrol">Desoxypipradrol</a></li>
<li><a href="/wiki/Dextromethylphenidate" title="Dextromethylphenidate" class="mw-redirect">Dextromethylphenidate</a></li>
<li><a href="/wiki/Difemetorex" title="Difemetorex">Difemetorex</a></li>
<li><a href="/wiki/Ethylphenidate" title="Ethylphenidate">Ethylphenidate</a></li>
<li><a href="/wiki/Methylnaphthidate" title="Methylnaphthidate" class="mw-redirect">Methylnaphthidate</a></li>
<li><a href="/wiki/Methylphenidate" title="Methylphenidate">Methylphenidate</a></li>
<li><a href="/wiki/Phencyclidine" title="Phencyclidine">Phencyclidine</a></li>
<li><a href="/wiki/Pipradrol" title="Pipradrol">Pipradrol</a>; <i>Pyrrolidines</i>: <a href="/wiki/Diphenylprolinol" title="Diphenylprolinol">Diphenylprolinol</a></li>
<li><a href="/wiki/Methylenedioxypyrovalerone" title="Methylenedioxypyrovalerone">MDPV</a></li>
<li><a href="/wiki/Naphyrone" title="Naphyrone">Naphyrone</a></li>
<li><a href="/wiki/Prolintane" title="Prolintane">Prolintane</a></li>
<li><a href="/wiki/Pyrovalerone" title="Pyrovalerone">Pyrovalerone</a>; <i>Tropanes</i>: <a href="/wiki/Altropane" title="Altropane">Altropane</a></li>
<li><a href="/wiki/Brasofensine" title="Brasofensine">Brasofensine</a></li>
<li><a href="/wiki/WIN_35428" title="WIN 35428">CFT</a></li>
<li><a href="/wiki/Cocaine" title="Cocaine">Cocaine</a></li>
<li><a href="/wiki/Dichloropane" title="Dichloropane">Dichloropane</a></li>
<li><a href="/wiki/Difluoropine" title="Difluoropine">Difluoropine</a></li>
<li><a href="/wiki/FE-%CE%B2-CPPIT" title="FE-β-CPPIT">FE-β-CPPIT</a></li>
<li><a href="/wiki/FP-%CE%B2-CPPIT" title="FP-β-CPPIT">FP-β-CPPIT</a></li>
<li><a href="/wiki/Ioflupane_(123I)" title="Ioflupane (123I)">Ioflupane (<sup>123</sup>I)</a></li>
<li><a href="/wiki/Iometopane" title="Iometopane" class="mw-redirect">Iometopane</a></li>
<li><a href="/wiki/RTI-112" title="RTI-112">RTI-112</a></li>
<li><a href="/wiki/RTI-113" title="RTI-113">RTI-113</a></li>
<li><a href="/wiki/RTI-121" title="RTI-121">RTI-121</a></li>
<li><a href="/wiki/RTI-126" title="RTI-126" class="mw-redirect">RTI-126</a></li>
<li><a href="/wiki/RTI-150" title="RTI-150">RTI-150</a></li>
<li><a href="/wiki/RTI-177" title="RTI-177">RTI-177</a></li>
<li><a href="/wiki/RTI-229" title="RTI-229">RTI-229</a></li>
<li><a href="/wiki/RTI-336" title="RTI-336" class="mw-redirect">RTI-336</a></li>
<li><a href="/wiki/Tenocyclidine" title="Tenocyclidine">Tenocyclidine</a></li>
<li><a href="/wiki/Tesofensine" title="Tesofensine">Tesofensine</a></li>
<li><a href="/wiki/Troparil" title="Troparil">Troparil</a></li>
<li><a href="/wiki/Tropoxane" title="Tropoxane">Tropoxane</a></li>
<li><a href="/wiki/2%CE%B2-Propanoyl-3%CE%B2-(4-tolyl)-tropane" title="2β-Propanoyl-3β-(4-tolyl)-tropane">WF-11</a></li>
<li><a href="/wiki/2%CE%B2-Propanoyl-3%CE%B2-(2-naphthyl)-tropane" title="2β-Propanoyl-3β-(2-naphthyl)-tropane">WF-23</a></li>
<li><a href="/wiki/2-Propanoyl-3-(4-isopropylphenyl)-tropane" title="2-Propanoyl-3-(4-isopropylphenyl)-tropane">WF-31</a></li>
<li><a href="/wiki/2%CE%B1-(Propanoyl)-3%CE%B2-(2-(6-methoxynaphthyl))-tropane" title="2α-(Propanoyl)-3β-(2-(6-methoxynaphthyl))-tropane">WF-33</a>; <i>Others</i>: <a href="/wiki/Adrafinil" title="Adrafinil">Adrafinil</a></li>
<li><a href="/wiki/Armodafinil" title="Armodafinil">Armodafinil</a></li>
<li><a href="/wiki/Amfonelic_acid" title="Amfonelic acid">Amfonelic acid</a></li>
<li><a href="/wiki/Amphetamine" title="Amphetamine">Amphetamine</a></li>
<li><a href="/wiki/Amineptine" title="Amineptine">Amineptine</a></li>
<li><a href="/wiki/Benzatropine" title="Benzatropine">Benzatropine</a></li>
<li><a href="/wiki/Bromantane" title="Bromantane">Bromantane</a></li>
<li><a href="/wiki/2-Butyl-3-(p-tolyl)quinuclidine" title="2-Butyl-3-(p-tolyl)quinuclidine" class="mw-redirect">BTQ</a></li>
<li><a href="/wiki/BTS-74,398" title="BTS-74,398" class="mw-redirect">BTS-74,398</a></li>
<li><a href="/wiki/Bupropion" title="Bupropion">Bupropion</a></li>
<li><a href="/wiki/Ciclazindol" title="Ciclazindol">Ciclazindol</a></li>
<li><a href="/wiki/Diclofensine" title="Diclofensine">Diclofensine</a></li>
<li><a href="/wiki/Dimethocaine" title="Dimethocaine">Dimethocaine</a></li>
<li><a href="/wiki/Diphenylpyraline" title="Diphenylpyraline">Diphenylpyraline</a></li>
<li><a href="/wiki/Dizocilpine" title="Dizocilpine">Dizocilpine</a></li>
<li><a href="/wiki/DOV-102,677" title="DOV-102,677">DOV-102,677</a></li>
<li><a href="/wiki/DOV-21,947" title="DOV-21,947" class="mw-redirect">DOV-21,947</a></li>
<li><a href="/wiki/DOV-216,303" title="DOV-216,303">DOV-216,303</a></li>
<li><a href="/wiki/Etybenzatropine" title="Etybenzatropine">Etybenzatropine</a></li>
<li><a href="/wiki/EXP-561" title="EXP-561">EXP-561</a></li>
<li><a href="/wiki/Fencamine" title="Fencamine">Fencamine</a></li>
<li><a href="/wiki/Fencamfamine" title="Fencamfamine">Fencamfamine</a></li>
<li><a href="/wiki/Fezolamine" title="Fezolamine">Fezolamine</a></li>
<li><a href="/wiki/Fluorenol" title="Fluorenol">Fluorenol</a></li>
<li><a href="/wiki/GYKI-52,895" title="GYKI-52,895" class="mw-redirect">GYKI-52,895</a></li>
<li><a href="/wiki/Indatraline" title="Indatraline">Indatraline</a></li>
<li><a href="/wiki/Ketamine" title="Ketamine">Ketamine</a></li>
<li><a href="/wiki/Lefetamine" title="Lefetamine">Lefetamine</a></li>
<li><a href="/wiki/Levophacetoperane" title="Levophacetoperane">Levophacetoperane</a></li>
<li><a href="/wiki/LR-5182" title="LR-5182">LR-5182</a></li>
<li><a href="/wiki/Manifaxine" title="Manifaxine">Manifaxine</a></li>
<li><a href="/wiki/Mazindol" title="Mazindol">Mazindol</a></li>
<li><a href="/wiki/Medifoxamine" title="Medifoxamine">Medifoxamine</a></li>
<li><a href="/wiki/Mesocarb" title="Mesocarb">Mesocarb</a></li>
<li><a href="/wiki/Modafinil" title="Modafinil">Modafinil</a></li>
<li><a href="/wiki/Nefopam" title="Nefopam">Nefopam</a></li>
<li><a href="/wiki/Nomifensine" title="Nomifensine">Nomifensine</a></li>
<li><a href="/wiki/NS-2359" title="NS-2359">NS-2359</a></li>
<li><a href="/wiki/O-2172" title="O-2172">O-2172</a></li>
<li><a href="/wiki/Pridefrine" title="Pridefrine" class="mw-redirect">Pridefrine</a></li>
<li><a href="/wiki/Propylamphetamine" title="Propylamphetamine">Propylamphetamine</a></li>
<li><a href="/wiki/Radafaxine" title="Radafaxine">Radafaxine</a></li>
<li><a href="/wiki/SEP-225,289" title="SEP-225,289" class="mw-redirect">SEP-225,289</a></li>
<li><a href="/wiki/SEP-227,162" title="SEP-227,162">SEP-227,162</a></li>
<li><a href="/wiki/Sertraline" title="Sertraline">Sertraline</a></li>
<li><a href="/wiki/Sibutramine" title="Sibutramine">Sibutramine</a></li>
<li><a href="/wiki/Tametraline" title="Tametraline">Tametraline</a></li>
<li><a href="/wiki/Tedatioxetine" title="Tedatioxetine">Tedatioxetine</a></li>
<li><a href="/wiki/Tripelennamine" title="Tripelennamine">Tripelennamine</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Vesicle_(biology)" title="Vesicle (biology)" class="mw-redirect">Vesicular</a></div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Vesicular_monoamine_transporter" title="Vesicular monoamine transporter">VMAT</a> inhibitors</div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Deserpidine" title="Deserpidine">Deserpidine</a></li>
<li><a href="/wiki/Ibogaine" title="Ibogaine">Ibogaine</a></li>
<li><a href="/wiki/Reserpine" title="Reserpine">Reserpine</a></li>
<li><a href="/wiki/Tetrabenazine" title="Tetrabenazine">Tetrabenazine</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<td colspan="2" class="navbox-list navbox-odd hlist" style="width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks collapsible collapsed navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="col" class="navbox-title" colspan="2" style=";background-color: LightYellow;"><span style="float:left;width:6em;">&#160;</span>
<div style="font-size:110%;"><a href="/wiki/Dopamine_releasing_agent" title="Dopamine releasing agent" class="mw-redirect">Releasing agents</a></div>
</th>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><i>Morpholines</i>: <a href="/wiki/Fenbutrazate" title="Fenbutrazate">Fenbutrazate</a></li>
<li><a href="/wiki/Fenmetramide" title="Fenmetramide">Fenmetramide</a></li>
<li><a href="/wiki/Morazone" title="Morazone">Morazone</a></li>
<li><a href="/wiki/Phendimetrazine" title="Phendimetrazine">Phendimetrazine</a></li>
<li><a href="/wiki/Phenmetrazine" title="Phenmetrazine">Phenmetrazine</a></li>
<li><a href="/wiki/Pseudophenmetrazine" title="Pseudophenmetrazine">Pseudophenmetrazine</a>; <i>Oxazolines</i>: <a href="/wiki/4-Methylaminorex" title="4-Methylaminorex">4-MAR</a></li>
<li><a href="/wiki/Aminorex" title="Aminorex">Aminorex</a></li>
<li><a href="/wiki/Clominorex" title="Clominorex">Clominorex</a></li>
<li><a href="/wiki/Cyclazodone" title="Cyclazodone">Cyclazodone</a></li>
<li><a href="/wiki/Fenozolone" title="Fenozolone">Fenozolone</a></li>
<li><a href="/wiki/Fluminorex" title="Fluminorex">Fluminorex</a></li>
<li><a href="/wiki/Pemoline" title="Pemoline">Pemoline</a></li>
<li><a href="/wiki/Thozalinone" title="Thozalinone">Thozalinone</a>; <i>Phenethylamines</i> (also <i>amphetamines</i>, <i>cathinones</i>, etc): <a href="/wiki/2-Hydroxyphenethylamine" title="2-Hydroxyphenethylamine" class="mw-redirect">2-OH-PEA</a></li>
<li><a href="/wiki/4-Chlorophenylisobutylamine" title="4-Chlorophenylisobutylamine">4-CAB</a></li>
<li><a href="/wiki/4-Fluoroamphetamine" title="4-Fluoroamphetamine">4-FA</a></li>
<li><a href="/wiki/4-Fluoromethamphetamine" title="4-Fluoromethamphetamine">4-FMA</a></li>
<li><a href="/wiki/4-Methylamphetamine" title="4-Methylamphetamine">4-MA</a></li>
<li><a href="/wiki/4-Methylmethamphetamine" title="4-Methylmethamphetamine">4-MMA</a></li>
<li><a href="/wiki/Alfetamine" title="Alfetamine">Alfetamine</a></li>
<li><a href="/wiki/Amfecloral" title="Amfecloral">Amfecloral</a></li>
<li><a href="/wiki/Amfepentorex" title="Amfepentorex">Amfepentorex</a></li>
<li><a href="/wiki/Amfepramone" title="Amfepramone">Amfepramone</a></li>
<li><a href="/wiki/Amphetamine" title="Amphetamine">Amphetamine</a> (<a href="/wiki/Dextroamphetamine" title="Dextroamphetamine">Dextroamphetamine</a></li>
<li><a href="/wiki/Levoamphetamine" title="Levoamphetamine">Levoamphetamine</a>)</li>
<li><a href="/wiki/Amphetaminil" title="Amphetaminil">Amphetaminil</a></li>
<li><a href="/wiki/Beta-Methylphenethylamine" title="Beta-Methylphenethylamine" class="mw-redirect">β-Me-PEA</a></li>
<li><a href="/wiki/Benzodioxolylbutanamine" title="Benzodioxolylbutanamine" class="mw-redirect">BDB</a></li>
<li><a href="/wiki/Benzodioxolylhydroxybutanamine" title="Benzodioxolylhydroxybutanamine" class="mw-redirect">BOH</a></li>
<li><a href="/wiki/Benzphetamine" title="Benzphetamine">Benzphetamine</a></li>
<li><a href="/wiki/Buphedrone" title="Buphedrone">Buphedrone</a></li>
<li><a href="/wiki/Butylone" title="Butylone">Butylone</a></li>
<li><a href="/wiki/Cathine" title="Cathine">Cathine</a></li>
<li><a href="/wiki/Cathinone" title="Cathinone">Cathinone</a></li>
<li><a href="/wiki/Clobenzorex" title="Clobenzorex">Clobenzorex</a></li>
<li><a href="/wiki/Clortermine" title="Clortermine">Clortermine</a></li>
<li><a href="/wiki/D-Deprenyl" title="D-Deprenyl">D-Deprenyl</a></li>
<li><a href="/wiki/Dimethoxyamphetamine" title="Dimethoxyamphetamine">DMA</a></li>
<li><a href="/wiki/Dimethoxymethamphetamine" title="Dimethoxymethamphetamine">DMMA</a></li>
<li><a href="/wiki/Dimethylamphetamine" title="Dimethylamphetamine">Dimethylamphetamine</a></li>
<li><a href="/wiki/Dimethylcathinone" title="Dimethylcathinone" class="mw-redirect">Dimethylcathinone</a></li>
<li><a href="/wiki/Ephedrine" title="Ephedrine">Ephedrine</a></li>
<li><a href="/wiki/Ethcathinone" title="Ethcathinone">Ethcathinone</a></li>
<li><a href="/wiki/Ethylbenzodioxolylbutanamine" title="Ethylbenzodioxolylbutanamine" class="mw-redirect">EBDB</a></li>
<li><a href="/wiki/Ethylone" title="Ethylone">Ethylone</a></li>
<li><a href="/wiki/Etilamfetamine" title="Etilamfetamine">Etilamfetamine</a></li>
<li><a href="/wiki/Famprofazone" title="Famprofazone">Famprofazone</a></li>
<li><a href="/wiki/Fenethylline" title="Fenethylline">Fenethylline</a></li>
<li><a href="/wiki/Fenproporex" title="Fenproporex">Fenproporex</a></li>
<li><a href="/wiki/Flephedrone" title="Flephedrone">Flephedrone</a></li>
<li><a href="/wiki/Fludorex" title="Fludorex">Fludorex</a></li>
<li><a href="/wiki/Furfenorex" title="Furfenorex">Furfenorex</a></li>
<li><a href="/wiki/Hordenine" title="Hordenine">Hordenine</a></li>
<li><a href="/wiki/Hydroxyamphetamine" title="Hydroxyamphetamine">Hydroxyamphetamine</a></li>
<li><a href="/wiki/Iofetamine" title="Iofetamine" class="mw-redirect">Iofetamine</a></li>
<li><a href="/wiki/Lophophine" title="Lophophine">Lophophine</a></li>
<li><a href="/wiki/Mefenorex" title="Mefenorex">Mefenorex</a></li>
<li><a href="/wiki/Mephedrone" title="Mephedrone">Mephedrone</a></li>
<li><a href="/wiki/Methamphetamine" title="Methamphetamine">Methamphetamine</a> (<a href="/wiki/Dextromethamphetamine" title="Dextromethamphetamine" class="mw-redirect">Dextromethamphetamine</a>, <a href="/wiki/Levomethamphetamine" title="Levomethamphetamine">Levomethamphetamine</a>)</li>
<li><a href="/wiki/Methcathinone" title="Methcathinone">Methcathinone</a></li>
<li><a href="/wiki/Methedrone" title="Methedrone">Methedrone</a></li>
<li><a href="/wiki/Methoxymethylenedioxyamphetamine" title="Methoxymethylenedioxyamphetamine" class="mw-redirect">MMDA</a></li>
<li><a href="/wiki/Methoxymethylenedioxymethamphetamine" title="Methoxymethylenedioxymethamphetamine" class="mw-redirect">MMDMA</a></li>
<li><a href="/wiki/Methylbenzodioxolylbutanamine" title="Methylbenzodioxolylbutanamine" class="mw-redirect">MBDB</a></li>
<li><a href="/wiki/Methylenedioxyamphetamine" title="Methylenedioxyamphetamine" class="mw-redirect">MDA</a></li>
<li><a href="/wiki/Methylenedioxyethylamphetamine" title="Methylenedioxyethylamphetamine">MDEA</a></li>
<li><a href="/wiki/Methylenedioxymethamphetamine" title="Methylenedioxymethamphetamine" class="mw-redirect">MDMA</a></li>
<li><a href="/wiki/Methylenedioxymethylphenethylamine" title="Methylenedioxymethylphenethylamine">MDMPEA</a></li>
<li><a href="/wiki/Methylenedioxyhydroxyamphetamine" title="Methylenedioxyhydroxyamphetamine">MDOH</a></li>
<li><a href="/wiki/Methylenedioxyphenethylamine" title="Methylenedioxyphenethylamine">MDPEA</a></li>
<li><a href="/wiki/Methylone" title="Methylone">Methylone</a></li>
<li><a href="/wiki/Ortetamine" title="Ortetamine">Ortetamine</a></li>
<li><a href="/wiki/Parabromoamphetamine" title="Parabromoamphetamine" class="mw-redirect"><i>p</i>BA</a></li>
<li><a href="/wiki/Parachloroamphetamine" title="Parachloroamphetamine" class="mw-redirect"><i>p</i>CA</a></li>
<li><a href="/wiki/Paraiodoamphetamine" title="Paraiodoamphetamine" class="mw-redirect"><i>p</i>IA</a></li>
<li><a href="/wiki/Pholedrine" title="Pholedrine">Pholedrine</a></li>
<li><a href="/wiki/Phenethylamine" title="Phenethylamine">Phenethylamine</a></li>
<li><a href="/wiki/Pholedrine" title="Pholedrine">Pholedrine</a></li>
<li><a href="/wiki/Phenpromethamine" title="Phenpromethamine">Phenpromethamine</a></li>
<li><a href="/wiki/Prenylamine" title="Prenylamine">Prenylamine</a></li>
<li><a href="/wiki/Propylamphetamine" title="Propylamphetamine">Propylamphetamine</a></li>
<li><a href="/wiki/Pseudoephedrine" title="Pseudoephedrine">Pseudoephedrine</a></li>
<li><a href="/wiki/Tiflorex" title="Tiflorex">Tiflorex</a></li>
<li><a href="/wiki/Tyramine" title="Tyramine">Tyramine</a></li>
<li><a href="/wiki/Xylopropamine" title="Xylopropamine">Xylopropamine</a></li>
<li><a href="/wiki/Zylofuramine" title="Zylofuramine">Zylofuramine</a>; <i>Piperazines</i>: <a href="/wiki/2C-B-BZP" title="2C-B-BZP">2C-B-BZP</a></li>
<li><a href="/wiki/Benzylpiperazine" title="Benzylpiperazine">BZP</a></li>
<li><a href="/wiki/Methylbenzylpiperazine" title="Methylbenzylpiperazine">MBZP</a></li>
<li><a href="/wiki/Methylenedioxybenzylpiperazine" title="Methylenedioxybenzylpiperazine">MDBZP</a></li>
<li><a href="/wiki/Methoxyphenylpiperazine" title="Methoxyphenylpiperazine" class="mw-redirect">MeOPP</a>; <i>Others</i>: <a href="/wiki/2-Amino-1,2-dihydronaphthalene" title="2-Amino-1,2-dihydronaphthalene">2-ADN</a></li>
<li><a href="/wiki/2-Aminoindane" title="2-Aminoindane">2-AI</a></li>
<li><a href="/wiki/2-Aminotetralin" title="2-Aminotetralin">2-AT</a></li>
<li><a href="/wiki/4-Benzylpiperidine" title="4-Benzylpiperidine">4-BP</a></li>
<li><a href="/wiki/5-Iodo-2-aminoindane" title="5-Iodo-2-aminoindane" class="mw-redirect">5-IAI</a></li>
<li><a href="/wiki/Clofenciclan" title="Clofenciclan">Clofenciclan</a></li>
<li><a href="/wiki/Cyclopentamine" title="Cyclopentamine">Cyclopentamine</a></li>
<li><a href="/wiki/Cypenamine" title="Cypenamine">Cypenamine</a></li>
<li><a href="/wiki/Cyprodenate" title="Cyprodenate">Cyprodenate</a></li>
<li><a href="/wiki/Feprosidnine" title="Feprosidnine">Feprosidnine</a></li>
<li><a href="/wiki/Gilutensin" title="Gilutensin">Gilutensin</a></li>
<li><a href="/wiki/Heptaminol" title="Heptaminol">Heptaminol</a></li>
<li><a href="/wiki/Hexacyclonate" title="Hexacyclonate">Hexacyclonate</a></li>
<li><a href="/wiki/Indanylaminopropane" title="Indanylaminopropane" class="mw-redirect">IAP</a></li>
<li><a href="/wiki/Indanorex" title="Indanorex">Indanorex</a></li>
<li><a href="/wiki/Isometheptene" title="Isometheptene">Isometheptene</a></li>
<li><a href="/wiki/Methylhexanamine" title="Methylhexanamine">Methylhexanamine</a></li>
<li><a href="/wiki/Naphthylisopropylamine" title="Naphthylisopropylamine" class="mw-redirect">Naphthylisopropylamine</a></li>
<li><a href="/wiki/Octodrine" title="Octodrine">Octodrine</a></li>
<li><a href="/wiki/Phthalimidopropiophenone" title="Phthalimidopropiophenone">Phthalimidopropiophenone</a></li>
<li><a href="/wiki/Propylhexedrine" title="Propylhexedrine">Propylhexedrine</a> (<a href="/wiki/Levopropylhexedrine" title="Levopropylhexedrine">Levopropylhexedrine</a>)</li>
<li><a href="/wiki/Tuaminoheptane" title="Tuaminoheptane">Tuaminoheptane</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<td colspan="2" class="navbox-list navbox-even hlist" style="width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks collapsible collapsed navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="col" class="navbox-title" colspan="2" style=";background-color: LightYellow;"><span style="float:left;width:6em;">&#160;</span>
<div style="font-size:110%;"><a href="/wiki/Allosteric_regulation" title="Allosteric regulation">Allosteric modulators</a></div>
</th>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><i>Quinazolinamines</i>: <a href="/w/index.php?title=N-(Diphenylmethyl)-2-phenyl-4-quinazolinamine&amp;action=edit&amp;redlink=1" class="new" title="N-(Diphenylmethyl)-2-phenyl-4-quinazolinamine (page does not exist)">SoRI-9804</a></li>
<li><a href="/w/index.php?title=N-(2,2-diphenylethyl)-2-phenyl-4-quinazolinamine&amp;action=edit&amp;redlink=1" class="new" title="N-(2,2-diphenylethyl)-2-phenyl-4-quinazolinamine (page does not exist)">SoRI-20040</a></li>
<li><a href="/wiki/SoRI-20041" title="SoRI-20041">SoRI-20041</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<td colspan="2" class="navbox-list navbox-odd hlist" style="width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks collapsible collapsed navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="col" class="navbox-title" colspan="2" style=";background-color: LightYellow;"><span style="float:left;width:6em;">&#160;</span>
<div style="font-size:110%;"><a href="/wiki/Enzyme_inhibitor" title="Enzyme inhibitor">Enzyme inhibitors</a></div>
</th>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Anabolism" title="Anabolism">Anabolism</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Phenylalanine_hydroxylase" title="Phenylalanine hydroxylase">PAH</a> inhibitors</div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/3,4-Dihydroxystyrene" title="3,4-Dihydroxystyrene">3,4-Dihydroxystyrene</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Tyrosine_hydroxylase" title="Tyrosine hydroxylase">TH</a> inhibitors</div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/3-Iodotyrosine" title="3-Iodotyrosine">3-Iodotyrosine</a></li>
<li><a href="/wiki/Aquayamycin" title="Aquayamycin">Aquayamycin</a></li>
<li><a href="/wiki/Bulbocapnine" title="Bulbocapnine">Bulbocapnine</a></li>
<li><a href="/wiki/Metirosine" title="Metirosine">Metirosine</a></li>
<li><a href="/wiki/Oudenone" title="Oudenone">Oudenone</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Aromatic_L-amino_acid_decarboxylase" title="Aromatic L-amino acid decarboxylase">AAAD/DDC</a> <a href="/wiki/Aromatic_L-amino_acid_decarboxylase_inhibitor" title="Aromatic L-amino acid decarboxylase inhibitor">inhibitors</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Benserazide" title="Benserazide">Benserazide</a></li>
<li><a href="/wiki/Carbidopa" title="Carbidopa">Carbidopa</a></li>
<li><a href="/wiki/Alpha-Difluoromethyl-DOPA" title="Alpha-Difluoromethyl-DOPA">DFMD</a></li>
<li><a href="/wiki/Genistein" title="Genistein">Genistein</a></li>
<li><a href="/wiki/Methyldopa" title="Methyldopa">Methyldopa</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Catabolism" title="Catabolism">Catabolism</a></div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Monoamine_oxidase_inhibitor" title="Monoamine oxidase inhibitor">MAO inhibitors</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><i>Nonselective</i>: <a href="/wiki/Benmoxin" title="Benmoxin">Benmoxin</a></li>
<li><a href="/wiki/Caroxazone" title="Caroxazone">Caroxazone</a></li>
<li><a href="/wiki/Echinopsidine" title="Echinopsidine">Echinopsidine</a></li>
<li><a href="/wiki/Furazolidone" title="Furazolidone">Furazolidone</a></li>
<li><a href="/wiki/Hydralazine" title="Hydralazine">Hydralazine</a></li>
<li><a href="/wiki/Indantadol" title="Indantadol">Indantadol</a></li>
<li><a href="/wiki/Iproclozide" title="Iproclozide">Iproclozide</a></li>
<li><a href="/wiki/Iproniazid" title="Iproniazid">Iproniazid</a></li>
<li><a href="/wiki/Isocarboxazid" title="Isocarboxazid">Isocarboxazid</a></li>
<li><a href="/wiki/Isoniazid" title="Isoniazid">Isoniazid</a></li>
<li><a href="/wiki/Linezolid" title="Linezolid">Linezolid</a></li>
<li><a href="/wiki/Mebanazine" title="Mebanazine">Mebanazine</a></li>
<li><a href="/wiki/Metfendrazine" title="Metfendrazine">Metfendrazine</a></li>
<li><a href="/wiki/Nialamide" title="Nialamide">Nialamide</a></li>
<li><a href="/wiki/Octamoxin" title="Octamoxin">Octamoxin</a></li>
<li><a href="/wiki/Paraxazone" title="Paraxazone">Paraxazone</a></li>
<li><a href="/wiki/Phenelzine" title="Phenelzine">Phenelzine</a></li>
<li><a href="/wiki/Pheniprazine" title="Pheniprazine">Pheniprazine</a></li>
<li><a href="/wiki/Phenoxypropazine" title="Phenoxypropazine">Phenoxypropazine</a></li>
<li><a href="/wiki/Pivalylbenzhydrazine" title="Pivalylbenzhydrazine">Pivalylbenzhydrazine</a></li>
<li><a href="/wiki/Procarbazine" title="Procarbazine">Procarbazine</a></li>
<li><a href="/wiki/Safrazine" title="Safrazine">Safrazine</a></li>
<li><a href="/wiki/Tranylcypromine" title="Tranylcypromine">Tranylcypromine</a>; <i>MAO-A selective</i>: <a href="/wiki/Amiflamine" title="Amiflamine">Amiflamine</a></li>
<li><a href="/wiki/Bazinaprine" title="Bazinaprine">Bazinaprine</a></li>
<li><a href="/wiki/Befloxatone" title="Befloxatone">Befloxatone</a></li>
<li><a href="/wiki/Brofaromine" title="Brofaromine">Brofaromine</a></li>
<li><a href="/wiki/Cimoxatone" title="Cimoxatone">Cimoxatone</a></li>
<li><a href="/wiki/Clorgiline" title="Clorgiline">Clorgiline</a></li>
<li><a href="/wiki/Eprobemide" title="Eprobemide">Eprobemide</a></li>
<li><a href="/wiki/Esuprone" title="Esuprone">Esuprone</a></li>
<li><a href="/wiki/Harmala_alkaloid" title="Harmala alkaloid">Harmala alkaloids</a></li>
<li><a href="/wiki/Methylene_blue" title="Methylene blue">Methylene Blue</a></li>
<li><a href="/wiki/Metralindole" title="Metralindole">Metralindole</a></li>
<li><a href="/wiki/Minaprine" title="Minaprine">Minaprine</a></li>
<li><a href="/wiki/Moclobemide" title="Moclobemide">Moclobemide</a></li>
<li><a href="/wiki/Pirlindole" title="Pirlindole">Pirlindole</a></li>
<li><a href="/wiki/Sercloremine" title="Sercloremine">Sercloremine</a></li>
<li><a href="/wiki/Tetrindole" title="Tetrindole">Tetrindole</a></li>
<li><a href="/wiki/Toloxatone" title="Toloxatone">Toloxatone</a></li>
<li><a href="/wiki/Tyrima" title="Tyrima" class="mw-redirect">Tyrima</a>; <i>MAO-B selective</i>: <a href="/wiki/D-Deprenyl" title="D-Deprenyl">D-Deprenyl</a></li>
<li><a href="/wiki/Ethanol" title="Ethanol">Ethanol</a></li>
<li><a href="/wiki/L-Deprenyl" title="L-Deprenyl" class="mw-redirect">L-Deprenyl</a> (Selegiline)</li>
<li><a href="/wiki/Ladostigil" title="Ladostigil">Ladostigil</a></li>
<li><a href="/wiki/Lazabemide" title="Lazabemide">Lazabemide</a></li>
<li><a href="/wiki/Milacemide" title="Milacemide">Milacemide</a></li>
<li><a href="/wiki/Nicotine" title="Nicotine">Nicotine</a></li>
<li><a href="/wiki/Pargyline" title="Pargyline">Pargyline</a></li>
<li><a href="/wiki/Rasagiline" title="Rasagiline">Rasagiline</a></li>
<li><a href="/wiki/Safinamide" title="Safinamide">Safinamide</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/COMT_inhibitor" title="COMT inhibitor">COMT inhibitors</a></div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Entacapone" title="Entacapone">Entacapone</a></li>
<li><a href="/wiki/Nitecapone" title="Nitecapone">Nitecapone</a></li>
<li><a href="/wiki/Tolcapone" title="Tolcapone">Tolcapone</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Dopamine-beta-hydroxylase" title="Dopamine-beta-hydroxylase" class="mw-redirect">DBH</a> inhibitors</div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Disulfiram" title="Disulfiram">Disulfiram</a></li>
<li><a href="/wiki/Dopastin" title="Dopastin">Dopastin</a></li>
<li><a href="/wiki/Fusaric_acid" title="Fusaric acid">Fusaric acid</a></li>
<li><a href="/wiki/Nepicastat" title="Nepicastat">Nepicastat</a></li>
<li><a href="/wiki/Tropolone" title="Tropolone">Tropolone</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<td colspan="2" class="navbox-list navbox-even hlist" style="width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks collapsible collapsed navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="col" class="navbox-title" colspan="2" style=";background-color: LightYellow;"><span style="float:left;width:6em;">&#160;</span>
<div style="font-size:110%;">Others</div>
</th>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Precursor_(chemistry)" title="Precursor (chemistry)">Precursors</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/L-Phenylalanine" title="L-Phenylalanine" class="mw-redirect">L-Phenylalanine</a> → <a href="/wiki/Tyrosine" title="Tyrosine">L-Tyrosine</a> → <a href="/wiki/L-DOPA" title="L-DOPA">L-DOPA</a> (Levodopa)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Cofactor_(biochemistry)" title="Cofactor (biochemistry)">Cofactors</a></div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Ferrous" title="Ferrous">Ferrous</a> <a href="/wiki/Iron" title="Iron">iron</a> (Fe<sup>2+</sup>)</li>
<li><a href="/wiki/Tetrahydrobiopterin" title="Tetrahydrobiopterin">Tetrahydrobiopterin</a></li>
<li><a href="/wiki/Vitamin_B3" title="Vitamin B3" class="mw-redirect">Vitamin B<sub>3</sub></a> (<a href="/wiki/Niacin" title="Niacin">Niacin</a></li>
<li><a href="/wiki/Nicotinamide" title="Nicotinamide">Nicotinamide</a> → <a href="/wiki/NADPH" title="NADPH" class="mw-redirect">NADPH</a>)</li>
<li><a href="/wiki/Vitamin_B6" title="Vitamin B6">Vitamin B<sub>6</sub></a> (<a href="/wiki/Pyridoxine" title="Pyridoxine">Pyridoxine</a></li>
<li><a href="/wiki/Pyridoxamine" title="Pyridoxamine">Pyridoxamine</a></li>
<li><a href="/wiki/Pyridoxal" title="Pyridoxal">Pyridoxal</a> → <a href="/wiki/Pyridoxal_phosphate" title="Pyridoxal phosphate">Pyridoxal phosphate</a>)</li>
<li><a href="/wiki/Vitamin_B9" title="Vitamin B9" class="mw-redirect">Vitamin B<sub>9</sub></a> (<a href="/wiki/Folic_acid" title="Folic acid">Folic acid</a> → <a href="/wiki/Tetrahydrofolic_acid" title="Tetrahydrofolic acid">Tetrahydrofolic acid</a>)</li>
<li><a href="/wiki/Vitamin_C" title="Vitamin C">Vitamin C</a> (<a href="/wiki/Ascorbic_acid" title="Ascorbic acid">Ascorbic acid</a>)</li>
<li><a href="/wiki/Zinc" title="Zinc">Zinc</a> (Zn<sup>2+</sup>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;">Others</div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><i>Activity enhancers</i>: <a href="/wiki/Benzofuranylpropylaminopentane" title="Benzofuranylpropylaminopentane">BPAP</a> * <a href="/wiki/Phenylpropylaminopentane" title="Phenylpropylaminopentane">PPAP</a>; <i>Toxins</i>: <a href="/wiki/6-Hydroxydopamine" title="6-Hydroxydopamine" class="mw-redirect">6-OHDA</a>; <a href="/wiki/Steroids" title="Steroids" class="mw-redirect">Steroids</a>: <a href="/wiki/Anabolic-androgenic_steroids" title="Anabolic-androgenic steroids" class="mw-redirect">Anabolic-androgenic steroids</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2">
<div><b><a href="/wiki/List_of_dopaminergic_drugs" title="List of dopaminergic drugs">List of dopaminergic drugs</a></b></div>
</td>
</tr>
</table>
</td>
</tr>
</table>
<table cellspacing="0" class="navbox" style="border-spacing:0;">
<tr>
<td style="padding:2px;">
<table cellspacing="0" class="nowraplinks collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit;">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Phenethylamines" title="Template:Phenethylamines"><span title="View this template" style=";;background:none transparent;border:none;;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Phenethylamines" title="Template talk:Phenethylamines"><span title="Discuss this template" style=";;background:none transparent;border:none;;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Phenethylamines&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%;"><a href="/wiki/Substituted_phenethylamines" title="Substituted phenethylamines" class="mw-redirect">Phenethylamines</a></div>
</th>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Substituted_phenethylamine" title="Substituted phenethylamine">Phenethylamines</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><i>Psychedelics:</i> <a href="/wiki/25B-NBOMe" title="25B-NBOMe">25B-NBOMe</a></li>
<li><a href="/wiki/25C-NBOMe" title="25C-NBOMe">25C-NBOMe</a></li>
<li><a href="/wiki/25D-NBOMe" title="25D-NBOMe">25D-NBOMe</a></li>
<li><a href="/wiki/25I-NBOMe" title="25I-NBOMe">25I-NBOMe</a></li>
<li><a href="/wiki/25N-NBOMe" title="25N-NBOMe">25N-NBOMe</a></li>
<li><a href="/wiki/2C-B" title="2C-B">2C-B</a></li>
<li><a href="/wiki/2C-B-FLY" title="2C-B-FLY">2C-B-FLY</a></li>
<li><a href="/wiki/%CE%92k-2C-B" title="Βk-2C-B" class="mw-redirect">βk-2C-B</a></li>
<li><a href="/wiki/2C-C" title="2C-C">2C-C</a></li>
<li><a href="/wiki/2C-D" title="2C-D">2C-D</a></li>
<li><a href="/wiki/2C-E" title="2C-E">2C-E</a></li>
<li><a href="/wiki/2C-EF" title="2C-EF">2C-EF</a></li>
<li><a href="/wiki/2C-F" title="2C-F">2C-F</a></li>
<li><a href="/wiki/2C-G" title="2C-G">2C-G</a></li>
<li><a href="/wiki/2C-I" title="2C-I">2C-I</a></li>
<li><a href="/wiki/2C-N" title="2C-N">2C-N</a></li>
<li><a href="/wiki/2C-P" title="2C-P">2C-P</a></li>
<li><a href="/wiki/2C-SE" title="2C-SE">2C-SE</a></li>
<li><a href="/wiki/2C-T" title="2C-T">2C-T</a></li>
<li><a href="/wiki/2C-T-2" title="2C-T-2">2C-T-2</a></li>
<li><a href="/wiki/2C-T-4" title="2C-T-4">2C-T-4</a></li>
<li><a href="/wiki/2C-T-7" title="2C-T-7">2C-T-7</a></li>
<li><a href="/wiki/2C-T-8" title="2C-T-8">2C-T-8</a></li>
<li><a href="/wiki/2C-T-9" title="2C-T-9" class="mw-redirect">2C-T-9</a></li>
<li><a href="/wiki/2C-T-13" title="2C-T-13">2C-T-13</a></li>
<li><a href="/wiki/2C-T-15" title="2C-T-15">2C-T-15</a></li>
<li><a href="/wiki/2C-T-17" title="2C-T-17">2C-T-17</a></li>
<li><a href="/wiki/2C-T-21" title="2C-T-21">2C-T-21</a></li>
<li><a href="/wiki/2C-TFM" title="2C-TFM">2C-TFM</a></li>
<li><a href="/wiki/2C-YN" title="2C-YN">2C-YN</a></li>
<li><a href="/wiki/Allylescaline" title="Allylescaline">Allylescaline</a></li>
<li><a href="/wiki/DESOXY" title="DESOXY">DESOXY</a></li>
<li><a href="/wiki/Escaline" title="Escaline">Escaline</a></li>
<li><a href="/wiki/Isoproscaline" title="Isoproscaline">Isoproscaline</a></li>
<li><a href="/wiki/Jimscaline" title="Jimscaline">Jimscaline</a></li>
<li><a href="/wiki/Macromerine" title="Macromerine">Macromerine</a></li>
<li><a href="/wiki/3-Methoxy-4-ethoxyphenethylamine" title="3-Methoxy-4-ethoxyphenethylamine">MEPEA</a></li>
<li><a href="/wiki/Mescaline" title="Mescaline">Mescaline</a></li>
<li><a href="/wiki/Metaescaline" title="Metaescaline">Metaescaline</a></li>
<li><a href="/wiki/Methallylescaline" title="Methallylescaline">Methallylescaline</a></li>
<li><a href="/wiki/Proscaline" title="Proscaline">Proscaline</a></li>
<li><a href="/wiki/Psi-2C-T-4" title="Psi-2C-T-4" class="mw-redirect">Psi-2C-T-4</a></li>
<li><a href="/wiki/TCB-2" title="TCB-2">TCB-2</a><br />
<i>Stimulants:</i> <a href="/wiki/Phenylethanolamine" title="Phenylethanolamine">Phenylethanolamine</a></li>
<li><a href="/wiki/Hordenine" title="Hordenine">Hordenine</a></li>
<li><a href="/wiki/Phenethylamine" title="Phenethylamine">Phenethylamine</a></li>
<li><a href="/wiki/Amphetamine" title="Amphetamine">α-Methylphenethylamine</a> (amphetamine)</li>
<li><a href="/wiki/%CE%92-Methylphenethylamine" title="Β-Methylphenethylamine">β-Methylphenethylamine</a></li>
<li><a href="/wiki/N-Methylphenethylamine" title="N-Methylphenethylamine"><i>N</i>-Methylphenethylamine</a></li>
<li><a href="/w/index.php?title=O-Methylphenethylamine&amp;action=edit&amp;redlink=1" class="new" title="O-Methylphenethylamine (page does not exist)">o-Methylphenethylamine</a></li>
<li><a href="/w/index.php?title=P-Methylphenethylamine&amp;action=edit&amp;redlink=1" class="new" title="P-Methylphenethylamine (page does not exist)">p-Methylphenethylamine</a></li>
</ul>
<p><i>Entactogens:</i> <a href="/wiki/Lophophine" title="Lophophine">Lophophine</a></p>
<ul>
<li><a href="/wiki/Methylenedioxyphenethylamine" title="Methylenedioxyphenethylamine">MDPEA</a></li>
<li><a href="/wiki/Methylenedioxymethylphenethylamine" title="Methylenedioxymethylphenethylamine">MDMPEA</a><br />
<i>Others:</i> <a href="/wiki/Benzodioxolylhydroxybutanamine" title="Benzodioxolylhydroxybutanamine" class="mw-redirect">BOH</a></li>
<li><a href="/wiki/3,4-Dimethoxyphenethylamine" title="3,4-Dimethoxyphenethylamine">DMPEA</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Substituted_amphetamine" title="Substituted amphetamine">Amphetamines</a><br /></th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><i>Psychedelics:</i> <a href="/wiki/3C-BZ" title="3C-BZ">3C-BZ</a></li>
<li><a href="/wiki/3C-E" title="3C-E">3C-E</a></li>
<li><a href="/wiki/3C-P" title="3C-P">3C-P</a></li>
<li><a href="/wiki/Aleph_(psychedelic)" title="Aleph (psychedelic)">Aleph</a></li>
<li><a href="/wiki/Beatrice_(psychedelic)" title="Beatrice (psychedelic)">Beatrice</a></li>
<li><a href="/wiki/Bromo-DragonFLY" title="Bromo-DragonFLY">Bromo-DragonFLY</a></li>
<li><a href="/wiki/D-Deprenyl" title="D-Deprenyl">D-Deprenyl</a></li>
<li><a href="/wiki/Dimethoxyamphetamine" title="Dimethoxyamphetamine">DMA</a></li>
<li><a href="/w/index.php?title=4-Methyl-2,5-methoxycyclopropylamine&amp;action=edit&amp;redlink=1" class="new" title="4-Methyl-2,5-methoxycyclopropylamine (page does not exist)">DMCPA</a></li>
<li><a href="/wiki/DMMDA" title="DMMDA">DMMDA</a></li>
<li><a href="/wiki/2,5-Dimethoxy-4-bromoamphetamine" title="2,5-Dimethoxy-4-bromoamphetamine">DOB</a></li>
<li><a href="/wiki/2,5-Dimethoxy-4-chloroamphetamine" title="2,5-Dimethoxy-4-chloroamphetamine">DOC</a></li>
<li><a href="/wiki/2,5-Dimethoxy-4-fluoroethylamphetamine" title="2,5-Dimethoxy-4-fluoroethylamphetamine" class="mw-redirect">DOEF</a></li>
<li><a href="/wiki/2,5-Dimethoxy-4-ethylamphetamine" title="2,5-Dimethoxy-4-ethylamphetamine">DOET</a></li>
<li><a href="/wiki/2,5-Dimethoxy-4-iodoamphetamine" title="2,5-Dimethoxy-4-iodoamphetamine">DOI</a></li>
<li><a href="/wiki/2,5-Dimethoxy-4-methylamphetamine" title="2,5-Dimethoxy-4-methylamphetamine">DOM</a></li>
<li><a href="/wiki/2,5-Dimethoxy-4-nitroamphetamine" title="2,5-Dimethoxy-4-nitroamphetamine">DON</a></li>
<li><a href="/wiki/2,5-Dimethoxy-4-propylamphetamine" title="2,5-Dimethoxy-4-propylamphetamine">DOPR</a></li>
<li><a href="/wiki/2,5-Dimethoxy-4-trifluoromethylamphetamine" title="2,5-Dimethoxy-4-trifluoromethylamphetamine">DOTFM</a></li>
<li><a href="/wiki/Ganesha_(psychedelic)" title="Ganesha (psychedelic)">Ganesha</a></li>
<li><a href="/wiki/MMDA_(drug)" title="MMDA (drug)">MMDA</a></li>
<li><a href="/wiki/MMDA-2" title="MMDA-2">MMDA-2</a></li>
<li><a href="/wiki/Psi-DOM" title="Psi-DOM">Psi-DOM</a></li>
<li><a href="/wiki/Trimethoxyamphetamine" title="Trimethoxyamphetamine">TMA</a></li>
<li><a href="/wiki/Tetramethoxyamphetamine" title="Tetramethoxyamphetamine" class="mw-redirect">TeMA</a><br />
<i>Stimulants:</i> <a href="/wiki/3-Fluoromethamphetamine" title="3-Fluoromethamphetamine">3-FMA</a></li>
<li><a href="/wiki/4-Methamphetamine" title="4-Methamphetamine" class="mw-redirect">4-MA</a></li>
<li><a href="/wiki/4-Methylmethamphetamine" title="4-Methylmethamphetamine">4-MMA</a></li>
<li><a href="/wiki/4-Methylthioamphetamine" title="4-Methylthioamphetamine">4-MTA</a></li>
<li><a href="/wiki/5-(2-Aminopropyl)indole" title="5-(2-Aminopropyl)indole">5-IT</a></li>
<li><a href="/wiki/Alfetamine" title="Alfetamine">Alfetamine</a></li>
<li><a href="/wiki/Amfecloral" title="Amfecloral">Amfecloral</a></li>
<li><a href="/wiki/Amfepentorex" title="Amfepentorex">Amfepentorex</a></li>
<li><a href="/wiki/Amphetamine" title="Amphetamine">Amphetamine</a> (<a href="/wiki/Dextroamphetamine" title="Dextroamphetamine">Dextroamphetamine</a>, <a href="/wiki/Levoamphetamine" title="Levoamphetamine">Levoamphetamine</a>)</li>
<li><a href="/wiki/Amphetaminil" title="Amphetaminil">Amphetaminil</a></li>
<li><a href="/wiki/Benfluorex" title="Benfluorex">Benfluorex</a></li>
<li><a href="/wiki/Benzphetamine" title="Benzphetamine">Benzphetamine</a></li>
<li><a href="/wiki/Cathine" title="Cathine">Cathine</a></li>
<li><a href="/wiki/Clobenzorex" title="Clobenzorex">Clobenzorex</a></li>
<li><a href="/wiki/Dimethylamphetamine" title="Dimethylamphetamine">Dimethylamphetamine</a></li>
<li><a href="/wiki/Ephedrine" title="Ephedrine">Ephedrine</a></li>
<li><a href="/wiki/Etilamfetamine" title="Etilamfetamine">Etilamfetamine</a></li>
<li><a href="/wiki/Fencamfamine" title="Fencamfamine">Fencamfamine</a></li>
<li><a href="/wiki/Fencamine" title="Fencamine">Fencamine</a></li>
<li><a href="/wiki/Fenethylline" title="Fenethylline">Fenethylline</a></li>
<li><a href="/wiki/Fenfluramine" title="Fenfluramine">Fenfluramine</a> (<a href="/wiki/Dexfenfluramine" title="Dexfenfluramine">Dexfenfluramine</a>, <a href="/wiki/Levofenfluramine" title="Levofenfluramine">Levofenfluramine</a>)</li>
<li><a href="/wiki/Fenproporex" title="Fenproporex">Fenproporex</a></li>
<li><a href="/wiki/Fludorex" title="Fludorex">Fludorex</a></li>
<li><a href="/wiki/Furfenorex" title="Furfenorex">Furfenorex</a></li>
<li><a href="/wiki/Gepefrine" title="Gepefrine">Gepefrine</a></li>
<li><a href="/wiki/Hydroxyamphetamine" title="Hydroxyamphetamine">Hydroxyamphetamine</a></li>
<li><a href="/wiki/Iofetamine" title="Iofetamine" class="mw-redirect">Iofetamine</a></li>
<li><a href="/wiki/Isopropylamphetamine" title="Isopropylamphetamine">Isopropylamphetamine</a></li>
<li><a href="/wiki/Lefetamine" title="Lefetamine">Lefetamine</a></li>
<li><a href="/wiki/Lisdexamfetamine" title="Lisdexamfetamine">Lisdexamfetamine</a></li>
<li><a href="/wiki/Mefenorex" title="Mefenorex">Mefenorex</a></li>
<li><a href="/wiki/Metaraminol" title="Metaraminol">Metaraminol</a></li>
<li><a href="/wiki/Methamphetamine" title="Methamphetamine">Methamphetamine</a> (Dextromethamphetamine, <a href="/wiki/Levomethamphetamine" title="Levomethamphetamine">Levomethamphetamine</a>)</li>
<li><a href="/wiki/Methoxyphenamine" title="Methoxyphenamine">Methoxyphenamine</a></li>
<li><a href="/wiki/3-Methoxy-4-methylamphetamine" title="3-Methoxy-4-methylamphetamine">MMA</a></li>
<li><a href="/wiki/Norfenfluramine" title="Norfenfluramine">Norfenfluramine</a></li>
<li><a href="/wiki/L-Norpseudoephedrine" title="L-Norpseudoephedrine"><small>L</small>-Norpseudoephedrine</a></li>
<li><a href="/wiki/Oxilofrine" title="Oxilofrine">Oxilofrine</a></li>
<li><a href="/wiki/Ortetamine" title="Ortetamine">Ortetamine</a></li>
<li><a href="/wiki/Parabromoamphetamine" title="Parabromoamphetamine" class="mw-redirect">PBA</a></li>
<li><a href="/wiki/Parachloroamphetamine" title="Parachloroamphetamine" class="mw-redirect">PCA</a></li>
<li><a href="/wiki/Phenpromethamine" title="Phenpromethamine">Phenpromethamine</a></li>
<li><a href="/wiki/4-Fluoroamphetamine" title="4-Fluoroamphetamine">PFA</a></li>
<li><a href="/wiki/4-Fluoromethamphetamine" title="4-Fluoromethamphetamine">PFMA</a></li>
<li><a href="/wiki/Paraiodoamphetamine" title="Paraiodoamphetamine" class="mw-redirect">PIA</a></li>
<li><a href="/wiki/Para-Methoxyamphetamine" title="Para-Methoxyamphetamine">PMA</a></li>
<li><a href="/wiki/Para-Methoxyethylamphetamine" title="Para-Methoxyethylamphetamine" class="mw-redirect">PMEA</a></li>
<li><a href="/wiki/Paramethoxymethamphetamine" title="Paramethoxymethamphetamine" class="mw-redirect">PMMA</a></li>
<li><a href="/wiki/Phenylpropanolamine" title="Phenylpropanolamine">Phenylpropanolamine</a></li>
<li><a href="/wiki/Pholedrine" title="Pholedrine">Pholedrine</a></li>
<li><a href="/wiki/Prenylamine" title="Prenylamine">Prenylamine</a></li>
<li><a href="/wiki/Propylamphetamine" title="Propylamphetamine">Propylamphetamine</a></li>
<li><a href="/wiki/Pseudoephedrine" title="Pseudoephedrine">Pseudoephedrine</a></li>
<li><a href="/wiki/Sibutramine" title="Sibutramine">Sibutramine</a></li>
<li><a href="/wiki/Tiflorex" title="Tiflorex">Tiflorex</a></li>
<li><a href="/wiki/Tranylcypromine" title="Tranylcypromine">Tranylcypromine</a></li>
<li><a href="/wiki/Xylopropamine" title="Xylopropamine">Xylopropamine</a></li>
<li><a href="/wiki/Zylofuramine" title="Zylofuramine">Zylofuramine</a><br />
<i>Entactogens:</i> <a href="/wiki/5-APB" title="5-APB">5-APB</a></li>
<li><a href="/wiki/5-APDB" title="5-APDB">5-APDB</a></li>
<li><a href="/wiki/5-MAPB" title="5-MAPB">5-MAPB</a></li>
<li><a href="/wiki/6-APB" title="6-APB">6-APB</a></li>
<li><a href="/wiki/6-APDB" title="6-APDB">6-APDB</a></li>
<li><a href="/wiki/6-MAPB" title="6-MAPB">6-MAPB</a></li>
<li><a href="/wiki/Ethylidenedioxyamphetamine" title="Ethylidenedioxyamphetamine" class="mw-redirect">EDA</a></li>
<li><a href="/wiki/Indanylaminopropane" title="Indanylaminopropane" class="mw-redirect">IAP</a></li>
<li><a href="/wiki/Methylenedioxyamphetamine" title="Methylenedioxyamphetamine" class="mw-redirect">MDA</a></li>
<li><a href="/wiki/Methylenedioxyethylamphetamine" title="Methylenedioxyethylamphetamine">MDEA</a></li>
<li><a href="/wiki/Methylenedioxyhydroxylmethamphetamine" title="Methylenedioxyhydroxylmethamphetamine" class="mw-redirect">MDHMA</a></li>
<li><a href="/wiki/Methylenedioxymethamphetamine" title="Methylenedioxymethamphetamine" class="mw-redirect">MDMA</a></li>
<li><a href="/wiki/Methylenedioxyhydroxyamphetamine" title="Methylenedioxyhydroxyamphetamine">MDOH</a></li>
<li><a href="/wiki/Methoxymethylenedioxymethamphetamine" title="Methoxymethylenedioxymethamphetamine" class="mw-redirect">MMDMA</a></li>
<li><a href="/wiki/Naphthylaminopropane" title="Naphthylaminopropane">NAP</a></li>
<li><a href="/wiki/Tetralinylaminopropane" title="Tetralinylaminopropane" class="mw-redirect">TAP</a><br />
<i>Others:</i> <a href="/wiki/Amiflamine" title="Amiflamine">Amiflamine</a></li>
<li><a href="/wiki/Difluoromethylenedioxyamphetamine" title="Difluoromethylenedioxyamphetamine" class="mw-redirect">DFMDA</a></li>
<li><a href="/wiki/Selegiline" title="Selegiline">Selegiline</a> (also <a href="/wiki/D-Deprenyl" title="D-Deprenyl"><small>D</small>-Deprenyl</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Phentermine" title="Phentermine">Phentermines</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><i>Stimulants:</i> <a href="/wiki/Chlorphentermine" title="Chlorphentermine">Chlorphentermine</a></li>
<li><a href="/wiki/Cloforex" title="Cloforex">Cloforex</a></li>
<li><a href="/wiki/Clortermine" title="Clortermine">Clortermine</a></li>
<li><a href="/wiki/Etolorex" title="Etolorex">Etolorex</a></li>
<li><a href="/wiki/Mephentermine" title="Mephentermine">Mephentermine</a></li>
<li><a href="/wiki/Pentorex" title="Pentorex">Pentorex</a></li>
<li><a href="/wiki/Phentermine" title="Phentermine">Phentermine</a><br />
<i>Entactogens:</i> <a href="/wiki/Methylenedioxyphentermine" title="Methylenedioxyphentermine">MDPH</a></li>
<li><a href="/wiki/Methylenedioxymethylphentermine" title="Methylenedioxymethylphentermine" class="mw-redirect">MDMPH</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Substituted_cathinone" title="Substituted cathinone">Cathinones</a></th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><i>Stimulants:</i> <a href="/wiki/Amfepramone" title="Amfepramone">Amfepramone</a></li>
<li><a href="/wiki/Brephedrone" title="Brephedrone" class="mw-redirect">Brephedrone</a></li>
<li><a href="/wiki/Buphedrone" title="Buphedrone">Buphedrone</a></li>
<li><a href="/wiki/Bupropion" title="Bupropion">Bupropion</a></li>
<li><a href="/wiki/Cathinone" title="Cathinone">Cathinone</a></li>
<li><a href="/wiki/Dimethylcathinone" title="Dimethylcathinone" class="mw-redirect">Dimethylcathinone</a></li>
<li><a href="/wiki/Ethcathinone" title="Ethcathinone">Ethcathinone</a></li>
<li><a href="/wiki/Flephedrone" title="Flephedrone">Flephedrone</a></li>
<li><a href="/wiki/Methcathinone" title="Methcathinone">Methcathinone</a></li>
<li><a href="/wiki/Mephedrone" title="Mephedrone">Mephedrone</a></li>
<li><a href="/wiki/Methedrone" title="Methedrone">Methedrone</a><br />
<i>Entactogens:</i> <a href="/wiki/Ethylone" title="Ethylone">Ethylone</a></li>
<li><a href="/wiki/Methylone" title="Methylone">Methylone</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Phenylisobutylamine" title="Phenylisobutylamine">Phenylisobutylamines</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><i>Entactogens:</i> <a href="/wiki/4-Chlorophenylisobutylamine" title="4-Chlorophenylisobutylamine">4-CAB</a></li>
<li><a href="/wiki/4-Methylphenylisobutylamine" title="4-Methylphenylisobutylamine">4-MAB</a></li>
<li><a href="/wiki/Ariadne_(psychedelic)" title="Ariadne (psychedelic)">Ariadne</a></li>
<li><a href="/wiki/Benzodioxolylbutanamine" title="Benzodioxolylbutanamine" class="mw-redirect">BDB</a></li>
<li><a href="/wiki/Butylone" title="Butylone">Butylone</a></li>
<li><a href="/wiki/Ethylbenzodioxolylbutanamine" title="Ethylbenzodioxolylbutanamine" class="mw-redirect">EBDB</a></li>
<li><a href="/wiki/Eutylone" title="Eutylone">Eutylone</a></li>
<li><a href="/wiki/Methylbenzodioxolylbutanamine" title="Methylbenzodioxolylbutanamine" class="mw-redirect">MBDB</a><br />
<i>Stimulants:</i> <a href="/wiki/Phenylisobutylamine" title="Phenylisobutylamine">Phenylisobutylamine</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Phenylethylpyrrolidine" title="Phenylethylpyrrolidine">Phenylalkylpyrrolidines</a></th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><i>Stimulants:</i> <a href="/wiki/Alpha-Pyrrolidinobutiophenone" title="Alpha-Pyrrolidinobutiophenone">a-PBP</a></li>
<li><a href="/wiki/Alpha-Pyrrolidinopropiophenone" title="Alpha-Pyrrolidinopropiophenone">a-PPP</a></li>
<li><a href="/wiki/Alpha-Pyrrolidinopentiophenone" title="Alpha-Pyrrolidinopentiophenone">a-PVP</a></li>
<li><a href="/w/index.php?title=3%27,4%27-Methylenedioxy-a-pyrrolidinobutiophenone&amp;action=edit&amp;redlink=1" class="new" title="3',4'-Methylenedioxy-a-pyrrolidinobutiophenone (page does not exist)">MDPBP</a></li>
<li><a href="/w/index.php?title=3%27,4%27-Methylenedioxy-a-pyrrolidinopropiophenone&amp;action=edit&amp;redlink=1" class="new" title="3',4'-Methylenedioxy-a-pyrrolidinopropiophenone (page does not exist)">MDPPP</a></li>
<li><a href="/wiki/3,4-Methylenedioxypyrovalerone" title="3,4-Methylenedioxypyrovalerone" class="mw-redirect">MDPV</a></li>
<li><a href="/w/index.php?title=4%27-Methoxy-a-pyrrolidinopropiophenone&amp;action=edit&amp;redlink=1" class="new" title="4'-Methoxy-a-pyrrolidinopropiophenone (page does not exist)">MOPPP</a></li>
<li><a href="/w/index.php?title=4%27-Methyl-a-pyrrolidinobutiophenone&amp;action=edit&amp;redlink=1" class="new" title="4'-Methyl-a-pyrrolidinobutiophenone (page does not exist)">MPBP</a></li>
<li><a href="/w/index.php?title=4%27-Methyl-a-pyrrolidinohexiophenone&amp;action=edit&amp;redlink=1" class="new" title="4'-Methyl-a-pyrrolidinohexiophenone (page does not exist)">MPHP</a></li>
<li><a href="/w/index.php?title=4%27-Methyl-a-pyrrolidinopropiophenone&amp;action=edit&amp;redlink=1" class="new" title="4'-Methyl-a-pyrrolidinopropiophenone (page does not exist)">MPPP</a></li>
<li><a href="/wiki/Naphyrone" title="Naphyrone">Naphyrone</a></li>
<li><a href="/wiki/Phenylethylpyrrolidine" title="Phenylethylpyrrolidine">PEP</a></li>
<li><a href="/wiki/Prolintane" title="Prolintane">Prolintane</a></li>
<li><a href="/wiki/Pyrovalerone" title="Pyrovalerone">Pyrovalerone</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Catecholamine" title="Catecholamine">Catecholamines</a><br />
<small>(and close relatives)</small></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/6-Fluoronorepinephrine" title="6-Fluoronorepinephrine">6-FNE</a></li>
<li><a href="/wiki/6-Hydroxydopamine" title="6-Hydroxydopamine" class="mw-redirect">6-OHDA</a></li>
<li><a href="/wiki/Alpha-Methyldopamine" title="Alpha-Methyldopamine">a-Me-DA</a></li>
<li><a href="/wiki/Alpha-Methyltyramine" title="Alpha-Methyltyramine" class="mw-redirect">a-Me-TRA</a></li>
<li><a href="/wiki/Adrenochrome" title="Adrenochrome">Adrenochrome</a></li>
<li><a href="/wiki/Ciladopa" title="Ciladopa">Ciladopa</a></li>
<li><a href="/wiki/D-DOPA" title="D-DOPA"><small>D</small>-DOPA</a> (Dextrodopa)</li>
<li><a href="/wiki/Dimetofrine" title="Dimetofrine">Dimetofrine</a></li>
<li><strong class="selflink">Dopamine</strong></li>
<li><a href="/wiki/Epinephrine" title="Epinephrine">Epinephrine</a></li>
<li><a href="/wiki/Epinine" title="Epinine" class="mw-redirect">Epinine</a></li>
<li><a href="/wiki/Etilefrine" title="Etilefrine">Etilefrine</a></li>
<li><a href="/wiki/Ethylnorepinephrine" title="Ethylnorepinephrine">Ethylnorepinephrine</a></li>
<li><a href="/wiki/Fenclonine" title="Fenclonine">Fenclonine</a></li>
<li><a href="/wiki/Ibopamine" title="Ibopamine">Ibopamine</a></li>
<li><a href="/wiki/Isoprenaline" title="Isoprenaline">Isoprenaline</a></li>
<li><a href="/wiki/Isoetarine" title="Isoetarine">Isoetarine</a></li>
<li><a href="/wiki/L-DOPA" title="L-DOPA"><small>L</small>-DOPA</a> (Levodopa)</li>
<li><a href="/wiki/L-DOPS" title="L-DOPS" class="mw-redirect"><small>L</small>-DOPS</a> (Droxidopa)</li>
<li><a href="/wiki/L-Phenylalanine" title="L-Phenylalanine" class="mw-redirect"><small>L</small>-Phenylalanine</a></li>
<li><a href="/wiki/L-Tyrosine" title="L-Tyrosine" class="mw-redirect"><small>L</small>-Tyrosine</a></li>
<li><a href="/wiki/Meta-Tyramine" title="Meta-Tyramine"><i>m</i>-Tyramine</a></li>
<li><a href="/wiki/Metanephrine" title="Metanephrine">Metanephrine</a></li>
<li><a href="/wiki/Metaraminol" title="Metaraminol">Metaraminol</a></li>
<li><a href="/wiki/Metaterol" title="Metaterol">Metaterol</a></li>
<li><a href="/wiki/Metirosine" title="Metirosine">Metirosine</a></li>
<li><a href="/wiki/Methyldopa" title="Methyldopa">Methyldopa</a></li>
<li><a href="/wiki/N,N-Dimethyldopamine" title="N,N-Dimethyldopamine">N,N-Dimethyldopamine</a></li>
<li><a href="/wiki/Nordefrin" title="Nordefrin" class="mw-redirect">Nordefrin</a> (<a href="/wiki/Levonordefrin" title="Levonordefrin">Levonordefrin</a>)</li>
<li><a href="/wiki/Norepinephrine" title="Norepinephrine">Norepinephrine</a></li>
<li><a href="/wiki/Norfenefrine" title="Norfenefrine">Norfenefrine</a> (<i>m</i>-Octopamine)</li>
<li><a href="/wiki/Normetanephrine" title="Normetanephrine">Normetanephrine</a></li>
<li><a href="/wiki/Orciprenaline" title="Orciprenaline">Orciprenaline</a></li>
<li><a href="/wiki/Octopamine" title="Octopamine"><i>p</i>-Octopamine</a></li>
<li><a href="/wiki/Tyramine" title="Tyramine"><i>p</i>-Tyramine</a></li>
<li><a href="/wiki/Phenylephrine" title="Phenylephrine">Phenylephrine</a></li>
<li><a href="/wiki/Synephrine" title="Synephrine">Synephrine</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Miscellaneous</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Amidephrine" title="Amidephrine">Amidephrine</a></li>
<li><a href="/wiki/Arbutamine" title="Arbutamine">Arbutamine</a></li>
<li><a href="/wiki/Cafedrine" title="Cafedrine">Cafedrine</a></li>
<li><a href="/wiki/Denopamine" title="Denopamine">Denopamine</a></li>
<li><a href="/wiki/Dobutamine" title="Dobutamine">Dobutamine</a></li>
<li><a href="/wiki/Dopexamine" title="Dopexamine">Dopexamine</a></li>
<li><a href="/wiki/Etafedrine" title="Etafedrine">Etafedrine</a></li>
<li><a href="/wiki/Famprofazone" title="Famprofazone">Famprofazone</a></li>
<li><a href="/wiki/Hexapradol" title="Hexapradol">Hexapradol</a></li>
<li><a href="/wiki/Methoxamine" title="Methoxamine">Methoxamine</a></li>
<li><a href="/wiki/Pronethalol" title="Pronethalol">Pronethalol</a></li>
<li><a href="/wiki/Salbutamol" title="Salbutamol">Salbutamol</a> (<a href="/wiki/Levosalbutamol" title="Levosalbutamol">Levosalbutamol</a>)</li>
<li><a href="/wiki/Theodrenaline" title="Theodrenaline">Theodrenaline</a></li>
<li><a href="/wiki/UWA-101" title="UWA-101">UWA-101</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
<table cellspacing="0" class="navbox" style="border-spacing:0;">
<tr>
<td style="padding:2px;">
<table cellspacing="0" class="nowraplinks hlist collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit;">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:TAAR_ligands" title="Template:TAAR ligands"><span title="View this template" style=";;background:none transparent;border:none;;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:TAAR_ligands" title="Template talk:TAAR ligands"><span title="Discuss this template" style=";;background:none transparent;border:none;;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:TAAR_ligands&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%;"><a href="/wiki/Trace_amine-associated_receptor" title="Trace amine-associated receptor">Trace amine-associated receptor</a> (human TAAR) <a href="/wiki/Ligand" title="Ligand">ligands</a></div>
</th>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/TAAR1" title="TAAR1">TAAR1</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="row" class="navbox-group" style="width:6em;">
<center><a href="/wiki/Agonist" title="Agonist">Agonists</a><sup>†</sup></center>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Amphetamine" title="Amphetamine">Amphetamine</a></li>
<li><a href="/wiki/N,N-Dimethyltryptamine" title="N,N-Dimethyltryptamine" class="mw-redirect">DMT</a></li>
<li><strong class="selflink">Dopamine</strong></li>
<li><a href="/wiki/2-Fluoroamphetamine" title="2-Fluoroamphetamine">2-Fluoroamphetamine</a></li>
<li><a href="/wiki/3-Iodothyronamine" title="3-Iodothyronamine">3-Iodothyronamine</a></li>
<li><a href="/wiki/Lysergic_acid_diethylamide" title="Lysergic acid diethylamide">LSD</a></li>
<li><a href="/wiki/3,4-Methylenedioxy-N-methylamphetamine" title="3,4-Methylenedioxy-N-methylamphetamine" class="mw-redirect">MDMA</a></li>
<li><a href="/wiki/Methamphetamine" title="Methamphetamine">Methamphetamine</a></li>
<li><a href="/wiki/3-Methoxytyramine" title="3-Methoxytyramine">3-Methoxytyramine</a></li>
<li><a href="/wiki/N-Methylphenethylamine" title="N-Methylphenethylamine"><i>N</i>-Methylphenethylamine</a></li>
<li><a href="/wiki/N-Methyltryptamine" title="N-Methyltryptamine"><i>N</i>-Methyltryptamine</a></li>
<li><a href="/wiki/N-Methyltyramine" title="N-Methyltyramine"><i>N</i>-Methyltyramine</a></li>
<li><a href="/wiki/Norepinephrine" title="Norepinephrine">Norepinephrine</a></li>
<li><a href="/wiki/Meta-Octopamine" title="Meta-Octopamine" class="mw-redirect"><i>m</i>-Octopamine</a></li>
<li><a href="/wiki/Para-Octopamine" title="Para-Octopamine" class="mw-redirect"><i>p</i>-Octopamine</a></li>
<li><a href="/wiki/Phenethylamine" title="Phenethylamine">Phenethylamine</a></li>
<li><a href="/wiki/Phentermine" title="Phentermine">Phentermine</a></li>
<li><a href="/wiki/O-Phenyl-3-iodotyramine" title="O-Phenyl-3-iodotyramine">O-Phenyl-3-iodotyramine</a></li>
<li><a href="/wiki/Propylhexedrine" title="Propylhexedrine">Propylhexedrine</a></li>
<li><a href="/wiki/RO5166017" title="RO5166017">RO5166017</a></li>
<li><a href="/wiki/Serotonin" title="Serotonin">Serotonin</a></li>
<li><a href="/wiki/Synephrine" title="Synephrine">Synephrine</a></li>
<li><a href="/wiki/Tryptamine" title="Tryptamine">Tryptamine</a></li>
<li><a href="/wiki/Meta-Tyramine" title="Meta-Tyramine"><i>m</i>-Tyramine</a></li>
<li><a href="/wiki/Para-Tyramine" title="Para-Tyramine" class="mw-redirect"><i>p</i>-Tyramine</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="width:6em;">
<center><a href="/wiki/Receptor_antagonist" title="Receptor antagonist">Antagonists</a></center>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/EPPTB" title="EPPTB">EPPTB</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/TAAR2" title="TAAR2">TAAR2</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="row" class="navbox-group" style="width:6em;">
<center><b>Agonists</b></center>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/3-Iodothyronamine" title="3-Iodothyronamine">3-Iodothyronamine</a></li>
<li><a href="/wiki/Phenethylamine" title="Phenethylamine">Phenethylamine</a></li>
<li><a href="/wiki/Tyramine" title="Tyramine">Tyramine</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="width:6em;">
<center><b>Antagonists</b></center>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li>&#160;</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/TAAR5" title="TAAR5">TAAR5</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="row" class="navbox-group" style="width:6em;">
<center><b>Agonists</b></center>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/w/index.php?title=Dimethylethylamine&amp;action=edit&amp;redlink=1" class="new" title="Dimethylethylamine (page does not exist)">Dimethylethylamine</a></li>
<li><a href="/wiki/Trimethylamine" title="Trimethylamine">Trimethylamine</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="width:6em;">
<center><b>Antagonists</b></center>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li>&#160;</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2">
<div>
<ul>
<li><sup>†</sup>Other <a href="/wiki/Phenethylamine" title="Phenethylamine">phenethylamines</a>, <a href="/wiki/Tryptamine" title="Tryptamine">tryptamines</a>, <a href="/wiki/Ergoline" title="Ergoline">ergolines</a>, and <a href="/wiki/Thyronamine" title="Thyronamine">thyronamines</a> are either known to or are likely to be TAAR1 agonists as well.</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>


<!-- 
NewPP limit report
Parsed by mw1051
CPU time usage: 7.748 seconds
Real time usage: 7.988 seconds
Preprocessor visited node count: 13273/1000000
Preprocessor generated node count: 58876/1500000
Post‐expand include size: 540555/2048000 bytes
Template argument size: 55801/2048000 bytes
Highest expansion depth: 17/40
Expensive parser function count: 11/500
Lua time usage: 0.473/10.000 seconds
Lua memory usage: 3.17 MB/50 MB
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:48548-0!*!0!!en!4!* and timestamp 20140330015937
 -->
<noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript></div>								<div class="printfooter">
				Retrieved from "<a href="http://en.wikipedia.org/w/index.php?title=Dopamine&amp;oldid=599801436">http://en.wikipedia.org/w/index.php?title=Dopamine&amp;oldid=599801436</a>"				</div>
												<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:Catecholamines" title="Category:Catecholamines">Catecholamines</a></li><li><a href="/wiki/Category:Hormones_of_the_hypothalamus" title="Category:Hormones of the hypothalamus">Hormones of the hypothalamus</a></li><li><a href="/wiki/Category:Inotropic_agents" title="Category:Inotropic agents">Inotropic agents</a></li><li><a href="/wiki/Category:Motivation" title="Category:Motivation">Motivation</a></li><li><a href="/wiki/Category:Neurotransmitters" title="Category:Neurotransmitters">Neurotransmitters</a></li><li><a href="/wiki/Category:World_Health_Organization_essential_medicines" title="Category:World Health Organization essential medicines">World Health Organization essential medicines</a></li><li><a href="/wiki/Category:TAAR1_agonists" title="Category:TAAR1 agonists">TAAR1 agonists</a></li></ul></div><div id="mw-hidden-catlinks" class="mw-hidden-catlinks mw-hidden-cats-hidden">Hidden categories: <ul><li><a href="/wiki/Category:Use_dmy_dates_from_February_2014" title="Category:Use dmy dates from February 2014">Use dmy dates from February 2014</a></li><li><a href="/wiki/Category:All_articles_with_unsourced_statements" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_June_2011" title="Category:Articles with unsourced statements from June 2011">Articles with unsourced statements from June 2011</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_November_2013" title="Category:Articles with unsourced statements from November 2013">Articles with unsourced statements from November 2013</a></li></ul></div></div>												<div class="visualClear"></div>
							</div>
		</div>
		<div id="mw-navigation">
			<h2>Navigation menu</h2>
			<div id="mw-head">
				<div id="p-personal" role="navigation" class="" aria-labelledby="p-personal-label">
	<h3 id="p-personal-label">Personal tools</h3>
	<ul>
<li id="pt-createaccount"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Dopamine&amp;type=signup">Create account</a></li><li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Dopamine" title="You're encouraged to log in; however, it's not mandatory. [o]" accesskey="o">Log in</a></li>	</ul>
</div>
				<div id="left-navigation">
					<div id="p-namespaces" role="navigation" class="vectorTabs" aria-labelledby="p-namespaces-label">
	<h3 id="p-namespaces-label">Namespaces</h3>
	<ul>
					<li  id="ca-nstab-main" class="selected"><span><a href="/wiki/Dopamine"  title="View the content page [c]" accesskey="c">Article</a></span></li>
					<li  id="ca-talk"><span><a href="/wiki/Talk:Dopamine"  title="Discussion about the content page [t]" accesskey="t">Talk</a></span></li>
			</ul>
</div>
<div id="p-variants" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-variants-label">
	<h3 id="mw-vector-current-variant">
		</h3>
	<h3 id="p-variants-label"><span>Variants</span><a href="#"></a></h3>
	<div class="menu">
		<ul>
					</ul>
	</div>
</div>
				</div>
				<div id="right-navigation">
					<div id="p-views" role="navigation" class="vectorTabs" aria-labelledby="p-views-label">
	<h3 id="p-views-label">Views</h3>
	<ul>
					<li id="ca-view" class="selected"><span><a href="/wiki/Dopamine" >Read</a></span></li>
					<li id="ca-edit"><span><a href="/w/index.php?title=Dopamine&amp;action=edit"  title="You can edit this page. &#10;Please review your changes before saving. [e]" accesskey="e">Edit</a></span></li>
					<li id="ca-history" class="collapsible"><span><a href="/w/index.php?title=Dopamine&amp;action=history"  title="Past versions of this page [h]" accesskey="h">View history</a></span></li>
			</ul>
</div>
<div id="p-cactions" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-cactions-label">
	<h3 id="p-cactions-label"><span>Actions</span><a href="#"></a></h3>
	<div class="menu">
		<ul>
					</ul>
	</div>
</div>
<div id="p-search" role="search">
	<h3><label for="searchInput">Search</label></h3>
	<form action="/w/index.php" id="searchform">
					<div id="simpleSearch">
					<input type="search" name="search" placeholder="Search" title="Search Wikipedia [f]" accesskey="f" id="searchInput" /><input type="hidden" value="Special:Search" name="title" /><input type="submit" name="fulltext" value="Search" title="Search Wikipedia for this text" id="mw-searchButton" class="searchButton mw-fallbackSearchButton" /><input type="submit" name="go" value="Go" title="Go to a page with this exact name if one exists" id="searchButton" class="searchButton" />		</div>
	</form>
</div>
				</div>
			</div>
			<div id="mw-panel">
					<div id="p-logo" role="banner"><a style="background-image: url(//upload.wikimedia.org/wikipedia/en/b/bc/Wiki.png);" href="/wiki/Main_Page"  title="Visit the main page"></a></div>
				<div class="portal" role="navigation" id='p-navigation' aria-labelledby='p-navigation-label'>
	<h3 id='p-navigation-label'>Navigation</h3>
	<div class="body">
		<ul>
			<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li>
			<li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li>
			<li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content – the best of Wikipedia">Featured content</a></li>
			<li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li>
			<li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li>
			<li id="n-sitesupport"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en" title="Support us">Donate to Wikipedia</a></li>
			<li id="n-shoplink"><a href="//shop.wikimedia.org" title="Visit the Wikimedia Shop">Wikimedia Shop</a></li>
		</ul>
	</div>
</div>
<div class="portal" role="navigation" id='p-interaction' aria-labelledby='p-interaction-label'>
	<h3 id='p-interaction-label'>Interaction</h3>
	<div class="body">
		<ul>
			<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li>
			<li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li>
			<li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li>
			<li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="A list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li>
			<li id="n-contactpage"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact page</a></li>
		</ul>
	</div>
</div>
<div class="portal" role="navigation" id='p-tb' aria-labelledby='p-tb-label'>
	<h3 id='p-tb-label'>Tools</h3>
	<div class="body">
		<ul>
			<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Dopamine" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li>
			<li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Dopamine" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li>
			<li id="t-upload"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u">Upload file</a></li>
			<li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q">Special pages</a></li>
			<li id="t-permalink"><a href="/w/index.php?title=Dopamine&amp;oldid=599801436" title="Permanent link to this revision of the page">Permanent link</a></li>
			<li id="t-info"><a href="/w/index.php?title=Dopamine&amp;action=info">Page information</a></li>
			<li id="t-wikibase"><a href="//www.wikidata.org/wiki/Q170304" title="Link to connected data repository item [g]" accesskey="g">Data item</a></li>
<li id="t-cite"><a href="/w/index.php?title=Special:Cite&amp;page=Dopamine&amp;id=599801436" title="Information on how to cite this page">Cite this page</a></li>		</ul>
	</div>
</div>
<div class="portal" role="navigation" id='p-coll-print_export' aria-labelledby='p-coll-print_export-label'>
	<h3 id='p-coll-print_export-label'>Print/export</h3>
	<div class="body">
		<ul>
			<li id="coll-create_a_book"><a href="/w/index.php?title=Special:Book&amp;bookcmd=book_creator&amp;referer=Dopamine">Create a book</a></li>
			<li id="coll-download-as-rl"><a href="/w/index.php?title=Special:Book&amp;bookcmd=render_article&amp;arttitle=Dopamine&amp;oldid=599801436&amp;writer=rl">Download as PDF</a></li>
			<li id="t-print"><a href="/w/index.php?title=Dopamine&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>
		</ul>
	</div>
</div>
<div class="portal" role="navigation" id='p-lang' aria-labelledby='p-lang-label'>
	<h3 id='p-lang-label'>Languages</h3>
	<div class="body">
		<ul>
			<li class="interlanguage-link interwiki-ar"><a href="//ar.wikipedia.org/wiki/%D8%AF%D9%88%D8%A8%D8%A7%D9%85%D9%8A%D9%86" title="دوبامين – Arabic" lang="ar" hreflang="ar">العربية</a></li>
			<li class="interlanguage-link interwiki-az"><a href="//az.wikipedia.org/wiki/Dopamin" title="Dopamin – Azerbaijani" lang="az" hreflang="az">Azərbaycanca</a></li>
			<li class="interlanguage-link interwiki-be"><a href="//be.wikipedia.org/wiki/%D0%94%D0%B0%D1%84%D0%B0%D0%BC%D1%96%D0%BD" title="Дафамін – Belarusian" lang="be" hreflang="be">Беларуская</a></li>
			<li class="interlanguage-link interwiki-be-x-old"><a href="//be-x-old.wikipedia.org/wiki/%D0%94%D0%B0%D1%84%D0%B0%D0%BC%D1%96%D0%BD" title="Дафамін – беларуская (тарашкевіца)‎" lang="be-x-old" hreflang="be-x-old">Беларуская (тарашкевіца)‎</a></li>
			<li class="interlanguage-link interwiki-bg"><a href="//bg.wikipedia.org/wiki/%D0%94%D0%BE%D0%BF%D0%B0%D0%BC%D0%B8%D0%BD" title="Допамин – Bulgarian" lang="bg" hreflang="bg">Български</a></li>
			<li class="interlanguage-link interwiki-ca"><a href="//ca.wikipedia.org/wiki/Dopamina" title="Dopamina – Catalan" lang="ca" hreflang="ca">Català</a></li>
			<li class="interlanguage-link interwiki-cs"><a href="//cs.wikipedia.org/wiki/Dopamin" title="Dopamin – Czech" lang="cs" hreflang="cs">Čeština</a></li>
			<li class="interlanguage-link interwiki-da"><a href="//da.wikipedia.org/wiki/Dopamin" title="Dopamin – Danish" lang="da" hreflang="da">Dansk</a></li>
			<li class="interlanguage-link interwiki-de"><a href="//de.wikipedia.org/wiki/Dopamin" title="Dopamin – German" lang="de" hreflang="de">Deutsch</a></li>
			<li class="interlanguage-link interwiki-dv"><a href="//dv.wikipedia.org/wiki/%DE%91%DE%AF%DE%95%DE%A6%DE%89%DE%A9%DE%82%DE%B0" title="ޑޯޕަމީން – Divehi" lang="dv" hreflang="dv">ދިވެހިބަސް</a></li>
			<li class="interlanguage-link interwiki-et"><a href="//et.wikipedia.org/wiki/Dopamiin" title="Dopamiin – Estonian" lang="et" hreflang="et">Eesti</a></li>
			<li class="interlanguage-link interwiki-el"><a href="//el.wikipedia.org/wiki/%CE%9D%CF%84%CE%BF%CF%80%CE%B1%CE%BC%CE%AF%CE%BD%CE%B7" title="Ντοπαμίνη – Greek" lang="el" hreflang="el">Ελληνικά</a></li>
			<li class="interlanguage-link interwiki-es"><a href="//es.wikipedia.org/wiki/Dopamina" title="Dopamina – Spanish" lang="es" hreflang="es">Español</a></li>
			<li class="interlanguage-link interwiki-eo"><a href="//eo.wikipedia.org/wiki/Dopamino" title="Dopamino – Esperanto" lang="eo" hreflang="eo">Esperanto</a></li>
			<li class="interlanguage-link interwiki-eu"><a href="//eu.wikipedia.org/wiki/Dopamina" title="Dopamina – Basque" lang="eu" hreflang="eu">Euskara</a></li>
			<li class="interlanguage-link interwiki-fa"><a href="//fa.wikipedia.org/wiki/%D8%AF%D9%88%D9%BE%D8%A7%D9%85%DB%8C%D9%86" title="دوپامین – Persian" lang="fa" hreflang="fa">فارسی</a></li>
			<li class="interlanguage-link interwiki-fr"><a href="//fr.wikipedia.org/wiki/Dopamine" title="Dopamine – French" lang="fr" hreflang="fr">Français</a></li>
			<li class="interlanguage-link interwiki-ga"><a href="//ga.wikipedia.org/wiki/Dopaim%C3%ADn" title="Dopaimín – Irish" lang="ga" hreflang="ga">Gaeilge</a></li>
			<li class="interlanguage-link interwiki-gl"><a href="//gl.wikipedia.org/wiki/Dopamina" title="Dopamina – Galician" lang="gl" hreflang="gl">Galego</a></li>
			<li class="interlanguage-link interwiki-ko"><a href="//ko.wikipedia.org/wiki/%EB%8F%84%ED%8C%8C%EB%AF%BC" title="도파민 – Korean" lang="ko" hreflang="ko">한국어</a></li>
			<li class="interlanguage-link interwiki-hr"><a href="//hr.wikipedia.org/wiki/Dopamin" title="Dopamin – Croatian" lang="hr" hreflang="hr">Hrvatski</a></li>
			<li class="interlanguage-link interwiki-id"><a href="//id.wikipedia.org/wiki/Dopamin" title="Dopamin – Indonesian" lang="id" hreflang="id">Bahasa Indonesia</a></li>
			<li class="interlanguage-link interwiki-is"><a href="//is.wikipedia.org/wiki/D%C3%B3pam%C3%ADn" title="Dópamín – Icelandic" lang="is" hreflang="is">Íslenska</a></li>
			<li class="interlanguage-link interwiki-it"><a href="//it.wikipedia.org/wiki/Dopamina" title="Dopamina – Italian" lang="it" hreflang="it">Italiano</a></li>
			<li class="interlanguage-link interwiki-he"><a href="//he.wikipedia.org/wiki/%D7%93%D7%95%D7%A4%D7%9E%D7%99%D7%9F" title="דופמין – Hebrew" lang="he" hreflang="he">עברית</a></li>
			<li class="interlanguage-link interwiki-lv"><a href="//lv.wikipedia.org/wiki/Dofam%C4%ABns" title="Dofamīns – Latvian" lang="lv" hreflang="lv">Latviešu</a></li>
			<li class="interlanguage-link interwiki-lt"><a href="//lt.wikipedia.org/wiki/Dopaminas" title="Dopaminas – Lithuanian" lang="lt" hreflang="lt">Lietuvių</a></li>
			<li class="interlanguage-link interwiki-hu"><a href="//hu.wikipedia.org/wiki/Dopamin" title="Dopamin – Hungarian" lang="hu" hreflang="hu">Magyar</a></li>
			<li class="interlanguage-link interwiki-mk"><a href="//mk.wikipedia.org/wiki/%D0%94%D0%BE%D0%BF%D0%B0%D0%BC%D0%B8%D0%BD" title="Допамин – Macedonian" lang="mk" hreflang="mk">Македонски</a></li>
			<li class="interlanguage-link interwiki-nl"><a href="//nl.wikipedia.org/wiki/Dopamine" title="Dopamine – Dutch" lang="nl" hreflang="nl">Nederlands</a></li>
			<li class="interlanguage-link interwiki-ja"><a href="//ja.wikipedia.org/wiki/%E3%83%89%E3%83%BC%E3%83%91%E3%83%9F%E3%83%B3" title="ドーパミン – Japanese" lang="ja" hreflang="ja">日本語</a></li>
			<li class="interlanguage-link interwiki-no"><a href="//no.wikipedia.org/wiki/Dopamin" title="Dopamin – Norwegian (bokmål)" lang="no" hreflang="no">Norsk bokmål</a></li>
			<li class="interlanguage-link interwiki-pl"><a href="//pl.wikipedia.org/wiki/Dopamina" title="Dopamina – Polish" lang="pl" hreflang="pl">Polski</a></li>
			<li class="interlanguage-link interwiki-pt"><a href="//pt.wikipedia.org/wiki/Dopamina" title="Dopamina – Portuguese" lang="pt" hreflang="pt">Português</a></li>
			<li class="interlanguage-link interwiki-ro"><a href="//ro.wikipedia.org/wiki/Dopamin%C4%83" title="Dopamină – Romanian" lang="ro" hreflang="ro">Română</a></li>
			<li class="interlanguage-link interwiki-ru"><a href="//ru.wikipedia.org/wiki/%D0%94%D0%BE%D1%84%D0%B0%D0%BC%D0%B8%D0%BD" title="Дофамин – Russian" lang="ru" hreflang="ru">Русский</a></li>
			<li class="interlanguage-link interwiki-simple"><a href="//simple.wikipedia.org/wiki/Dopamine" title="Dopamine – Simple English" lang="simple" hreflang="simple">Simple English</a></li>
			<li class="interlanguage-link interwiki-sk"><a href="//sk.wikipedia.org/wiki/Dopam%C3%ADn" title="Dopamín – Slovak" lang="sk" hreflang="sk">Slovenčina</a></li>
			<li class="interlanguage-link interwiki-sl"><a href="//sl.wikipedia.org/wiki/Dopamin" title="Dopamin – Slovenian" lang="sl" hreflang="sl">Slovenščina</a></li>
			<li class="interlanguage-link interwiki-sr"><a href="//sr.wikipedia.org/wiki/%D0%94%D0%BE%D0%BF%D0%B0%D0%BC%D0%B8%D0%BD" title="Допамин – Serbian" lang="sr" hreflang="sr">Српски / srpski</a></li>
			<li class="interlanguage-link interwiki-sh"><a href="//sh.wikipedia.org/wiki/Dopamin" title="Dopamin – Serbo-Croatian" lang="sh" hreflang="sh">Srpskohrvatski / српскохрватски</a></li>
			<li class="interlanguage-link interwiki-su"><a href="//su.wikipedia.org/wiki/Dopamin" title="Dopamin – Sundanese" lang="su" hreflang="su">Basa Sunda</a></li>
			<li class="interlanguage-link interwiki-fi"><a href="//fi.wikipedia.org/wiki/Dopamiini" title="Dopamiini – Finnish" lang="fi" hreflang="fi">Suomi</a></li>
			<li class="interlanguage-link interwiki-sv"><a href="//sv.wikipedia.org/wiki/Dopamin" title="Dopamin – Swedish" lang="sv" hreflang="sv">Svenska</a></li>
			<li class="interlanguage-link interwiki-th"><a href="//th.wikipedia.org/wiki/%E0%B9%82%E0%B8%94%E0%B8%9E%E0%B8%B2%E0%B8%A1%E0%B8%B5%E0%B8%99" title="โดพามีน – Thai" lang="th" hreflang="th">ไทย</a></li>
			<li class="interlanguage-link interwiki-tr"><a href="//tr.wikipedia.org/wiki/Dopamin" title="Dopamin – Turkish" lang="tr" hreflang="tr">Türkçe</a></li>
			<li class="interlanguage-link interwiki-uk"><a href="//uk.wikipedia.org/wiki/%D0%94%D0%BE%D1%84%D0%B0%D0%BC%D1%96%D0%BD" title="Дофамін – Ukrainian" lang="uk" hreflang="uk">Українська</a></li>
			<li class="interlanguage-link interwiki-ur"><a href="//ur.wikipedia.org/wiki/Dopamine" title="Dopamine – Urdu" lang="ur" hreflang="ur">اردو</a></li>
			<li class="interlanguage-link interwiki-zh"><a href="//zh.wikipedia.org/wiki/%E5%A4%9A%E5%B7%B4%E8%83%BA" title="多巴胺 – Chinese" lang="zh" hreflang="zh">中文</a></li>
			<li class="uls-p-lang-dummy"><a href="#"></a></li>
			<li class="wbc-editpage"><a href="//www.wikidata.org/wiki/Q170304#sitelinks-wikipedia" title="Edit interlanguage links">Edit links</a></li>
		</ul>
	</div>
</div>
			</div>
		</div>
		<div id="footer" role="contentinfo">
							<ul id="footer-info">
											<li id="footer-info-lastmod"> This page was last modified on 16 March 2014 at 01:22.<br /></li>
											<li id="footer-info-copyright">Text is available under the <a rel="license" href="//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License">Creative Commons Attribution-ShareAlike License</a><a rel="license" href="//creativecommons.org/licenses/by-sa/3.0/" style="display:none;"></a>;
additional terms may apply.  By using this site, you agree to the <a href="//wikimediafoundation.org/wiki/Terms_of_Use">Terms of Use</a> and <a href="//wikimediafoundation.org/wiki/Privacy_policy">Privacy Policy.</a> <br/>
Wikipedia® is a registered trademark of the <a href="//www.wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>
									</ul>
							<ul id="footer-places">
											<li id="footer-places-privacy"><a href="//wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
											<li id="footer-places-about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
											<li id="footer-places-disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
											<li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li>
											<li id="footer-places-developers"><a class="external" href="https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute">Developers</a></li>
											<li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/wiki/Dopamine" class="noprint stopMobileRedirectToggle">Mobile view</a></li>
									</ul>
										<ul id="footer-icons" class="noprint">
					<li id="footer-copyrightico">
						<a href="//wikimediafoundation.org/"><img src="//bits.wikimedia.org/images/wikimedia-button.png" width="88" height="31" alt="Wikimedia Foundation"/></a>
					</li>
					<li id="footer-poweredbyico">
						<a href="//www.mediawiki.org/"><img src="//bits.wikimedia.org/static-1.23wmf19/skins/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" width="88" height="31" /></a>
					</li>
				</ul>
						<div style="clear:both"></div>
		</div>
		<script>/*<![CDATA[*/window.jQuery && jQuery.ready();/*]]>*/</script><script>if(window.mw){
mw.loader.state({"site":"loading","user":"ready","user.groups":"ready"});
}</script>
<script>if(window.mw){
mw.loader.load(["ext.cite","mobile.desktop","mediawiki.action.view.postEdit","mediawiki.user","mediawiki.hidpi","mediawiki.page.ready","mediawiki.searchSuggest","ext.gadget.teahouse","ext.gadget.ReferenceTooltips","ext.gadget.DRN-wizard","ext.gadget.charinsert","mw.MwEmbedSupport.style","ext.navigationTiming","schema.UniversalLanguageSelector","ext.uls.eventlogger","ext.uls.interlanguage","skins.vector.collapsibleNav"],null,true);
}</script>
<script src="//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&amp;lang=en&amp;modules=site&amp;only=scripts&amp;skin=vector&amp;*"></script>
<!-- Served by mw1181 in 0.394 secs. -->
	</body>
</html>
